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“Mr President and Gentlemen – 
 - What I propose studying is the medium by which the pathogenic material 
of yellow fever is carried from the bodies of the infected to be implanted in the 
bodies of the non-infected.”  
On August 14, 1881, this is how Dr. Carlos Juan Finley introduced his 
hypothesis to the Royal Academy of Sciences in Havana. At that time, Yellow 
fever virus (YFV) transmission was thought to occur through the air or via 
physical contact. With a series of keen observations and a rather barbaric 
experiment, Finley was the first to describe that mosquitoes are responsible for 
the transmission of YFV (1). Numerous species of mosquitoes and other 
haematophagous arthropods like ticks, sand flies and midges are now widely 
implicated in the transmission of pathogenic agents from protozoan, bacterial, 
nematode and viral origin. Arthropod-borne viruses (arboviruses) are the 
causative agents of many diseases in humans, animals and plants. Arboviruses 
have RNA genomes and belong to the families Togaviridae, Flaviviridae, 
Bunyaviridae, Reoviridae, Rhabdoviridae, or Orthomyxoviridae, with the 
exception of the dsDNA virus African swine fever virus (2). Arboviruses actively 
replicate in vertebrate as well as in invertebrate hosts. Most arboviruses infect 
wild animals and ‘spillover’ from their enzootic cycle occurs incidentally when 
an infected invertebrate feeds on humans. Some arboviruses, however, have 
developed urban transmission 
cycles, in which humans have 
become the main amplifying 
hosts (Figure 1.1). In humans, 
arbovirus infections often 
cause febrile illness, the more 
severe infections can result in 
arthritogenic, encephalitic or 
haemorrhagic disease and 
sometimes death (3–5). YVF 
still infects thousands of 
people each year, with a case 
fatality rate of 20% to 50% (6). 
In addition, Japanese 
encephalitis virus (JEV) causes 
encephalitic disease in over 
50,000 people resulting in 
15,000 deaths annually (7). 
Dengue virus (DENV) infects 
50 to 100 million people each 
year, with 250 to 500 thousand 
Enzootic Urban 
Figure 1.1. Arbovirus transmission cycles. Left, 
enzootic arbovirus transmission (e.g. WNV). In this 
example, the virus cycles between mosquitoes and avian 
amplifying hosts, with incidental infections in humans 
and horses. Right, urban arbovirus transmission (e.g. 
CHIKV). The virus is transmitted to humans by urban 
mosquitoes. The infected individual develops viral titres 
which are sufficient to infect blood feeding mosquitoes.
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suffering from potentially lethal haemorrhagic disease (8). Outbreaks of 
arboviral disease continue to emerge as global travel and trade constantly 
relocates arboviruses and their vectors. Two highly pathogenic arboviruses, 
West Nile virus (WNV) and chikungunya virus (CHIKV), recently (re-)emerged 
in both Europe and the Americas, resulting in large-scale epidemics of severe 
encephalitic and arthritogenic disease, respectively. 
WNV and CHIKV are unrelated viruses and belong to two distinct 
viral families. Moreover, WNV exists in an enzootic transmission cycle and is 
transmitted by numerous mosquito species from the Culex genus (9). It is unclear 
whether Culex mosquito populations from WNV-free areas can transmit WNV, 
although this information is imperative to assess the risk levels for outbreaks 
of WNV disease. The urban transmission cycle of CHIKV is maintained by 
two Aedes mosquito species (Figure 1.1). However, the molecular interactions 
that determine effective viral replication throughout the mosquito vector are 
poorly characterized. Currently there are no licensed vaccines or antiviral 
drugs available for human use against either WNV or CHIKV. Understanding 
the strategies that WNV and CHIKV employ to counteract cellular antiviral 
responses will contribute towards the development of safe and efficacious 
pharmaceuticals. 
This thesis describes how effectively potential mosquito vectors transmit 
the flaviviruses WNV and Usutu virus (USUV) and provides novel insights on 
the underlying molecular mechanisms that enable the togavirus CHIKV to 
accomplish successful infections in both the mosquito and human hosts. 
West Nile Virus
WNV is a flavivirus from the family Flaviviridae. The Flavivirus genus 
contains many tick and mosquito-borne viruses, including: YFV, DENV, and 
JEV. Flaviviruses are spherical enveloped viruses with a single stranded, positive 
sense RNA genome (ss(+)RNA) that contains a single open reading frame 
(ORF), flanked by 5’ and 3’ untranslated regions (UTR). In the infected cell, the 
ORF is translated into a single polyprotein that is further processed by viral and 
cellular proteases into both the viral structural and non-structural proteins 
(Figure 1.2, top). The 5’- and 3’-UTRs are highly structured and crucial for viral 
replication (10). WNV is transmitted mainly by Culex species mosquitoes and 
maintained in an enzootic cycle between the vector and susceptible bird species 
(11–14). Humans and horses are incidentally infected and considered dead-end 
hosts, as they generally do not develop sufficiently high viral titres to infect the 
next mosquito vector (Figure 1.1, left). Infection in humans is associated with 
febrile illness, which  may develop into meningitis, encephalitis, myelitis and 
death (15). WNV was first isolated in 1937, Uganda, and a number of lineages 
have been described since, from which strains belonging to lineage 1 and 2 
WNV have caused severe pathogenesis in humans (16). 
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Figure 1.2. Viral particles and genome arrangement. Flavivirus (top) and alphavirus 
(bottom). Left, typical flavivirus and alphavirus virions. Right, schematic representation of the 
viral genomes and polyprotein(s). Images of virus particles courtesy of Jean-Yves Sgro. 
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Lineage 1 WNV has long been endemic in Africa, the Middle East, Asia 
and southern Europe (16, 17). August 23, 1999, a physician reported two patients 
with encephalitis in New York City (USA). At the same time, a substantial die-
off in New York City birds was being reported. These events led to the first 
isolation of WNV in the western hemisphere (18). The resulting epidemic swept 
through North America, reaching the West Coast within three years. From 2008, 
WNV activity in the USA declined and was expected to reach low-level endemic 
activity. However, in 2012 WNV resurged and has remained highly active 
throughout 2013 and 2014 (19, 20). Lineage 1 WNV is now endemic in North 
America and has evolved into the largest outbreak of neuroinvasive disease to 
date (Figure 1.3)(18, 19). In addition, neuroinvasive WNV was detected in 2011, 
in Australia, after it caused disease in horses. This isolate was closely related 
to the naturally attenuated WNV lineage 1c, Kunjin virus, which is endemic in 
Australia and not normally associated with overt disease in humans or horses 
(Figure 1.3)(21).
In 2010, a lineage 2 WNV isolate initiated a large outbreak in Greece, 
resulting in 262 cases of human disease and 35 deaths (22). Until that moment, 
lineage 2 WNV strains were considered to be of low pathogenicity (16, 17). 
Lineage 2 WNV is now endemic in southern Europe and causes annual outbreaks 
in the region (Figure 1.3)(23, 24). In Central Europe, a related flavivirus, USUV, 
emerged a few years earlier. Like WNV, USUV is transmitted to birds by Culex 
species mosquitoes. Although pathogenesis in non-avian vertebrates is rare, 
incidental USUV infections have resulted in neuroinvasive disease in humans 
and horses (25–27). The emergence of USUV highlights the importance of 
understanding the transmission dynamics in order to assess potential risk levels 
and derive intervention strategies for these Culex-transmitted flaviviruses.  
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Chikungunya virus
CHIKV belongs to the Togaviridae family and the Alphavirus genus. The 
alphavirus genus contains 30 viruses, such as: Semliki forest virus (SFV), Sindbis 
virus (SINV), and O’nyong nyong virus (ONNV).  The CHIKV ss(+)RNA genome 
of approximately 11.8 kb contains two ORFs, one of which is directly translated 
into a polyprotein containing non-structural proteins (nsP) 1234. NsP4 is 
proteolytically cleaved from this polyprotein. The remaining polyprotein and 
nsP4 form the replication complex (RC) that produces the (-)RNA. Further 
cleavage by the protease within nsP2 results in four individual nsPs, which 
collectively form the RC that produces the (+)RNA genomes and subgenomic 
messenger RNAs (28). NsP1 is the membrane anchor of the RC and possesses 
guanine-7-methyltransferase and guanylyl transferase activities necessary for 
capping of the viral RNA. NsP2 is the protease that cleaves the polyprotein, has 
helicase activity and causes general host shut-off. The functions of nsP3 are 
unknown, but it is an essential component of the RC. nsP4 is the RNA-
dependent RNA polymerase (29). The subgenomic messengers are translated 
into the structural polyproteins (Figure 1.2, bottom). Capsid (C) is 
autocatalytically cleaved and encapsulates (+)sense viral RNA genomes in the 
cytoplasm forming nucleocapsids. The envelope proteins E1 and E2 mature 
while they are transported through the endoplasmic reticulum (ER) and Golgi 
apparatus to the plasma membrane, where the nucleocapsids are met and 
budding of  progeny virus occurs (28). 
Figure 1.3. Global distribution of CHIKV and pathogenic WNV. Countries and areas with 
autochthonous transmission of pathogenic WNV (blue) and CHIKV (red). As of February 2015, 
adapted from (3,4,36,137). 
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In humans CHIKV infection can cause symptoms of high fever, rash and 
arthralgia. CHIKV exists in a sylvatic cycle between African, forest dwelling 
Aedes mosquito species and non-human primates. However, in urban areas 
CHIKV cycles between the more urban Aedes aegypti and Aedes albopictus 
mosquitoes and humans (Figure 1.1, right). Since its discovery in 1952, sporadic 
CHIKV outbreaks have been recorded in Central Africa and Southern Asia (30). 
However, from 2001 onwards several major outbreaks have occurred affecting 
the islands of Mauritius, Madagascar, Mayotte and Reunion. On Reunion Island 
CHIKV affected up to a third of the human population during the outbreak 
of 2005/2006. In 2006, mainland India suffered a major outbreak resulting 
in more than 1.4 million infected individuals. CHIKV activity has continued 
throughout Southern Asia where CHIKV is currently endemic (Figure 1.3)
(31). In 2007, the first autochthonous transmission of CHIKV occurred on the 
European continent, infecting almost 250 people in Italy (32). In 2010 and 2014, 
CHIKV was again transmitted on European territory in the southeast of France 
(33, 34). In October 2013, the first cases of autochthonous CHIKV transmission 
in the western hemisphere were detected in the French Caribbean (35). Within 
the year, the distribution of CHIKV into the Americas has expanded greatly, 
affecting countries in South and Middle America as well as the South of the 
USA (Figure 1.3)(36).   
The recent WNV and CHIKV outbreaks in Europe and the Americas 
illustrate that these viruses can adapt to new environments and different 
vector populations. The emergence of USUV in Central Europe suggests 
that more northern Culex species mosquitoes are also competent vectors 
for some flaviviruses. A better understanding of what factors drive arbovirus 
transmission is therefore necessary to assess the risk for the (re-)emergence of 
these arboviral diseases.
The mosquito vector
WNV can be transmitted by a long list of Culex species, which are present 
on every continent except Antarctica. Transmission is mostly horizontal i.e. 
via viraemic vertebrates. However, vertical, trans generational transmission to 
mosquito offspring has also been observed (37). In North America the most 
prevalent and effective vector species for WNV are Culex pipiens, Culex tarsalis 
and Culex quinquefasciatus (38, 39). After its first introduction into the USA, 
a number of WNV genotypes have evolved, and the currently circulating 
genotypes all have acquired a mutation in the envelope protein (V159A), which 
results in more efficient transmission by native Culex species (40).  In Europe, 
the main Culex species found positive during WNV surveys is the common 
northern house mosquito Cx. pipiens (Figure 1.4)(41, 42). 
Until recently CHIKV’s only vector in urban areas was Ae. aegypti. 
However, in 2004 a point mutation was discovered in glycoprotein E1 at position 
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226 which enabled CHIKV to effectively use a second urban mosquito, Ae. 
albopictus, as a vector (Figure 1.4)(43). Ae. aegypti originated in Africa but is 
now widespread as global travel and trade have introduced it into tropical and 
subtropical regions across the globe. Similarly, the novel vector Ae. albopictus 
is originally from South-East Asia and has been introduced into Africa, the 
Americas, Europe and Australia where it has established stable populations. 
Ae. albopictus is a highly invasive species and its distribution extends further 
into more temperate climates. Both mosquito species are well adapted to 
urban environments and their daytime biting patterns and aggressive biting 
behaviour can cause intense nuisance. 
In Europe, the distribution of the invasive mosquito species Ae. aegypti 
and Ae. albopictus, as well as the native species Cx. pipiens is well documented. 
The CHIKV outbreaks in Italy and France were confined to areas where Ae. 
albopictus has established stable populations. Outbreaks of WNV have occurred 
throughout southern Europe, even though the distribution of its vector Cx. 
pipiens extends into Scandinavia and the United Kingdom (Figure 1.4)(33, 42).
Culex pipiens 
Aedes albopictus 
Aedes aegypti 
Figure 1.4. Mosquito vectors in Europe. Left, common WNV and CHIKV vectors, Cx pipiens 
and Ae. albopictus and Ae. aegypti, respectively. Right, vector distribution as of October 2014. 
The Blue line represents the northern border of the territory of Cx. pipiens. Locations where 
Ae. albopictus or Ae. aegypti have established stable populations are coloured red and orange, 
respectively. Yellow, indicates sites where Ae. albopictus has been introduced and green, areas 
where both Aedes species are absent. The presence of these mosquito species in the grey areas 
has not been investigated. Distribution of Aedes mosquitoes adapted from (319) and Cx. Pipiens 
from (42). Images of Cx. Pipiens and Ae. aegypti courtesy of Hans Smid.
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Outbreaks of arboviral disease depend on the presence and abundance of 
vertebrate amplifying hosts, competent vector species and their capacity to 
transmit the disease. The vectorial capacity is therefore a function of the vector 
density in relation to its vertebrate host, the frequency of feeding, the vector’s 
life expectancy, the extrinsic incubation period (EIP), and the vector competence. 
The vector competence represents the ability of a vector to become infected and 
successfully transmit the virus to a subsequent vertebrate host. After the 
mosquito imbibes the blood of a viraemic vertebrate (Figure 1.5a), the virus 
enters the midgut (Figure 1.5b) and infects the midgut epithelium cells (figure 
1.5c). After successful replication in these cells, the virus must infect the 
haemolymph (Figure 1.5d) and disseminate into other tissues, including the 
salivary glands (Figure 1.5e). When the virus accumulates in the salivary gland 
ducts, the mosquito is able to infect the next vertebrate host during a subsequent 
blood meal, marking the end of the EIP (Figure 1.5f)(38). The vector competence 
is an evaluation of the vector’s capability to transmit a pathogen. The vector 
competence is often presented as an infection rate at a certain initial virus dose, 
e.g. percentage of infected mosquitoes, and transmission rate e.g. percentage of 
mosquitoes with detectable virus in their saliva. 
a 
b 
b 
c 
d 
d f 
e 
Figure 1.5. Schematic representation of an arbovirus infection in the mosquito vector. A. 
The mosquito ingests blood from an infected vertebrate. B. The virus (green) enters the midgut 
and infects the epithelium cells. C. Viral replication is established in the midgut epithelium cells. 
D. Virus escapes from the midgut epithelium into the haemolymph. E. dissemination into the 
salivary glands. F. Infected saliva is injected during subsequent blood feeding.
Chapter 1
20
Arboviruses persistently infect their arthropod vector with little to no 
pathogenesis. This suggests that antiviral responses in the vector control the 
level of virus replication. Indeed, several mosquito antiviral defence pathways 
are implicated in the control of arbovirus infections. Insects possess immune 
pathways that are analogous to those found in humans and other vertebrates 
(e.g. the Toll pathway, the immune deficiency pathway (IMD) and the  Janus 
kinase signal transducer and activator of transcription  (JAK-STAT)) and   
RNA-mediated gene silencing pathways (reviewed by (44)). 
The Toll and IMD pathways detect specific pathogen derived ligands 
and activate toll-regulated and IMD-regulated gene transcription via their 
respective intracellular signalling pathways. Both pathways play crucial roles 
in the invertebrate defence against pathogens. However, their role in fighting 
off arbovirus infections is less pronounced. The Toll pathway controls DENV 
infection and activates Toll-regulated gene transcription in the midgut of Ae. 
aegypti (45). Infections with SINV and DENV also upregulate IMD-regulated 
genes in Ae. aegypti (45–47). The invertebrate JAK-STAT pathway is activated 
by binding of an invertebrate cytokine to the transmembrane receptor dome. 
Kinases on the cytoplasmic tail of the receptor activate, by phosphorylation, 
STAT molecules, which then form dimers and translocate to the nucleus to 
induce antiviral gene transcription (48). The JAK-STAT pathway is also involved 
in the control of DENV infections in the mosquito midgut (49). 
The RNA interference (RNAi) pathway is a predominant innate immune 
response in plants and insects. Double-stranded viral RNA from replication 
intermediates or secondary RNA structures are cleaved by the enzyme Dicer 
2 (Dcr-2) into short interfering RNAs (siRNA) of usually 21 base pairs. These 
siRNAs are loaded into a multi-protein RNA silencing complex (RISC)  and 
used as a template to target complementary viral RNA (reviewed in (50)). 
RNAi controls, among others, WNV and CHIKV infections in mosquitoes 
(51–54) and affects the infection of the mosquito midgut (51, 55). In addition, 
larger virus-derived RNAs (24-30 nt) have been found in CHIKV and DENV 
infected mosquitoes (56, 57). These RNAs suggest the involvement of a Dcr-
2-independent RNA-based antiviral defence pathway, the PIWI-interacting 
RNA pathway. To counteract the RNAi pathway, many plant and insect viruses 
encode viral suppressors of RNAi (VSRs) (58–60). However, VSRs have not 
been found in arboviruses (61, 62). Introducing VSRs in arbovirus genomes 
has resulted in reduced siRNA expression, increased replication and reduced 
mosquito survival (63). 
Additional mosquito host factors that influence viral entry, replication 
and the modulation of antiviral defences are poorly characterized. However, 
barriers surrounding the mosquito midgut have been identified. The mesenteron 
(midgut) infection barrier (MIB) prevents viral entry and replication in these 
midgut epithelial cells. The mesenteron escape barrier (MEB), prevents the 
escape of virions from the midgut cells and subsequent dissemination to other 
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tissues (64, 65). Similarly, salivary gland barriers have also been reported 
(reviewed in (65)). 
The human host
To combat viral infections, higher eukaryotes make use of both innate 
and adaptive immune responses. The most potent antiviral innate immune 
response in mammals is the type I interferon (IFN) response. Invading viruses 
are recognised by cytoplasmic pattern recognition receptors (PRRs) retinoic 
acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 
(MDA5) and/or members of the membrane bound Toll-like (TLR) receptor 
family. These receptors detect viral dsRNA, ssRNA and CpG DNA ligands and 
transduce the signal via a number of intracellular pathways to activate NF-κβ 
and IFN response factors (IRF) 3 and 7. The latter then translocate to the 
nucleus, inducing the expression of pro-inflammatory cytokines and type 1 
IFNs (IFN-α/β)(Figure 1.6, left). Type 1 IFNs are secreted and attach to hetero-
dimeric cell surface receptors IFN alpha receptor (IFNAR) 1 and 2. Tyrosine 
Figure 1.6. Interferon response. Left, Viral replication activates TLRs, RIG-I, and MDA5. 
Via their respective signalling cascades, IRF3/7 and NF-κβ are activated and subsequently 
upregulate the transcription of inflammatory cytokines and type 1 IFNs. Right, type 1 IFN binds 
to IFNAR1/2 and transduces the signal through TYK2 and JAK1 to phosphorylate STAT1/2. The 
STAT heterodimer translocates to the nucleus and induces expression of antiviral genes.
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kinase 2 (Tyk2) is associated with the cytoplasmic tail of IFNAR1 and is 
phosphorylated upon IFN binding. This creates a strong docking site for STAT2. 
STAT2 associates with STAT1 and both STAT1 and STAT2 are phosphorylated by 
Tyk2 and JAK1. The phosphorylated STAT hetero-dimer is then transported to 
the nucleus. Together with the protein IRF-9, the STAT hetero-dimer binds to 
the IFN-stimulated response element (ISRE), resulting in the transcription of 
many IFN-stimulated genes (ISG)(Figure 1.6, right). ISGs include the above 
mentioned PRRs and many of the downstream signalling proteins and 
transcription factors, but also antiviral effector genes e.g. IFIT and mx proteins. 
The up-regulation of these ISGs renders cells more resistant to viral infection, 
bringing them in an anti-viral state (reviewed by (66, 67)). During in vivo 
infections, the type 1 IFN  response is required to limit CHIKV infection and 
IFN-α can inhibit CHIKV replication when administered before, but not after 
infection (68–70). Similarly, WNV infections in inbred mice, lacking crucial 
components of the type 1 IFN response, were highly pathogenic. However, pre-
treatment with IFN-α protected against lethal WNV infection (71–73). 
Given the potency of the IFN response and the resulting antiviral state, 
it is not surprising that most vertebrate viruses have evolved countermeasures. 
Flaviviruses have evolved a range of mechanisms to suppress the IFN response. 
The NS5 proteins of WNV, JEV, Langat virus (LGTV) and tick borne encephalitis 
virus (TBEV) inhibit the phosphorylation of STAT1 (74–77). NS5 of DENV binds 
and degrades STAT2 (78, 79). Additionally, DENV, WNV and YFV NS4B have 
been shown to inhibit the IFN response by suppressing STAT1 signalling (80, 81) 
and the NS2A protein of Kunjin virus inhibits gene transcription driven by the 
IFN-β promoter (82). In contrast, replication of CHIKV and other alphaviruses 
in mammalian cells results in dramatic shut-off of host gene expression, which 
results in cytopathicity (83, 84). A P726S substitution in a conserved region of 
SINV nsP2 was previously reported to reduce SINV cytopathicity (85). General 
host shut-off also results in suppression of the innate immune response (28). 
However, the alphavirus Venezuelan equine encephalitis virus inhibits STAT1 
signalling, independent of host cell shut-off (86); for other alphaviruses direct 
mechanisms to antagonize the IFN response have been suggested (87, 88). 
Additional cellular responses, such as the occurrence of stress granules 
(SGs) may influence the outcome of an arboviral infection as SGs can have 
diverse pro- or antiviral activities (reviewed by (89)). SGs are non-membranous 
cytoplasmic focal structures, which rapidly aggregate in response to different 
types of local environmental stress. In an effort to maintain cellular homeostasis, 
SGs may function to delay or inhibit mRNA translation or increase mRNA 
stability during times of cellular stress, e.g. viral infection (90). SGs contain 
many RNA binding proteins, mRNAs and translation initiation factors (Figure 
1.7). Viral products of WNV and DENV have been suggested to interact with SG 
components, inhibiting the formation of SGs (91). SINV nsP3 interacts with the 
essential stress granule component Ras-GAP SH3 domain-binding protein 
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(G3BP)(92, 93), but whether this has a role in the modulation of SGs is unknown. 
Finally, the production of progeny virus requires that the envelope 
glycoproteins of many viruses including WNV and CHIKV translocate into the 
ER for post-translational modifications. Large amounts of viral glycoproteins 
can disrupt the homeostasis within the ER, resulting in the accumulation of 
misfolded proteins, which activates the unfolded protein response (UPR). The 
UPR aims to resolve ER-stress by increasing the protein folding capacity of the 
ER and reducing cellular protein synthesis via the phosphorylation of eukaryotic 
initiation factor 2α (eIF2α). However, when unsuccessful it will also initiate 
apoptosis. In the presence of misfolded proteins, three ER-transmembrane 
proteins; activating transcription factor 6 (ATF6), dsRNA-dependent protein 
kinase (PKR)-like ER kinase (PERK), and inositol-requiring 1α (IRE1α) detect 
Figure 1.7. Unfolded protein response and stress granule assembly. BiP binds unfolded 
proteins in the lumen of the ER, activating the three arms of the UPR. ATF6 translocates to the 
Golgi where it is cleaved resulting in an active transcription factor. IRE1α splices out an intron 
from XBP1 mRNA, which is now translated as a transcription factor. PERK phosphorylates eIF2α, 
shutting down general translation whilst ATF4 is still efficiently translated. The phosphorylation 
of eIF2α by PERK or other kinases may result in the formation of SGs.
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misfolded proteins in the ER via the release of ER resident protein Ca2+-
dissociated heavy-chain binding protein (BiP). ATF6 translocates via the Golgi 
apparatus to the nucleus. PERK phosphorylates eIF2α leading to a general 
inhibition of cellular translation, whilst the expression of transcription factor 
ATF4 is upregulated. Active IRE1α splices out an intron from X-box-binding 
protein 1 (XBP1) mRNA, to produce a potent transcription factor (reviewed by 
(94)). The three distinct UPR transcription factors upregulate the transcription 
of a number of UPR-associated genes (Figure 1.7). In addition, the UPR may 
also strengthen the IFN response by activating pro-inflammatory transcription 
factors and cytokine production (reviewed by (95)). WNV NS4A and NS4B 
regulate ER-stress responses which in turn correlate with the inhibition of JAK-
STAT signalling (96). The envelope proteins of SFV induce apoptosis via the 
activation of the UPR (97), whilst compounds that induce the UPR, reduced 
infections with SINV and other RNA viruses in mammalian cells (98).
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Outline of the thesis
The emerging arboviruses, CHIKV and WNV must replicate in both the 
vertebrate and invertebrate hosts to complete their respective transmission 
cycles. This requires both viruses to cope with diverse antiviral responses. In the 
case of mosquitoes infections lead to relatively high levels of virus production 
without disease symptoms, whereas in the vertebrate host virus replication 
initiates strong antiviral responses and disease. This thesis further describes 
how efficient WNV can be transmitted by potential mosquito vectors and 
provides novel insights of how CHIKV accomplishes successful transmission 
via modulation of the invertebrate and vertebrate host-cell responses (Figure 
1.8).
In Europe, the presence of invasive Ae. albopictus mosquitoes enabled 
CHIKV transmission in Italy and France (32–34). In contrast, WNV is endemic 
in the Mediterranean basin, whereas the geographic distribution of its vector 
Cx. pipiens extends North into Scandinavia (41, 42). In Chapter 2, the vector 
competence of north-western European Cx. pipiens mosquitoes is determined 
for two pathogenic WNV lineages, in comparison with American mosquitoes. 
In addition, this chapter evaluates what influences the current distribution of 
WNV in Europe to better assess the risk for further spread of both WNV lineages 
on this continent. USUV has also recently emerged in Europe. Compared to 
WNV, the distribution of USUV extends more into central and northern parts 
of Europe. Chapter 3 thus describes how the vector competence of European 
Cx. pipiens mosquitoes for USUV compares to that for WNV to better understand 
the transmission dynamics and assess the potential spread of these related 
flaviviruses.
The molecular mechanisms 
that determine vector competence are 
largely unknown. Interestingly, when 
the genes encoding nsP3 of CHIKV 
(vector; Aedes mosquitoes) and related 
alphavirus ONNV (vector; Anopheles 
mosquitoes) were exchanged, CHIKV 
became infectious for An. gambiae (99). 
Herein lies the hypothesis that a specific 
interaction between the vector and 
alphavirus nsP3 may determine the vector 
competence. NsP3 of the alphavirus SINV 
interacts with the endogenous mosquito 
protein Rasputin (Rin)(93). Chapter 4 
investigates the potential interaction 
between CHIKV nsP3 and mosquito Rin 
and whether Rin is essential to establish 
2,3 
4 5-8 
Figure 1.8. Schematic representation of 
the topics in this thesis. Summary of the 
arbovirus transmission cycle. Numbers 
indicate chapters at their respective 
location within the transmission cycle.
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transmissible CHIKV infections in Ae. albopictus. 
The mammalian homologue to mosquito Rasputin, G3BP also interacts 
with CHIKV nsP3 in vertebrate cells (93). G3BP itself is a functional and 
essential component of stress granules. Chapter 5 describes the first function 
of alphavirus nsP3 and demonstrates how the interaction between nsP3 and 
G3BP modulates the formation of SGs. While SGs contribute to a stronger and 
more specific innate immune response, the IFN response is the most potent 
antiviral response that vertebrates possess. Flaviviruses have a number of ways 
to inhibit the IFN-response, whereas alphavirus infection in mammalian cells 
causes a general host shut-off (84). Chapter 6 examines CHIKV for additional 
specific strategies to counteract the IFN response. The results in this chapter 
identify nsP2 as a specific and potent inhibitor of the JAK-STAT signalling 
pathway. Chapter 7 sheds more light on the multifunctionality of nsP2. It 
presents genetic evidence to identify three distinct functions of nsP2, its role 
in RNA replication, the inhibition of JAK-STAT signalling and the induction 
of general host shut-off. In the final phase of viral replication, viral envelope 
proteins mature in the ER before they translocate to the plasma membrane. 
Chapter 8 examines whether this process leads to ER-stress and investigates 
how CHIKV modulates the resulting unfolded protein response.
Chapter 9 integrates the experimental data presented in this thesis with 
the most recent insights from the literature. It discusses the risks of further 
spread of WNV and the intricate relationship between arboviruses and both the 
arthropod and mammalian host (cell). In addition, chapter 9 provides further 
insights as to how CHIKV nsP2 inhibits the JAK-STAT signalling pathway. 
To put the work presented in this thesis into a wider perspective, the 
current situation as to the control and prevention of flavi- and togavirus 
diseases is discussed. Currently there are no licensed vaccines or antiviral drugs 
available against either WNV or CHIKV for human use. Prevention of WNV and 
CHIKV disease is therefore limited to mosquito control. A better understanding 
of how these viruses establish productive infections in vertebrate cells will aid 
in the search for anti-viral drugs and safe efficacious vaccines. Additionally, 
understanding the molecular determinants of vector competence may lead to 
effective intervention strategies at different stages of the transmission cycle. 
Finally, defining the vector competence will aid in assessing the risk for these 
emerging arboviral diseases.
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West Nile virus: High transmission rate 
in north-western European mosquitoes 
indicates its epidemic potential and 
warrants increased surveillance 
West Nile virus (WNV) is on the rise in Europe, with increasing numbers 
of human cases of neurological disease and death since 2010. However, it is 
unknown whether or not WNV will continue to spread to north-western 
Europe, in a fashion similar to the WNV epidemic sweep in North America 
(1999-2004). Our study is the first to investigate transmissibility in north-
western European Culex pipiens for pathogenic lineage 2 WNV, in a systematic, 
direct comparison with North American Culex pipiens and the lineage 1 WNV 
strain. We demonstrate that European mosquitoes are highly competent for 
both WNV lineages, which underscores the epidemic potential of WNV in 
Europe. Significant lower transmission rates for lineage 2 WNV in American 
mosquitoes indicate different intercontinental risk levels for WNV transmission. 
We propose that WNV surveillance must be intensified in Europe to allow early 
detection, timely intervention strategies and better clinical diagnosis of WNV 
neurological cases.
This chapter has been submitted as:
Jelke J. Fros, Corinne Geertsema, Chantal B. Vogels, Peter P. Roosjen, Anna-Bella Failloux, Just 
M. Vlak, Constantianus J. Koenraadt, Willem Takken, and Gorben P. Pijlman. West Nile virus: 
High transmission rate in north-western European mosquitoes indicates its epidemic potential 
and warrants increased surveillance
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Introduction
West Nile virus (WNV; family Flaviviridae, genus Flavivirus) is an 
important mosquito-borne human pathogen associated with febrile illness, 
which may develop into severe neuroinvasive disease and death (1). The 
pathogenic isolates of WNV can be classified into two lineages. Lineage 1 WNV 
strains have long been endemic in Africa, Australia, the Middle East, Asia and 
Southern Europe (2,3). In the 1990s, lineage 1 WNV re-emerged in southern 
Europe and the Middle-East (4–6). In 1999, lineage 1 WNV was unintentionally 
introduced into New York City from where it spread rapidly across the United 
States where it is now endemic (7). With an accumulated 17,463 cases of 
neuroinvasive disease and 1,668 deaths between 1999 and 2013, this outbreak 
quickly evolved into the largest outbreak of neuroinvasive disease to date 
(8). Lineage 2 WNV strains have been endemic in sub-Saharan Africa and 
Madagascar and were previously considered to be of low pathogenicity (2,3). 
In 2010, a highly pathogenic lineage 2 WNV isolate caused a large outbreak 
in Greece (9), which resulted in 262 cases of human disease and 35 deaths. 
Lineage 2 WNV then quickly became endemic in South-East Europe and with 
annual outbreaks to date WNV activity in the region has increased seven-fold 
(10,11). At present, WNV activity does not extend into north-western Europe 
(11).  
During enzootic transmission, WNV circulates primarily between Culex 
species mosquitoes and birds. Many avian species in North America (12) and 
Europe (13,14) are suitable reservoirs/amplifying hosts and can produce high 
viral titres upon WNV infection. Infected mosquitoes also blood feed on other 
vertebrate hosts, which leads to frequent infections in humans and horses 
(15). In Europe, the main Culex species found positive during WNV surveys 
is the common house mosquito Culex pipiens (16). In North America the 
most prevalent and effective vector species for WNV are Culex pipiens, Culex 
tarsalis and Culex quinquefasciatus (17,18). Laboratory experiments show 
that American Culex pipiens mosquitoes are competent vectors for American 
isolates of lineage 1 WNV (19). The vector competence of European mosquitoes 
to lineage 1 WNV has not intensively been studied nor has it been compared 
directly to competent vectors from NA (20). The vector competence of American 
and European mosquitoes for transmission of novel European lineage 2 WNV 
isolates has not yet been determined, but this is of high importance now that a 
highly pathogenic lineage 2 WNV has emerged in Europe, which appears to be 
equally neuroinvasive as WNV isolates from lineage 1 (9). 
As the global activity of these pathogenic WNV lineages has significantly 
increased over the past two decades, we set out to assess the potential for virus 
transmission in areas that are free of either lineage 1 and/or lineage 2 WNV 
strains. 
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Materials and methods
Cells and viruses
C6/36 and Culex tarsalis cells were grown on Leibovitz L15 and Schneiders 
(Gibco) medium supplemented with 10% fetal bovine serum (FBS; Gibco). 
Hela, DF-1 and Vero E6 cells were cultured with DMEM Hepes (Gibco) buffered 
medium supplemented with 10% FBS containing penicillin (100 IU/ml) and 
streptomycin (100 μg/ml). When Vero E6 cells were incubated with mosquito 
lysates or saliva the growth medium was supplemented with fungizone (2,5 μg/
ml) and gentamycin (50 μg/ml). P2 virus stocks of the NY’99 and Gr’10 isolates 
were grown on C6/36 cells and titrated on Vero E6 cells. 
Mosquito rearing
The NWE Culex pipiens colony originated from Brummen, the Netherlands 
(°05'23.2"N 6°09'20.1"E) and was established in 2010 and maintained at 23⁰C. 
The American Culex pipiens colony (19) was maintained at 26⁰C. Both mosquito 
colonies were kept in Bugdorm cages with a 16:8 light:dark (L:D) cycle and 60% 
relative humidity (RH) and were provided with 6% glucose solution. Bovine 
or chicken whole blood was provided through the Hemotek® PS5 (Discovery 
Workshops) for egg production. Egg rafts were allowed to hatch in tap water 
supplemented with Liquifry No. 1 (Interpet Ltd.). Larvae were fed with a 1:1:1 
mixture of bovine liver powder, ground rabbit food and ground koi food.
 
In vivo infections
2-5 day old mosquitoes were infected either via ingestion of an infectious 
blood meal or via intrathoracic injections. Infectious blood meals: Whole chicken 
blood was mixed with the respective P2 virus stock to a final concentration of 
1.4*108 WNV infectious particles per ml.  Mosquitoes were allowed to membrane 
feed, using the Hemotek® system and a parafilm membrane, in a dark climate 
controlled room (24°C, 70% RH). After 1 hour, mosquitoes were sedated with 
100% CO2 and the fully engorged females were selected. Injections: Mosquitoes 
were sedated with CO2 and placed on a semi-permeable pad, attached to 100% 
CO2. Mosquitoes were infected by intrathoracic injection using the Drummond 
nanoject 2 (Drummond scientific company, United States). Infected mosquitoes 
were incubated at their respective temperatures with a 16:8 L:D cycle and fed 
with 6% sugar water during the course of the experiment. 
Salivation assay
Legs and wings of sedated mosquitoes were removed and their proboscis 
was inserted into a 200ul filter tip containing 5 ul of salivation medium (50% 
FBS and 50% sugar water (glucose, W/V 50%)). Mosquitoes were allowed to 
salivate for 45 minutes. Mosquito bodies were frozen in individual Eppendorf 
tubes containing 0.5 mm zirconium beads (Next Advance) at -80°C. The mixture 
containing the saliva was added to 55 ul of fully supplemented growth medium.
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WNV infectivity assay
Frozen mosquito bodies were homogenized in the bullet blender storm 
(Next Advance) in 100 µl of fully supplemented medium and centrifuged for 
90 s at 14000 rpm in a table top centrifuge. 30 ul of the supernatant from the 
mosquito homogenate or the saliva containing mixture was incubated on a 
monolayer of Vero cells in a 96-wells plate. After 2-4 hours the medium was 
replaced by 100 µl of fresh fully supplemented medium. Wells were scored for 
WNV-specific cytopathic effects (CPE), confirmed with immunofluorescence 
assay (IFA) against WNV E (31) at three days post infection (dpi). WNV titres 
were determined using 10 µl of the supernatant from the mosquito homogenate 
in end point dilution assays on Vero E6 cells. WNV infection was scored by CPE, 
confirmed with IFA at three dpi.
Temperature maps
Maps displaying the mean diurnal temperature during July and August 
of the indicated year (32). Human cases of WNV in Europe, during 2011, 2012 or 
2013 were projected on the location where they were reported (11). To eliminate 
potential imported cases, WNV cases were only considered when a country 
reported more than one case for that year.  
Statistical analysis
WNV infections in mosquito bodies and saliva were scored positive or 
negative and significant differences were calculated using the Fisher’s exact test 
(P<0.05). Differences in WNV titres (TCID50/ml) in infected mosquito bodies 
and heads were calculated using the Mann Whitney test (P<0.05). 
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Results
Transmission rate of lineage 2 WNV is higher in European versus American 
mosquitoes 
Culex pipiens mosquitoes from north-western Europe (NWE; the 
Netherlands), and a North American Culex pipiens colony (NA) (19) were 
infected with either the novel pathogenic lineage 2 WNV isolate (WNV-lin2) 
from Greece’10 or lineage 1 isolate (WNV-lin1), New York ’99. The vector 
competence of NA mosquitoes for WNV-lin1 has been well-described (19) and 
serves as a reference for the infection and transmission rates of WNV. The 
WNV-lin2 and WNV-lin1 isolates displayed similar growth kinetics in human, 
avian and mosquito cell cultures (Figure 2.1). Infectious blood meals containing 
1.4*108 TCID50/ml of either WNV-lin2 or WNV-lin1 isolates were fed to the NWE 
and NA Culex pipiens mosquitoes. Fully engorged females were selected and 
kept at an ambient temperature of 23°C. Immediately after completion of the 
blood meal, a subset of fully engorged females was tested for the presence of 
infectious WNV to confirm that both mosquito populations had ingested equal 
amounts of infectious virus particles (Figure 2.2). Infection with either WNV 
isolate did not influence mosquito survival during the course of the experiments 
(data not shown). After 14 days, saliva was collected from the mosquitoes and 
both the saliva as well as the mosquito bodies were examined for the presence 
of WNV (schematic representation of the experiment, Figure 2.3A). Both the 
NWE and NA mosquitoes were equally susceptible to infection, but with 
significant differences in the infection rates between the WNV-lin2 and WNV-
lin1 isolates (Figure 2.3B, Table 1, P<0.05). 
Dissemination of WNV into the saliva of a vector is a prerequisite for 
successful transmission. After consuming a blood meal that contained WNV-
lin1, 22% of both the NWE and NA mosquitoes had detectable levels of WNV 
in their saliva (Figure 2.3C). In contrast, the WNV-lin2 isolate was detectable in 
the saliva of 24% of the European mosquitoes, but only in 8% of the American 
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Figure 2.1. Growth kinetics of lineage 1 and 2 WNV strains. A. Human Hela, B. avian DF-1 
(duck fibroblasts), and C. mosquito CT (Culex tarsalis) cells infected with WNV-lin2 (red) or 
WNV-lin1 (blue) isolates at a multiplicity of infection of 1. Medium was harvested at the indicated 
days post infection and used in end point dilution assays. Error bars represent the standard error 
of the mean.
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Figure 2.2. Both NWE and NA Culex pipiens 
mosquitoes ingest equal amounts of infectious 
virus Mosquitoes were infected with WNV-lin2 via an 
infectious blood meal, homogenized, and the viral titres 
were determined in end point dilution assays.  Results are 
represented as a Tukey box plot. 
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Results
Transmission rate of lineage 2 WNV is higher in European versus American 
mosquitoes 
Culex pipiens mosquitoes from north-western Europe (NWE; the 
Netherlands), and a North American Culex pipiens colony (NA) (19) were 
infected with either the novel pathogenic lineage 2 WNV isolate (WNV-lin2) 
from Greece’10 or lineage 1 isolate (WNV-lin1), New York ’99. The vector 
competence of NA mosquitoes for WNV-lin1 has been well-described (19) and 
serves as a reference for the infection and transmission rates of WNV. The 
WNV-lin2 and WNV-lin1 isolates displayed similar growth kinetics in human, 
avian and mosquito cell cultures (Figure 2.1). Infectious blood meals containing 
1.4*108 TCID50/ml of either WNV-lin2 or WNV-lin1 isolates were fed to the NWE 
and NA Culex pipiens mosquitoes. Fully engorged females were selected and 
kept at an ambient temperature of 23°C. Immediately after completion of the 
blood meal, a subset of fully engorged females was tested for the presence of 
infectious WNV to confirm that both mosquito populations had ingested equal 
amounts of infectious virus particles (Figure 2.2). Infection with either WNV 
isolate did not influence mosquito survival during the course of the experiments 
(data not shown). After 14 days, saliva was collected from the mosquitoes and 
both the saliva as well as the mosquito bodies were examined for the presence 
of WNV (schematic representation of the experiment, Figure 2.3A). Both the 
NWE and NA mosquitoes were equally susceptible to infection, but with 
significant differences in the infection rates between the WNV-lin2 and WNV-
lin1 isolates (Figure 2.3B, Table 1, P<0.05). 
Dissemination of WNV into the saliva of a vector is a prerequisite for 
successful transmission. After consuming a blood meal that contained WNV-
lin1, 22% of both the NWE and NA mosquitoes had detectable levels of WNV 
in their saliva (Figure 2.3C). In contrast, the WNV-lin2 isolate was detectable in 
the saliva of 24% of the European mosquitoes, but only in 8% of the American 
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Figure 2.1. Growth kinetics of lineage 1 and 2 WNV strains. A. Human Hela, B. avian DF-1 
(duck fibroblasts), and C. mosquito CT (Culex tarsalis) cells infected with WNV-lin2 (red) or 
WNV-lin1 (blue) isolates at a multiplicity of infection of 1. Medium was harvested at the indicated 
days post infection and used in end point dilution assays. Error bars represent the standard error 
of the mean.
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Figure 2.2. Both NWE and NA Culex pipiens 
mosquitoes ingest equal amounts of infectious 
virus Mosquitoes were infected with WNV-lin2 via an 
infectious blood meal, homogenized, and the viral titres 
were determined in end point dilution assays.  Results are 
represented as a Tukey box plot. 
mosquitoes (Figure 2.3C, P<0.05) indicative of a strongly reduced susceptibility 
of the latter for WNV-lin2. The differential transmission rate of the WNV-lin2 
isolate is underscored when only WNV-infected mosquitoes are considered. 
From the population of WNV-infected mosquitoes (Figure 2.3B), successful 
replication and dissemination of WNV-lin2 into the saliva was found in 59% of 
the NWE, compared to only 24% of the NA mosquitoes (Table 2 and Figure 
2.3D). 
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Figure 2.3. European Culex pipiens mosquitoes are competent vectors for pathogenic 
WNV lineages 1 and 2. A. Schematic representation of the experiment. Mosquitoes from NWE 
or NA were given a blood meal containing virus from either WNV-lin2 or WNV-lin1 isolates. 
B. NWE or NA mosquitoes were fed an infectious blood meal containing either WNV-lin2 or 
WNV-lin1 isolates. Fourteen days post infection, saliva was isolated and the presence of WNV 
in these mosquitoes was assayed. Bars represent the percentage of WNV infected mosquitoes. 
C. Fourteen days post infection the saliva was harvested and scored for infectious WNV. Bars 
represent the percentage of mosquitoes with infectious saliva. D. Mosquito saliva was assayed 
for the presence of WNV. Bars represent the percentage of mosquitoes with WNV positive saliva 
from the WNV infected population. E. Ten μl of the homogenized mosquito bodies was titrated 
in end point dilution assays. For each sample population, the WNV titres of individual mosquito 
bodies were grouped into saliva negative (left) and positive (right) populations, represented 
in Tukey box plots. Individual outliers are indicated. Asterisks indicate significant differences 
(P<0.05, Fisher’s exact test (BCD), Man Whitney test (E)).
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In an effort to understand these differences in transmissibility we first 
determined the tissue culture infectious dose of WNV present in each positive 
mosquito body by end point dilution assays. The viral titres in individual 
mosquito bodies were highly variable and could reach up to 109 TCID50/ml for 
WNV-lin2 infected NWE mosquitoes, compared to a three logs lower maximum 
titre of only 106 TCID50/ml in NA mosquitoes (Figure 2.3E). Comparison between 
the WNV titres of saliva-positive and saliva-negative mosquitoes within the 
same sample population showed that significantly more infectious WNV 
particles were present in the bodies of mosquitoes with positive saliva than with 
negative saliva (Figure 2.3E). This indicates that the level of WNV replication 
in the mosquito body determines the dissemination into the salivary glands. 
 
Differential transmission rates of WNV-lin2 attributed to infection barriers
Efficient infection and escape from the midgut epithelial cells is necessary 
for dissemination of the virus to other tissues, including the salivary glands (21–
23). When the midgut was circumvented by injecting WNV-lin2 directly into 
the thorax, all mosquitoes from both NWE and NA became readily infected 
(Figure 2.4A, open symbols) and up to 100% of injected individuals were able to 
transmit WNV at day 8 post injection (Figure 2.4B, open symbols). In contrast, 
infectious blood meals resulted in differential proportions of the NWE and NA 
mosquitoes being able to transmit WNV-lin2 (Figure 2.4B, closed symbols), 
again with NWE as a more competent vector. Strikingly, as early as eight days 
post infection, the WNV-lin2 isolate was detected in the saliva of 14% of NWE 
mosquitoes, compared to 3% of NA mosquitoes (Figure 2.4B, closed symbols). 
Thus, infection with the WNV-lin2 isolate results in better dissemination 
and a shorter mean extrinsic incubation period, suggesting that WNV-lin2 
escapes more effectively from the midgut epithelial cells in mosquitoes from 
Mosquito 
population
WNV 
lineage
n
(#)
Infected
(#)
Infection rate 
(%)
NWE lin2 154 51 33
NA lin2 102 29 28
NWE lin1 131 64 49
NA lin1 87 36 42
Table 1. Infection rate of lineage 1 and 2 WNV isolates in NWE and NA Culex pipiens mosquitoes.
Mosquito 
population
WNV 
lineage
n
(#)
Infected 
(#)
Transmissible 
(#)
Transmission rate 
(%)
Positive saliva 
(% of positive mosquitoes)
NWE lin2 79 32 19 24 59
NA lin2 102 29 7 8 24
NWE lin1 67 40 15 22 38
NA lin1 74 33 14 22 42
Table 2. Transmission rate of lineage 1 and 2 WNV isolates in NWE and NA Culex pipiens mosquitoes.
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NWE compared to those from NA. Taken together, transmission of both WNV 
lineages is intrinsically possible in north-western Europe whereas there is no 
evidence to suggest that WNV-lin2 can utilize American mosquitoes as effective 
vectors due to limited dissemination to the salivary glands. 
Higher temperatures increase WNV infection rate
As the mosquito colonies used in this laboratory study are representatives 
of their respective populations from the described areas, the experiments 
presented here show that highly WNV-competent Culex pipiens mosquitoes 
are present in north-western Europe. Vector competence is, however, not only 
attributed to intrinsic factors, but also subjective to extrinsic factors, most 
notably the ambient temperature (19,24). Because indigenous WNV activity is 
currently absent in north-western Europe (11,25), but competent European bird 
species are present (13,14), we hypothesized that temperature limits the vector 
competence of European mosquitoes for WNV transmission. To test this 
hypothesis, we infected both NWE and NA mosquitoes with the WNV-lin2 
isolate via a WNV-containing blood meal and incubated the mosquitoes at 
three different temperatures. Two of which matched the average temperatures 
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Figure 2.4. Mesenteron infection barriers determine the transmission rate of WNV-lin2. 
Culex pipiens from either NWE (spherical symbols) or NA (square symbols) were infected with 
the WNV-lin2 isolate via infectious blood meals (closed symbols) or intrathoracic injections 
(open symbols). At the indicated times post infection, the percentages of effectively infected 
mosquitoes (A) or successive infectious saliva (B) were determined.
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Figure 2.5. Higher temperatures increase WNV 
infection rate in Culex pipiens. Both NA (open 
symbols) and NWE (closed symbols) mosquitoes were 
orally infected with the WNV-lin2 isolate via a blood 
meal. Engorged mosquitoes were separated into three 
groups which were incubated at either 18, 23 or 28°C. 
The infection rate was determined 14 days post oral 
infections. Asterisks indicate significant differences 
(Fisher’s exact test P<0.05).
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at the origin of our NWE mosquito colony (the Netherlands; 18°C) and the 
WNV-lin2 isolate (Greece; 28°C) (26) during the warmest period of the year 
(July and August) which also corresponded with the peak in WNV amplification 
and transmission8. The third incubation temperature was an intermediate of 
23°C. Higher temperatures significantly increased the percentage of WNV-
infected mosquito vectors, with no apparent difference between NWE and NA 
mosquitoes (Figure 2.5, P<0.05). At  18°C, 17% and 19% of mosquitoes were 
infected with WNV-lin2, whereas incubation at 28 °C increased the infection 
rates to 58% and 52% for NWE and NA mosquitoes, respectively. 
Comparison between the spatial arrangement of recent WNV outbreaks 
in Europe per annum and the corresponding mean temperature during peak 
transmission season strengthens this hypothesis by displaying a strong 
correlation between WNV outbreaks and the mean diurnal summer temperature 
throughout Europe (Figure 2.6A, B and C). The mean temperatures at which 
WNV outbreaks occurred in 2011, 2012 and 2013 were 24.6°C, 25.3°C, and 23.5°C, 
with standard deviations of  2.4°C, 2.7°C, and 2.1°C, respectively (Figure 2.6D). 
Together, the mean temperatures at the respective locations of individual 
outbreaks give an indication of the average summer temperatures at which 
there is an elevated risk for WNV activity. 
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Figure 2.6. Mean diurnal summer temperature correlates with European WNV outbreaks. 
Mean diurnal temperature during July-August of (A) 2011, (B) 2012 and (C) 2013. Dots represent 
human WNV cases reported in the respective year. D. Scatter plot displays the mean temperature 
during July and August of the indicated year at each individual location with WNV activity. The 
mean temperatures and standard deviations are indicated.  
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Discussion
Here we show that both pathogenic lineages of WNV can effectively infect 
mosquitoes from NWE. Our finding that two geographically separated Culex 
pipiens populations (NWE and NA) have a markedly different vector competence 
for WNV-lin2, indicates a high degree of genotype-genotype specificity in the 
interaction between virus and vector. As the differential infection rate is only 
apparent when WNV is infected orally and not via intrathoracic injections, this 
suggests that WNV-lin2 escapes more effectively from the midgut epithelial 
cells in mosquitoes from NWE compared to those from NA. The presence of 
highly competent vector species in WNV-free areas suggests that extrinsic 
factors such as temperature play an essential role in the current distribution 
of WNV. In Europe, the lower average summer temperature (<20°C) may 
provide a possible explanation for the current WNV epidemics, which remain 
restricted to southern Europe. However, other extrinsic factors can shape the 
vectorial capacity and may compensate for a reduced vector competence at low 
temperature by facilitating larger mosquito populations. The recent resurgence 
of WNV disease in the United States was most likely fuelled by climatic conditions 
that were favourable for local vector populations (27,28). In addition, hybrids 
between two closely related Culex pipiens forms may increase the incidence of 
human WNV disease, as these ‘bridge-vectors’ are considered less ornithophilic 
and more likely to feed on other vertebrates, including humans. These hybrids 
are relatively common in North America, but not in north-western Europe 
(29). Additionally, viral adaptations that increase the replication efficiency at 
lower temperatures could further facilitate and enhance transmission of WNV 
throughout Europe. Indeed, the WNV-lin1 isolate has already proven to be able 
to adapt to the different climatic conditions in the Americas (19), while other 
flaviviruses, including a close relative of WNV, Usutu virus, are already endemic 
in parts of north-western Europe (30). Finally, global warming or temporary 
weather extremes will likely favour the vectorial capacity of Culex pipiens and 
increase the risk of future WNV outbreaks worldwide. Based on our results and 
experimental evidence by others that European birds are suitable amplifying 
hosts (14), we propose that WNV surveillance in mosquitoes and birds should 
be intensified to allow early detection and the implementation of effective 
mitigation and intervention strategies. Furthermore, awareness in the clinic 
throughout Europe is warranted in order to more effectively diagnose cases of 
human WNV (neurological) disease.
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Usutu virus, highly transmissible by northern 
house mosquitoes and a prelude to West Nile 
virus activity in Europe
Originating from Africa, Usutu Virus (USUV) first emerged in Europe in 
2001. This mosquito-borne flavivirus displayed high mortality rates in its bird 
reservoirs, which strongly resembled the introduction of West Nile virus (WNV) 
in 1999 in the United States. Mosquitoes infected with USUV incidentally infect 
other vertebrates, including humans which can result in neuroinvasive disease. 
USUV and WNV co-circulate in parts of southern Europe, but the distribution 
of USUV extends into central and northwestern Europe. In the field, both 
viruses are most often detected in the northern house mosquito Culex pipiens. 
To understand the transmission dynamics and assess the potential spread of 
USUV, we determined how effective Culex pipiens is as a vector for USUV. We 
compared the vector competence for USUV with that for the better studied 
WNV. We show for the first time that European mosquitoes are highly effective 
vectors for USUV. Interestingly, at higher temperatures USUV was able to infect 
mosquitoes more effectively than WNV, which could be attributed to barriers 
present in the mosquito midgut. As both viruses utilize the same vector and 
reservoir species and only display differences in temperature dependent vector 
competence, this suggests that USUV may precede WNV transmission in 
Europe. 
This chapter is in preparation for submission as:
Jelke J. Fros, Pascal Miesen, Chantal B. F. Vogels, Paolo Gaibani, Vittorio Sambri, Constantianus 
J. M. Koenraadt, Ronald P. van Rij, Just M. Vlak, Willem Takken and Gorben P. Pijlman. Usutu 
virus, highly transmissible by northern house mosquitoes and a prelude to West Nile virus activity 
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Introduction
The last two decades a number of clinically significant arthropod-borne 
(arbo) viruses have (re-)emerged in continental Europe. Autochthonous 
transmission of dengue virus has occurred in France in 2014 (115) and 
chikungunya virus transmission has been recorded in Italy (2007) (32) and 
France (2010, 2014)(34)(33). Both these viruses are transmitted by the invasive 
Asian tiger mosquito Aedes albopictus, which has colonized parts of Europe 
(116). Alternatively, native Culex mosquitoes are the main vector for two 
pathogenic lineages of West Nile virus (WNV), which are now endemic in 
southern Europe (chapter 2)(23). The enzootic transmission cycle of WNV is 
maintained by mosquitoes and birds. Infected mosquitoes, however, may also 
feed on other vertebrates resulting in frequent infections in humans and horses 
(104). In 1999, WNV was introduced in the United States. The outbreak that 
followed was characterized by high mortality rates in various American bird 
species and resulted in the largest outbreak of human neuroinvasive disease to 
date (19). 
In Austria (2001), a sudden and substantial die-off in Eurasian blackbirds 
closely resembled the WNV outbreak in the United States. Not WNV, but 
another related flavivirus (family Flaviviridae), Usutu virus (USUV), was 
identified. This was the first isolation of USUV on the European continent 
(117). The virus was first discovered in South Africa in 1959 and since then its 
activity has been observed in a number of African countries (118). After the 
initial outbreak in Austria, USUV activity has been detected in Spain, Italy, 
Switzerland, the Czech Republic, Hungary, United Kingdom, Poland, Croatia, 
Germany and Belgium (119, 120). In some southern European countries USUV 
co-circulates with WNV (41). The high mortality in a large number of avian 
species enabled monitoring the spread of USUV via the surveillance of dead 
birds (121). Most of the USUV positive bird species were blackbirds (Turdus 
merula), which belong to the same genus as the suspected WNV reservoir 
in the United States, the American robin (Turdus migratorius)(122). USUV 
infected mosquitoes may also feed on other vertebrates, and the virus has been 
detected in horses (123) and  bats (124).  Infections in humans have resulted in 
two diagnosed clinical cases in Africa (118). In Europe, two Italian and three 
Croatian patients with neuroinvasive disease have been reported (25–27). 
However, serological evidence suggests that less severe and subclinical cases 
of human USUV infections occur regularly in USUV-endemic areas (125–127).  
Similar to WNV, USUV is mostly transmitted by Culex species 
mosquitoes. In Africa USUV has been isolated from Culex neavei, Culex 
perfuscus, Culex univitattus and Culex quinquefasciatus. Additionally, USUV 
has also been detected in a number of mosquito species from other genera (118). 
Among European mosquito species, USUV is mostly found in the northern 
house mosquito (Culex pipiens), which is abundant throughout the northern 
hemisphere (41). 
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The presence of competent mosquitoes dictates the potential spread of 
any arthropod-borne pathogen. Vectors are considered competent when they 
can transmit the pathogen from one vertebrate host to the next. Arboviruses, 
like USUV, are ingested via an infectious blood meal, infect the epithelial 
cells that line the mosquito midgut, escape to the haemolymph, and finally 
accumulate in the saliva to be transmitted during the next blood meal (64). 
Determining how competent a vector species is provides insight in the viral 
transmission dynamics and is essential to assess the risk for future outbreaks. 
The only laboratory experiments that determined vector competence for USUV 
were done with the African mosquito, Culex neavei (128). To better understand, 
predict and assess the potential spread of USUV in Europe we investigated how 
competent the northern house mosquito Culex pipiens is as vector for USUV. 
Here we show for the first time that Culex pipiens is a highly effective European 
USUV vector. We provide insight into the replication dynamics within the 
mosquito vector and show how the vector competence of USUV relates to that 
of WNV at different temperatures.
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Materials and methods
Cells and viruses
C6/36 cells were grown on Leibovitz L15 (Life technologies, Netherlands) 
medium which was supplemented with 10% FBS. Vero E6 cells were cultured 
with DMEM Hepes (Life technologies, Netherlands)-buffered medium 
supplemented with 10% FBS containing penicillin (100 IU/ml) and streptomycin 
(100 μg/ml). When Vero E6 cells were infected with mosquito lysates or saliva 
the growth medium was supplemented with fungizone (2,5 μg/ml) and 
gentamycin (50 μg/ml). This medium will be referred to as fully supplemented 
medium. P2 virus stocks of USUV, Bologna ‘09 and WNV Gr’10 lineage 2 were 
grown on C6/36 cells and titrated on Vero E6 cells. 
Mosquito rearing
The European Culex pipiens colony originated from Brummen, the 
Netherlands (°05’23.2”N 6°09’20.1”E) and was established in 2010 and maintained 
at 23⁰C. The mosquito colony was kept in Bugdorm cages with a 16:8 light:dark 
(L:D) cycle and 60% relative humidity (RH), and provided with a 6% glucose 
solution as food source. Bovine or chicken whole blood was provided through 
the Hemotek® PS5 (Discovery Workshops, UK) for egg production. Egg rafts 
were allowed to hatch in tap water supplemented with Liquifry No. 1 (Interpet 
Ltd., UK). Larvae were fed with a 1:1:1 mixture of bovine liver powder, ground 
rabbit food and ground koi food. 
In vivo infections
Two-to-five day old mosquitoes were infected either via ingestion of 
an infectious blood meal or via intrathoracic injections. Oral infections were 
performed by mixing whole chicken blood with the respective P2 virus stock to 
the indicated final concentration. Mosquitoes were allowed to membrane feed, 
using the Hemotek® system, in a dark climate controlled room (24oC, 70% RH). 
After 1 hour, mosquitoes were sedated with 100% CO2 and the fully engorged 
females were selected. During intrathoracic injections the mosquitoes were 
sedated with CO2 by placing them on a semi-permeable pad, attached to 100% 
CO2. Mosquitoes were infected by intrathoracic injection using the Drummond 
nanoject 2 (Drummond scientific company, United States). Infected mosquitoes 
were incubated at the indicated temperatures with a 16:8 L:D cycle and fed with 
6% sugar water during the course of the experiment. 
Salivation assay
Mosquitoes were sedated with 100% CO2 and their legs and wings were 
removed. Their proboscis was inserted into a 200 μl filter tip containing 5ul of 
salivation medium (50% FBS and 50% sugar water (W/V 50%)). Mosquitoes 
were allowed to salivate for 45 minutes. Mosquito bodies were frozen in 
individual Eppendorf tubes containing 0.5 mm zirconium beads at -80oC. The 
mixture containing the saliva was added to 55 μl of fully supplemented growth 
medium.
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Infectivity assays
Frozen mosquito bodies were homogenized in the bullet blender storm 
(Next Advance, United States) in 100 µl of fully supplemented medium and 
spun down for 90 seconds at 14,000 rpm in a table top centrifuge. Thirty μl 
of the supernatant from the mosquito homogenate or the saliva-containing 
mixture was incubated on a monolayer of Vero cells in a 96-wells plate. After 
2-4 hours the medium was replaced by 100 µl of fresh fully supplemented 
medium. Wells were scored for virus specific cytopathic effects (CPE) at three 
days post infection. Viral titres were determined using 10 µl of the supernatant 
from the mosquito homogenate in an end point dilution assay on Vero E6 cells. 
Infections were scored by CPE, three days post infection.
Analysis of small RNA libraries
Pools of twelve WNV or USUV infected mosquitoes were lysed in TRIzol 
(life technologies) reagent and total RNA was isolated. The isolation and 
sequencing of small RNAs was described previously (129). In short,  RNA was 
size separated by PAGE gel electrophoresis and small RNAs (19-33 nucleotides) 
were isolated. The small RNA library was prepared with the TruSeq Small RNA 
Sample Preparation Kit (Illumina) and sequenced on an Illumina HiSeq 2500 
by Baseclear (www.baseclear.nl). FASTQ sequence reads were generated with 
the Illumina Casava pipeline (version 1.8.3) and initial quality assessment was 
performed by Baseclear using in-house scripts and the FASTQC quality control 
tool (version 0.10.0). FASTQ sequence reads that passed this quality control 
were analyzed with Galaxy (130). Sequence reads were clipped from the adapter 
sequence (TruSeq 3’ adapter index #8) and mapped with Bowtie (version 1.1.2)
(131) to the WNV (GenBank: HQ537483.1) and USUV (GenBank: HM569263.1). 
A size profile of the viral small RNAs was obtained from all reads that mapped 
to their respective genomes. 
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Results
Culex pipiens is a highly competent vector for USUV.
Recently we showed that Culex pipiens from north-western Europe is a 
highly competent vector for pathogenic WNV isolates (chapter 2). To evaluate 
how competent this mosquito is as a vector for USUV mosquitoes were offered 
a blood meal containing a 50% tissue culture infectious dose (TCID50) of 4*10
7 
USUV or WNV per ml. The fully engorged females were kept at 28oC. After 
fourteen days saliva was isolated from each individual mosquito as a proxy for 
transmission. Virus in the saliva of a mosquito is a prerequisite for transmission 
and therefore used as an indication of its transmissibility. The presence of 
infectious USUV or WNV particles was detected on Vero E6 cells. The blood 
meal that contained WNV infected 46% of the mosquitoes, whereas the blood 
meal that contained USUV infected a significantly larger percentage (80%) of 
mosquitoes (Figure 3.1A, Fisher’s exact test, P<0.05). From the mosquitoes that 
ingested a WNV-containing blood meal, 33% had infectious WNV in their 
saliva, whereas an USUV containing blood meal resulted in 69% of mosquitoes 
with infectious saliva (Figure 3.1A, Fisher’s exact test P<0.05).  
 As the midgut epithelial cells can form a primary infection barrier (132) 
mosquitoes were also infected by injecting 5.5*103 TCID50 directly into the 
thorax. Injection of either virus into the thorax of Culex pipiens mosquitoes 
clearly circumvents the midgut barrier as it increases the infection rate and 
transmission rate of both WNV and USUV up to 100% (Figure 3.1B). Taken 
together, USUV not only infects a large percentage of Culex pipiens mosquitoes 
but also effectively disseminates into their saliva. This indicates that these 
WNV-competent mosquitoes are even more effective as vector for USUV. In 
addition, the differential infectivity and transmissibility of both viruses after 
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Figure 3.1. Culex pipiens is a highly competent vector for USUV. Mosquitoes were offered an 
infectious blood meal (A) or were injected (B) with either WNV or USUV. Fourteen days post 
infection mosquito saliva was collected and the mosquito body was homogenized in cell culture 
medium. The mosquito homogenate and saliva were incubated on Vero E6 cells to detect the 
presence of either WNV or USUV in the mosquito bodies and saliva. Bars represent the percent-
age of positive samples. Asterisk indicates significant difference (Fisher’s exact test, P<0.05).      
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an infectious blood meal but not after intrathoracic injection suggests that 
the midgut epithelial cells play a differentiating role that determines vector 
competence.   
USUV replication in the mosquito vector.
To investigate if the increased dissemination of USUV relates to higher 
viral titres in the vector, the viral titres present in individual mosquito bodies 
were determined using end point dilution assays. Interestingly, mosquitoes 
that were orally infected with either WNV or USUV showed a similar variation 
in viral titres (Figure 3.2, mean TCID50 of 1.1*10
6 and 1.5*106 per ml, respectively). 
In contrast, intrathoracic injection of either WNV or USUV resulted in 
significantly different viral titres, with a  mean TCID50 of 8.1*10
6 and 2.7*105 per 
ml, respectively (Figure 3.2, student t-test, P<0.05). Interestingly, USUV 
displayed viral titres that were 30 times lower compared to WNV, but without 
compromising dissemination to the salivary glands. This suggests that the 
bottleneck for vector competence is presented by the midgut epithelium, which 
differentially affects viral replication of WNV as compared to USUV. 
WNV and USUV viRNA in infected Culex pipiens 
Next, we investigated whether both WNV and USUV infections in 
Culex pipiens mosquitoes induced an antiviral response. The activation of 
the main invertebrate antiviral response, RNA interference (RNAi), occurs 
via the recognition and cleavage of dsRNA products into small-interfering 
RNA (siRNA) of usually 21 nucleotides (133). In response to WNV infections 
virus-derived siRNA (viRNA) has been detected in Culex quinquefasciatus 
(51). To investigate whether the RNAi pathway is activated by WNV and USUV 
infections in Culex pipiens, small RNAs were isolated from pools of WNV or 
USUV infected mosquitoes and analyzed using deep-sequencing. The small 
RNA libraries were mapped to the viral genomes and both WNV and USUV 
infected mosquitoes elicited an RNAi response with the expression of 21 
nucleotide viRNA (Figure 3.3).    
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Figure 3.2. USUV and WNV replicate to equally 
high titres in Culex pipiens after an infectious 
blood meal but not after injection of the 
viruses. Homogenates from infected mosquitoes 
were used in end point dilution assays and the 
tissue culture infectious dose 50% (TCID50)/ml 
was determined. Data points represent individual 
mosquitoes infected with either USUV or WNV via 
the indicated route.  Asterisk indicates significant 
difference (t-test, P<0.05).  
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USUV infection is more effective at higher ambient temperatures.
Culex pipiens mosquitoes are more competent for WNV at higher ambient 
temperatures (chapter 2). While both USUV and WNV are endemic in parts 
of Mediterranean Europe, USUV also extends its distribution into the cooler, 
more central and northern parts of Europe. We hypothesized that the ambient 
temperature could differentially affect the vector competence to either virus.
Oral infections were performed by offering the mosquitoes a blood meal 
containing either USUV or WNV, with 3.2*107 and 2.2*108 TCID50 per ml, 
respectively. We chose to use higher WNV titres to compensate for the lower 
vector competence for WNV (Figure 3.1). Fully engorged females were incubated 
at three different temperatures (18oC, 23oC and 28oC). These temperatures 
represented the mean diurnal summer (July-August) temperature in 
northwestern Europe, an intermediate temperature, and the mean diurnal 
summer temperature for Mediterranean Europe, respectively (111). After two 
weeks the mosquitoes were homogenized and the respective viruses were 
detected. WNV displayed higher infection rates at higher temperatures, 
infecting 17% at 18oC, 43% at 23oC and 58% at 28oC (Figure 3.4, open symbols). 
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Figure 3.3. RNAi activity in WNV and USUV infected mosquitoes. Size and relative 
abundance of small RNA reads mapping to the WNV and USUV genomes. Reads mapping to the 
positive strand (black) are shown above the axis and reads to the negative strand (gray) below 
the axis.
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Figure 3.4. USUV is more infectious 
than WNV at higher temperature. 
After infectious blood meals, engorged 
mosquitoes were incubated at three 
different temperatures for fourteen days, 
before determining the presence of WNV 
and USUV. Data points indicate the 
percentage of infected mosquitoes from the 
total sample size (n>25). Asterisk indicates 
significant difference between WNV and 
USUV (P<0.01, Fisher’s exact test).      
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At lower temperatures USUV infected a similar percentage of mosquitoes (11% 
at 18oC and 53 % at 23oC). Interestingly, at 28oC, 90% of the mosquitoes were 
infected with USUV (Figure 3.4, closed symbols), which was significantly more 
compared to the 58% for WNV (Fisher’s exact test, P<0.01). This was especially 
significant as the titre used for USUV in the infectious blood meals was seven 
times lower. This indicates that USUV is highly infectious for European Culex 
pipiens mosquitoes and that temperature differentially affects the  susceptibility 
of mosquitoes to either USUV or WNV.    
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Discussion
Here we show for the first time that USUV not only infects the northern 
house mosquito Culex pipiens, but also effectively disseminates and accumulates 
in its saliva (Figure 3.1A). In the field USUV is mostly detected in Culex species 
mosquitoes, although it has also been found in mosquitoes from four other 
genera within the family of Culicidae. To what extent mosquitoes from these 
genera may contribute to the dispersal of USUV is unclear. In southern Europe, 
USUV was detected in Culex pipiens, which is the most abundant mosquito 
species in Europe and a competent WNV vector (Chapter 2)(41, 118). Northern 
Europe has a second abundant Culex species: Culex torrentium. It would be 
interesting to investigate whether this mosquito species can act as a transmission 
vector for USUV.  
In addition to competent USUV vectors, sufficient vertebrate species are 
required as amplifying hosts. Susceptible bird species are prevalent in Europe 
as USUV has been detected in a large number of avian species, most notably 
within the Turdus genus (117, 121). In addition to birds, other vertebrates can 
become infected with USUV. Like WNV, humans and horses are incidental 
hosts. Whether bats develop viral titres that are high enough to contribute 
to the dispersal of USUV is unknown, but if bats are a reservoir this could 
dramatically influence transmission model predictions (124). Experimental 
WNV infections in birds can result in viraemia above 109 plaque forming units 
per ml, which is clearly sufficient to infect blood feeding mosquitoes (12). In the 
experiments presented here, the chicken blood used for infectious blood meals 
contained USUV titres of maximally 4*107 TCID50 per ml. Higher titers in the 
blood of USUV infected birds may further increase the percentage of vectors 
able to transmit USUV after blood feeding. 
Both USUV and WNV disseminated into the saliva of up to 100% of 
mosquitoes that were intrathoracically injected with either virus (Figure 3.1B). 
Interestingly, the viral titres that are present in orally infected mosquitoes 
were variable, whereas infection by injection displayed only limited variation 
(Figure 3.2). This indicates that the midgut acts as the major bottleneck for 
dissemination of the virus. Potentially, the induction of antiviral responses, 
and/or selective pressure for certain viral quasi species may influence 
subsequent viral replication and dissemination. Injection of WNV also resulted 
in titres that were higher than those of blood fed or USUV-injected mosquitoes. 
Together with the lower vector competence, this suggests that the barriers in 
the midgut epithelial cells of Culex pipiens are more effective against WNV as 
compared to USUV.   
Both viruses elicited an RNAi response by displaying viRNA, with the 
dicer-2 dependent signature of 21 nucleotides mapping to both the positive 
genomic RNA strand and the complementary negative strand. There were no 
apparent differences in viRNA expression that could explain the differential 
transmission rates between the two viruses. 
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Despite the observed differences in infectivity and transmissibility, both 
WNV and USUV can effectively be transmitted by Culex pipiens. However, 
their distribution throughout Europe only has limited overlap. The dispersal 
of WNV has a strong correlation with mean summer temperatures, which 
can be explained by the vector competence for WNV at the corresponding 
temperatures (Chapter 2). USUV activity is also found in more temperate 
regions, but surprisingly the infectivity in Culex pipiens showed a strong 
temperature dependency, which was more pronounced than for WNV. In 
the experiments presented here, we used a constant incubation temperature 
that represented a mean summer temperature. However, diurnal temperature 
fluctuations around this mean may have additional effects on the vector 
competence. Indeed, the vector competence of Aedes aegypti for dengue virus 
is influenced by the diurnal temperature range. Fluctuations around lower 
mean temperatures (<18oC) increased the vector competence in comparison to 
mosquitoes that were incubated at identical, yet constant, mean temperatures 
(134). Because Culex pipiens is more competent for USUV at higher temperatures, 
temperature fluctuations above a relatively low mean may still enable USUV 
to have a higher vectorial capacity compared to WNV, but clearly this needs 
further experimental evidence. 
In conclusion, both USUV and WNV can be transmitted by European 
Culex pipiens mosquitoes and at higher temperatures both the infection rates 
increase, when infected orally. At higher temperatures, however, Culex pipiens 
is significantly more competent for USUV as compared to WNV. As both viruses 
utilize the same reservoir species and global temperatures are expected to rise, 
this suggests that USUV may precede WNV transmission in Europe. 
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Mosquito Rasputin interacts with 
chikungunya virus nsP3 and determines 
the infection rate in Aedes albopictus
Chikungunya virus (CHIKV) is an arthritogenic alphavirus (family Togaviridae), 
transmitted by Aedes species mosquitoes. CHIKV re-emerged in 2004 with 
multiple outbreaks worldwide and recently reached the Americas where it 
has infected over a million individuals in a rapidly expanding epidemic. While 
alphavirus replication is well understood in general, the specific function(s) 
of non-structural protein nsP3 remain elusive. CHIKV nsP3 modulates the 
mammalian stress response by preventing stress granule formation through 
sequestration of G3BP. In mosquitoes, nsP3 is a determinant of vector specificity, 
but its functional interaction with mosquito proteins is unclear. In this research 
we studied the domains required for localization of CHIKV nsP3 in insect cells 
and demonstrated its molecular interaction with Rasputin (Rin), the mosquito 
homologue of G3BP. The biological involvement of Rin in CHIKV infection was 
investigated in  live Ae. albopictus mosquitoes.
In insect cells, nsP3 localized as cytoplasmic granules, which was 
dependent on the central domain and the C-terminal variable region but 
independent of the N-terminal macrodomain. Ae. albopictus Rin displayed a 
diffuse, cytoplasmic localization, but was effectively sequestered into nsP3-
granules upon nsP3 co-expression. Site-directed mutagenesis showed that the 
Rin-nsP3 interaction involved the NTF2-like domain of Rin and two conserved 
TFGD repeats in the C-terminal variable domain of nsP3. Silencing of Rin in 
cultured mosquito cells did not change nsP3 localization, CHIKV replication 
levels, viral glycoprotein expression or virus production. In vivo, however, Rin 
depletion significantly decreased the CHIKV infection rate and transmissibility 
in Ae. albopictus. 
We identified the nsP3 hypervariable C-terminal domain as critical 
factor for granular localization and sequestration of mosquito Rin. Our 
study offers novel insight into a conserved virus-mosquito interaction at the 
molecular level, and reveals a strong proviral role for G3BP homologue Rin in 
live mosquitoes, making the nsP3-Rin interaction a putative target to interfere 
with the CHIKV transmission cycle.
This chapter is in preparation for submission as:
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Introduction 
Chikungunya virus (CHIKV) is a member of the genus Alphavirus (family 
Togaviridae), a group of widely distributed human and animal pathogens. 
The New world alphaviruses can cause encephalitic disease in humans, while 
the Old world alphaviruses, including CHIKV, Sindbis virus (SINV), O’nyong 
nyong virus (ONNV) and Semliki Forest virus (SFV), are associated with 
rash, fever and (sometimes chronic) arthritis (135). CHIKV is transmitted by 
vector mosquitoes and actively replicates in mosquitoes of the genus Aedes, in 
particular Ae. aegypti and Ae. albopictus. CHIKV is endemic in most of Central 
Africa and South-East Asia. In 2005-2006, major outbreaks of CHIKV occurred 
on the Indian Ocean islands of Mayotte, Seychelles, Mauritius and La Réunion, 
where more than one-third of the population was infected and resultant deaths 
were reported (135)(Schwartz & Albert, 2010). In 2006-2007 CHIKV caused a 
major outbreak in India (~1.3 million cases), followed by outbreaks in the rest 
of South-East Asia (136). The first autochthonous CHIKV outbreak in Europe 
occurred in Italy in 2007, where more than 200 people were infected (32). 
Likewise, a local CHIKV transmission by Ae. albopictus occurred in France 
in 2010 (2 cases) and 2014 (4 cases) (33, 34). The outbreak that started in the 
Caribbean in 2013 has spread to the American main land and by December 2014 
over a million cases have been reported throughout the Americas (36, 137). No 
licensed vaccine or antiviral treatment against CHIKV is available at present, 
but many prototype vaccines are in development (138–144).
CHIKV proteins are translated from a viral single-stranded positive-
sense RNA of approximately 11.8kb (29, 145). The four alphavirus non-structural 
proteins (nsP1-4) are directly translated from genomic RNA and form a 
replication complex (RC), which is associated with the plasma membrane and 
endosomal membranes (146). A number of functions have been assigned to 
alphavirus nsPs: nsP1 is involved in capping of RNA (145) and is the membrane 
anchor of the RC (146), nsP2 has protease and helicase activity, causes host 
shut-off and inhibits interferon-induced JAK-STAT signaling and the unfolded 
protein response (147–150). NsP4 serves as RNA-dependent RNA polymerase 
(29). The functions of nsP3 are more enigmatic, but the protein is highly 
phosphorylated on serine and threonine residues (151, 152) and is essential for 
RNA synthesis (153) as part of the viral RC (146). CHIKV nsP3 can be divided 
in three regions; the macrodomain (amino acids 1-160) is conserved among 
alphaviruses, Coronaviridae, rubella and hepatitis E viruses and can bind ADP-
ribose, RNA and DNA in vitro (154).  The central, zinc-binding domain (amino 
acids 161-324) is conserved among alphaviruses, while the C-terminal region 
is highly variable and even shows substantial dissimilarity between CHIKV 
strains (155, 156). 
SINV nsP3 is found in cytoplasmic granules or foci which are also 
comprised of various host proteins (92, 93). In both mammalian and mosquito 
cells the cellular protein Ras-GAP SH3 domain binding proteins (G3BPs) were 
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found in nsP3-granules (92, 93). G3BPs are ubiquitously expressed proteins 
conserved among eukaryotes. Mammals have three G3BPs: G3BP1, 2a and 
2b, which are expressed from 2 distinct genes, while insects have one, named 
Rasputin (Rin) (157). Mammalian G3BP is a widely used marker for stress 
granules (SGs) (158), which are cytoplasmic messenger ribonucleoproteins 
(mRNPs) that form when translation is impaired in response to several types of 
cellular stress (90). NsP3-G3BP-granules are the explicit phenotype of the first 
reported function of alphavirus nsP3, as we have recently shown that CHIKV 
nsP3-G3BP granule formation prevents the establishment of bona fide SGs 
(159). These nsP3-G3BP-granules did not contain any other SG markers (e.g. 
eIF3) and cells expressing nsP3 were unable to respond normally to oxidative 
stress (159). The inhibition of SGs via an interaction between nsP3 and G3BP 
has now also been confirmed for SFV (160). Details on the interaction between 
nsP3 and mosquito Rin are currently lacking.
Mosquito vectors display different degrees of vector competence for 
different CHIKV isolates (161). Vector competence is a complex trait involving 
an interplay between vectors, pathogens and environmental factors (162) 
but the molecular details are not well understood. While it has been firmly 
established that antiviral RNAi pathways play a major role in controlling CHIKV 
and other arboviral infections in the mosquito (53, 133), other mechanisms of 
virus-host interactions that influence vector competence and the roles therein 
of viral (non)structural proteins need to be examined. Recently, however, nsP3 
of ONNV (transmitted by Anopheles mosquitoes), has been uncovered as an 
important determinant for vector specificity. CHIKV does not normally infect 
An. gambiae, however, a chimeric virus containing ONNV nsP3 in a CHIKV 
infectious clone backbone became infectious for An. gambiae mosquitoes (99). 
Thus, it is hypothesized that specific molecular interactions between mosquito 
host factors and alphavirus nsP3 determine the vector specificity.  
In the present study, we investigated the formation of nsP3-granules 
in insect cells and elucidated the molecular interactions between nsP3 and 
Rin. Moreover, we studied the effect of Rin silencing on virus replication in 
mosquito cell culture and on vector competence for CHIKV in mosquitoes. We 
show that Rin is an important, proviral determinant for CHIKV infection and 
dissemination in live mosquitoes.
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Materials and methods 
Cells and viruses  
Spodoptera frugiperda Sf21 cells were cultured in Grace’s medium 
(Invitrogen) with 10% fetal bovine serum (FBS; Invitrogen) and Sf9 cells in 
Sf900 medium (Invitrogen) with 5% FBS. Aedes albopictus U4.4 cells and 
C6/36 cells were cultured in Leibovitz’s medium (Invitrogen) supplemented 
with 10% FBS, 2% tryptose phosphate (Invitrogen) and 1% non-essential 
amino acids (Invitrogen). All insect cells were cultured at 27°C. Vero E6 and 
HEK293t mammalian cells were cultured in Dulbecco’s modified Eagle medium 
(Invitrogen) supplemented with 10% FBS at 37°C and 5% CO2. Infections in cell 
culture were performed with CHIKV isolate S27 and mosquitoes were infected 
with CHIKV 06-021 strain.    
Plasmid construction 
Cloning of EGFP-nsP3 was described previously and cloned via Gateway 
technology into pcDNA/Dest40 and pIB-GW plasmid backbones for CMV 
and OpIE2 driven expression, respectively. Plasmids pIB-EGFP-nsP3.2, pIB-
EGFP-nsP3-DDEL, and pIB-EGFP-nsP3-dUGA were generated by PCR from 
pIB-EGFP-nsP3 using the phosphorylated forward primer attB2-R-phos and 
reverse primers CHIKVnsP3-2R, CHIKVnsP3-DDEL-R, and CHIKVnsP3-
dUGA-R, respectively. Plasmids pIB-EGFP-nsP3.7, pIB-EGFP-nsP3.8, and pIB-
EGFP-nsP3.10 were generated from pIB-EGFP-nsP3 and pIB-EGFP-nsP3.2 using 
the phosphorylated reverse primer EGFP-R-phos and forward primers EcoRI-
nsP3-161-F (nsP3.7 and nsP3.8), or EcoRI-nsP3-319-F (nsP3.10). Ae. albopictus 
Rin was amplified by RT-PCR (Invitrogen) from total RNA isolated from U4.4 
cells using the Rin forward and revese primers and cloned into pGEM-T easy 
(Promega) and sequenced (Genbank accession number KP641128). To obtain 
pIB-Rin-mCherry, Rin was amplified by PCR from pGEM-Teasy-Rin using 
primers containing HindIII sites and was inserted as a HindIII fragment into pIB-
mCherry, in frame with and upstream of mCherry. Site-directed mutagenesis 
of pIB-EGFP-nsP3 and pIB-Rin-mCherry was performed using the forward 
and reverse primers for nsP3-P398A, nsP3-PRR401AAA, nsP3-FG479AA, nsP3-
FG497AA, Rin-F34A and Rin-F34W. All constructs were verified by sequencing 
and primer sequences are listed in Table 1. 
Transient expression of nsP3 and Rin  
Insect cells were transfected with the indicated expression plasmids using 
Fectofly I (Polyplus) or ExpreS2 rt (ExpreS2ion Biotechnologies). Mammalian 
cells were transfected with lipofectamine 2000 (Invitrogen). Twenty-four hours 
post transfection the fluorescence of EGFP-nsP3 and/or Rin-mCherry was 
analysed using a Zeiss Axio Observer Z1m inverted microscope in combination 
with an X-Cite 120 series lamp. 
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Rin Knockdown experiments 
Linear DNA of Ae. albopictus Rin and firefly luciferase was generated by 
PCR from pGEM-T easy plasmids using the T7 universal primer (New England 
Biolabs) and T7-pGEM-Teasy-R and double-stranded (ds)RNA was synthesized 
in vitro with T7 RNA polymerase (Invitrogen). Knockdown in cell culture was 
Table 4.1. Oligonucleotides used in this study. 
Name  Sequence 
attB2-R-phos  TCATACCCAGCTTTCTTGTAC 
CHIKVnsP3-2R TCAGCGTGATGGCACGTTATGG 
CHIKV nsP3-DDEL-R TCATAATTCGTCGTCCGTGTC 
CHIKV nsP3-dUGA-R TCACCCACCTGCCCTATCTAGTAATTCGTCGTCCGTGTCTG 
EGFP-R-phos CTTGTACAGCTCGTCCATG 
EcoRI-nsP3-161-F CAAGTGGAATTACTAGACGAAC 
nsP3-319-F GTTAGTCCAAGGGAATATAAATC 
Aalb-Rin-F ATGGTAATGGAAGCACAACC 
Aalb-Rin-R CTAACGTCGTCCTCCGTAG 
Aalb-Rin-intF TCCAAGTGTCGCTACC 
HindIII-EcoRI-Aalb-Rin-F GATAAGCTTGAATTCACCATGGTAATGGAAGCACAACC 
HindIII-Aalb-Rin-R GATAAGCTTACGTCGTCCTCCGTAGG 
nsP3-FG479AA F TAACGGCCGCGGATTTTGATGAAGGGGAGA
nsP3-FG479AA R AATCCGCGGCCGTTATGGGGAAAGTCTCGT
nsP3-FG497AA F TGACCGCTGCGGACTTCTCGCCGGGCGAAG
nsP3-FG497AA R GTCCGCAGCGGTCAGTAACTCAGAGGACAA
Rin-F34A F GCACCGTGCCTACAACAACTCGTCGAGCTTC
Rin-F34A R TGTTGTAGGCACGGTGCAGGTGATCCGGCG
Rin-F34A F GCACCGTTGGTACAACAACTCGTCGAGCTTC
Rin-F34A R TGTTGTACCAACGGTGCAGGTGATCCGGCG
T7-pGEM-Teasy-R TAATACGACTCACTATAGGGGCCGCGAATTCACTAGTG 
Aalb-Rin F2 GTATGCCAACCATTGATCCG
Aalb-Rin R2 GTCCAGTTCGTTCATTGACAG
nsP1-int F CTGACGGAAGGTAGACGAG
nsP1-int R2 GCACGTGAAGCTGAGCTTCCC
S7 F CCAGGCTATCCTGGAGTTG
S7 R GACGTGCTTGCCGGAGAAC
nsP3-P398A F GAATACCGCGGCAGTCGCA
nsP3-P398A R TGCGACTGCCGCGGTATTC
nsP3-PRR401AAA F CGCCAGTCGCAGCGGCCGCAAGAAGACGTGGGAA
nsP3-PRR401AAA R CCCACGTCTTCTTGCGGCCGCTGCGACTGGCGCGGTAT
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performed by transfecting dsRNA into U4.4 cells grown in 24-wells plates (1µg 
of RNA per well) using Fugene (promega). One day later, cells were transfected 
with plasmid pIB-EGFP-nsP3 to monitor nsP3-granule formation or infected 
with CHIKV at a multiplicity of infection (MOI) of five. At the indicated times 
post infection, the medium was removed from the cells and used in end point 
dilution assays on Vero E6 cells. The remaining cells were lysed in TRIzol (life 
technologies) reagent and total RNA was isolated. The RNA was DNase treated 
(Applied Biosystems) and reverse transcribed using random primers. Rin, S7 
and genomic CHIKV cDNA were amplified (primers: Rin F2/R2, S7 F/R and nsP1 
int F/R2) and detected with real-time PCR platinum SYBR Green (Invitrogen), 
in a Rotor Gene RG-3000 (Corbett Research). 
In parallel experiments, cells were washed with PBS and lysed in 
SDS-loading buffer [100 mM Tris-Cl (pH 6.8), 4% (w/v) sodium dodecyl 
sulfate (SDS), 0.2% (w/v) bromophenol blue, 20% (v/v) glycerol and 200 
mM β-mercaptoethanol]. Samples were heated at 95oC for 10 min, clarified 
by centrifugation for one min at 13 000 r.p.m and loaded on a 12% SDS-
Polyacrylamide gel. After electrophoresis, denatured proteins were transferred 
to an Immobilon membrane (Millipore) for analysis by Western blotting. 
Membranes were blocked in 3% skimmed milk in PBS with 0.05% Tween 60 
(PBST) for 1 h at room temperature. Membranes were washed three times for 5 
min each with PBST and subsequently incubated for 1 h at room temperature 
with rabbit polyclonal anti-E2 (diluted 1 : 20000; (163)) and anti-β-tubulin 
(diluted 1 : 4000; Abcam) in PBST, respectively. Membranes were washed and 
treated with alkaline phosphatase conjugated with goat anti-rabbit IgG mAb 
(Sigma), diluted 1 : 3000 in PBST, for 45 min at room temperature. Membranes 
were washed twice for 5 min each with PBST and once for 10 min with AP 
buffer [100 mM NaCl, 5 mM MgCl2, 100 mM Tris/HCl (pH 9.5), 0.1% Tween 
20]. Proteins were detected by nitro blue tetrazolium chloride/BCIP staining 
(Roche).
 In vivo knock down of Rin was performed in Ae. albopictus mosquitoes 
originating from la Reunion island (Providence, F11 generation). 500 ng of 
dsRin or dsLuc RNA was injected directly in the thorax of female mosquitoes 
(Drummond nanoject II). Two days post injection mosquitoes were either 
sacrificed and stored at -80oC or orally infected with an infectious blood 
meal containing 107 pfu/ml of CHIKV 06-021 strain. Mosquito rearing and 
preparation of the infectious blood meal was reported previously (162). Fully 
engorged females were selected and incubated in climatic chambers (Binder) 
at 28°C, with a light: dark cycle of 16h: 8h and 70% relative humidity. Forced 
salivation were performed 6 days post-infection as described previously (161). 
Saliva and mosquitoes were stored at -80oC pending further analysis.         
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Infectivity assays
Frozen mosquitoes were dissected, separating bodies (abdomen and 
thorax) from the head. Individual mosquito bodies and heads were homogenized 
in the bullet blender storm (Next Advance) in 100 µl of DMEM Hepes (Gibco)-
buffered medium supplemented with 10% FBS containing penicillin (100 IU/
ml), streptomycin (100 μg/ml), fungizone (2,5 μg/ml) and gentamycin (50 μg/
ml) and spun down for 90 seconds at 14,000 rpm in a   table top centrifuge. Thirty 
μl of the supernatant from the mosquito homogenate or the saliva-containing 
mixture was incubated on a monolayer of Vero cells in a 96-wells plate. After 
2-4 hours the medium was replaced by 100 µl of fresh cell culture medium, fully 
supplemented with antibiotics. Wells were scored for virus specific cytopathic 
effects (CPE) at three days post infection. Viral titres were determined using 10 
µl of the supernatant from the mosquito homogenates in an end point dilution 
assay on Vero E6 cells. Infections were scored by CPE, three days post infection.
Statistical analysis
CHIKV infections in mosquito bodies and heads were scored positive 
or negative and significant differences were calculated using the Fisher’s exact 
test (P<0.05).  Differences in CHIKV titers (TCID50/ml) in infected mosquito 
bodies and heads were calculated using the Mann Whitney test (P<0.05). 
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Results 
CHIKV nsP3 displays granular localization in both insect and mammalian 
cells 
Previous studies on the alphaviruses SINV, SFV and CHIKV showed that 
viral nonstructural protein nsP3, either in its authentic form or fused to markers 
like EGFP or mCherry, localized to cytoplasmic granules in mammalian cells 
(93, 159, 164, 165). To investigate if nsP3 has a similar intracellular distribution in 
insect cells, CHIKV nsP3 was transiently expressed, from an OpIE2 promoter-
driven insect expression vector, with a N-terminal EGFP fusion (Figure 4.1A) 
in cell lines derived from mosquitoes (Ae. albopictus, U4.4 and C6/36) (Figure 
4.1B, left) and lepidopteran insects (Spodoptera frugiperda, Sf21 and Sf9) 
(Figure 4.1B, middle). As a control, CHIKV nsP3 was also expressed in Vero and 
HEK293T cells (Figure 4.1B, right). In all cell lines tested, CHIKV nsP3 formed 
cytoplasmic granules (Figure 4.1B), which indicates that the intracellular 
localization of nsP3 is conserved in cells of both vertebrate and invertebrate 
origin. 
The gene encoding CHIKV nsP3 contains a natural leaky (opal) stop 
codon, six codons upstream of the nsP3-4 cleavage site. Two isoforms of nsP3 
are likely to be expressed from this gene during viral infections. To investigate 
whether both isoforms would have the same intracellular localization, two 
additional EGFP-fusions were made, one with nsP3 lacking the C-terminal six 
amino acids (CHIKV nsP3-DDEL) and one with nsP3 lacking the leaky stop 
codon (CHIKV nsP3-dUGA) (Figure 4.1A). When transiently expressed in 
insect cells, CHIKV nsP3 and the two isoforms displayed an identical granular 
localization (Figure 4.1C), which shows that the terminal six amino acids of 
CHIKV nsP3 do not impact its subcellular localization. 
The conserved domain of CHIKV nsP3 is sufficient for multimerization 
but the variable domain is required for the formation of nsP3-granules
In mammalian cells, the C-terminal variable domain was found to be 
essential for nsP3 granule formation, and upon deletion the localization 
changed to a filamentous phenotype (159). To determine which domains within 
nsP3 are responsible for the formation of nsP3-granules, truncated versions of 
nsP3 fused with EGFP (Figure 4.1A) were expressed in insect cells (Figure 4.1D). 
Removal of the entire C-terminal variable region (nsP3.2) resulted in the 
formation of filamentous, cytoplasmic structures. (Figure 4.1D, left). To 
investigate whether the macrodomain could be eliminated from nsP3 without 
affecting its localization, it was deleted from EGFP-fused nsP3 and nsP3.2, 
yielding truncated mutants nsP3.7 and nsP3.8, respectively (Figure 4.1A). When 
expressed in insect cells, nsP3.7 showed an identical granular phenotype as 
full-length nsP3, whereas nsP3.8 formed filaments that were very similar to 
those produced by nsP3.2 (Figure 4.1D, middle). To investigate if the C-terminal, 
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variable region alone could cause granule formation, it was N-terminally fused 
to EGFP (nsP3.10) (Figure 4.1A) and expressed in insect cells. The localization 
of nsP3.10 was diffuse, nuclear-cytoplasmic (Figure 4.1D, right), showing that 
the C-terminal region of CHIKV nsP3 is required, but not sufficient for the 
formation of nsP3 granules. 
Figure 4.1. CHIKV nsP3 forms granules in insect cells. A. Schematic representation of CHIKV 
nsP3 variants used in this study. Representing either the full length protein N-terminally fused 
to EGFP (nsP3), nsP3 isoforms with adapted C-terminal amino acids (nsP3, nsP3-DDEL and 
nsP3-dUAG) or truncated nsP3 variants (nsP3.2, 3.7, 3.8 and 3.10). Asterisk indicates opal stop 
codon between nsP3 and nsP4. B. Intracellular distribution of wild type CHIKV nsP3 in cultured 
insect and mammalian cells. Mosquito and lepidopteran cells were transfected with plasmids 
that express the nsP3 variants from  OpIE2 insect promoters. In mammalian cells expression 
of the nsP3 variants was driven by a cytomegalovirus promoter. C. Intracellular distribution of 
nsP3-DDEL and nsP3-dAUG in insect cells. D. Intracellular distribution of the truncated nsP3 
variants.
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NsP3 granules co-localize with Rasputin, the insect homolog of 
mammalian G3BP  
In SINV nsP3 pull-down studies, G3BP and its insect homologue Rasputin 
(Rin) were identified as predominant nsP3-interacting proteins in virus-
infected mammalian and mosquito cells, respectively (93). To study a putative 
interaction of CHIKV nsP3 with mosquito Rin in live cells, the gene encoding 
Ae. albopictus Rin was amplified by RT-PCR from total RNA isolated from U4.4 
cells using PCR primers specific for Ae. aegypti Rin. We cloned and sequenced 
Figure 4.2. CHIKV nsP3 sequesters mosquito Rasputin into cytoplasmic granules. A. 
Schematic representation of Ae.albopictus-Rin-mCherry. NTF2; nuclear transport factor 2-like 
domain, RRM: RNA recognition motif, RGG; arginine-glycine rich box. B. Ae.albopictus-Rin-
mCherry or EGFP-nsP3 were transiently expressed in insect cells and display diffuse and granular 
intracellular distributions, respectively. C. Ae.albopictus-Rin-mCherry and EGFP-nsP3 (top) or 
EGFP-nsP3.8 (bottom) were co-transfected into insect cells. Magnified images are presented.  
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the obtained amplicon. The Ae. albopictus Rin sequence (Genbank: KP641128) 
was 307 amino acids longer than human G3BP1, but the nuclear transport factor 
2 (NTF2)-like domain, the RNA recognition motif (RRM) and the arginine 
glycine-rich (RGG-)box were conserved between these species (Figure 4.2A). 
The subcellular localization of Rin was studied by transient expression 
in insect cells as C-terminal fusion with mCherry, in a similar fashion to a 
previously described and functional G3BP-EGFP fusion (158). When expressed 
in insect cells, Rin was evenly distributed throughout the cytoplasm (Figure 
4.2B, left). However, when Rin was co-expressed with nsP3, which localized to 
small nsP3 granules (Figure 4.2B, right), both proteins displayed complete co-
localization and formed much larger granules (Figure 4.2C, top). These nsP3- 
and Rin-positive granules or aggregates were larger and more asymmetrical 
than normal nsP3-granules. In this experiment, Rin was transiently (over)
expressed, which may explain the large size of the granules. In contrast, when 
mCherry-Rin was co-expressed with the C-terminal truncated, filamentous 
mutants EGFP-nsP3.8 (Figure 4.2C, bottom) or EGF-nsP3.2 (not shown), Rin 
did not co-localize with the filaments formed by these mutants and retained its 
diffuse, cytoplasmic localization (Figure 4.2C). In conclusion, the C-terminal 
hypervariable domain of nsP3 is important for the interaction with Rin in 
insect cells. 
The C-terminal TFGD repeats in the variable domain of CHIKV nsP3 
interact with Rasputin
Previously we showed that transiently expressed CHIKV nsP3 sequesters 
G3BP into cytoplasmic granules in mammalian cells. Deletion of a conserved 
SH3-domain binding motif (PVAPPRRRR) in the variable domain of nsP3 
resulted in a diffuse nuclear/cytoplasmic localization of nsP3 and abrogated 
the interaction between nsP3 and G3BP, restoring the potential of the cell 
to respond to oxidative stress (159). A recent study, however, convincingly 
showed that the interaction between nsP3 and mammalian G3BP depends on 
two conserved repeats (with core sequence TFGD) in the variable domain of 
nsP3 (166). To further investigate which domain(s) of nsP3 are crucial for the 
interaction between CHIKV nsP3 and Rin, both the SH3-domain binding motif 
and conserved TFGD repeats in  the variable domain of nsP3 were mutated 
using site-directed mutagenesis (Figure 4.3A). When EGFP-nsP3 and Rin-
mCherry were transiently expressed in insect cells, both wild type proteins 
displayed perfect co-localization. Deletion of the SH3-domain binding motif 
(nsP3-d398/406) resulted in a diffuse nuclear/cytoplasmic distribution of 
nsP3 and a diffuse mainly cytoplasmic localization of Rin (Figure 4.3B, second 
panel), identical to the distribution of nsP3 and G3BP in mammalian cells (159). 
However, when conserved proline and/or argenine residues from the SH3-
domain binding motif were substituted for alanines (nsP3-P398A and nsP3-
PRR401AAA) the co-localization of nsP3 and Rin in cytoplasmic nsP3-granules 
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remained unchanged (Figure 4.3B). 
   Next, we mutated both domains of the two conserved TFGD repeats 
separately or together resulting in pIB-EGFP-nsP3-FG479AA, pIB-EGFP-nsP3-
FG497AA, and pIB-EGFP-nsP3-FG479AA/FG497AA. The single and double 
EGFP-nsP3 TFGD mutants were transiently expressed in insect cells together 
with Rin-mCherry. Both the single FG479AA and FG497AA mutants still 
sequestered Rin into nsP3-granules (Figure 4.3C, top and middle panels).  The 
double TFGD mutant, however, displayed a completely diffuse intracellular 
distribution of Rin (Figure 4.3C, bottom panel) but retained a normal granular 
distribution similar to wildtype EGFP-nsP3 (Figure 4.1B).  
 These results indicate that deletion of the SH3-domain binding motif 
does abrogate the formation of nsP3 granules, but the formation of nsP3-
granules and the interaction with Rin is retained when conserved amino acids 
within the this domain are substituted for alanines. However, the formation of 
Figure 4.3. The C-terminal TFGD repeats of nsP3 interact with mosquito Ras-
putin. A. Schematic representation of nsP3 and the conserved domains within the 
C-terminal variable domain. Deletions and mutations are indicated in the amino acid 
sequence. Insect cells were co-transfected with Rin-mCherry and either one of the 
EGFP-nsP3 variants. B. SH3-domain binding motif, nsP3-d398/406, nsP3-P398A or 
nsP3-PRR401AAA. C. C-terminal repeats, EGFP-nsP3-FG479AA, EGFP-nsP3-FG497AA 
or EGFP-nsP3-FG479AA/FG497AA.
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CHIKV nsP3-Rin-granules is also abrogated when both the C-terminal 
conserved TFGD repeats are mutated, suggesting that these motifs are involved 
in the nsP3-rin interaction. 
Figure 4.4. nsP3 interacts with the NTF2-like domain of mosquito Rasputin. A. Protein 
alignment of the Rin/G3BP NTF2-like domains from Ae. albopictus (KP641128),  Ae. aegypti, 
(XP_001651045), Culex quincefasciatus (XP_001861860), Anopheles gambiae (XP_001688309), 
Anopheles sinensis (KFB40464), Drosophila melanogaster (AF231031), Ixodes ricinus 
(GANP01009274), and Homo sapiens (CAG38772). Genbank accession numbers in brackets. 
Alignment made with CLUSTALX and modified using Genedoc. B. Structural modeling of Ae. 
albopictus-Rin modeled onto Drosophila melanogaster Rin. Modeling was performed using the 
Phyre2 server (www.sbg.bio.ic.ac.uk/phyre2), results were visualized with PyMOL (www.pymol.
org). Left, Ae. albopictus Rin (deep blue) is depicted together with  D. melanogaster Rin (cyan). 
Right, the FxFG binding pocket is shown and phenyl alanine 34 is highlighted in red. C. Insect 
cells were co-transfected with EGFP-nsP3 and either Rin-mCherry (wild type), Rin-mCherry 
F34A or Rin-mCherry F34W.
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The NTF2-like domain of mosquito Rin interacts with CHIKV nsP3.  
The NTF2-like domain of G3BP has been shown to interact with SINV 
nsP3 in mammalian cells (92) . The first 140 amino acids of mosquito Rin show 
high sequence homology to that of human G3BP and other NTF2-like domains 
(Figure 4.4A). Protein structure prediction or Ae. albopictus Rin revealed a 
100% structural homology of the NTF2-like domain with those of G3BP and 
Drosophila Rin (Figure 4.4B, left).  Here we mutated a phenylalanine of Rin 
(F34) that is expected to interact with the phenylalanines of FxFG domains via 
pi-stacking (Figure 4.4B, right) (167). Indeed, mutations F34W or F34A strongly 
reduced the sequestration of Rin into nsP3-granules (Figure 4.4C), indicating 
that this amino acid is essential for nsP3-Rin interaction.  
Effect of Rasputin  silencing on the formation of CHIKV nsP3-granules
So far, we have shown that nsP3 has a granular localization and that Rin has 
a diffuse cytoplasmic localization when expressed individually. To investigate 
whether the formation of nsP3-granules requires Rin, localization of EGFP-nsP3 
was studied after Rin expression was silenced in mosquito cells using dsRNA-
mediated RNAi. U4.4 mosquito cells were transfected with dsRNA from either 
Rin (dsRin) or firefly luciferase (dsLuc) as a control. Semi-quantitative RT-PCR 
on Ae. albopictus Rin mRNA, normalized by housekeeping gene S7 mRNA, 
showed a 90% reduction in Rin mRNA when cells were transfected with dsRin 
RNA (Figure 4.5A). Subsequent transient expression of EGFP-nsP3 displayed 
clear nsP3-granules in both dsRin and dsLuc transfected cells (Figure 4.5B). 
This result indicates that mosquito Rasputin is not required for the formation 
of CHIKV nsP3-granules in mosquito cells.
Figure 4.5. Formation of nsP3-granules is independent of mosquito Rasputin. A. Rin 
silencing was determined by semi-quantitative RT-PCR on Ae. albopictus Rin mRNA, relative 
for the internal control S7. Bars represent relative Rin mRNA expression normalized to dsLuc 
transfected samples. Error bars indicate standard deviation of duplicate samples from a single 
representative experiment, which is presented in B. B. U4.4 mosquito cells were transfected 
with dsRNA against Ae. albopictus Rin or luciferase. Twenty-four hours later these cells were 
transfected with wild type EGFP-nsP3, displaying a granular localization.
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Effect of Rasputin silencing on CHIKV infection in mosquito cell culture 
Next, we examined the effects of Rin knock down on CHIKV infection 
in mosquito cell culture. U4.4 mosquito cells were transfected with dsRin or 
dsLuc. Twenty four hours later, cells were infected with CHIKV at an MOI 
of five. Sixteen and twenty-four hpi, total RNA was isolated, viral structural 
proteins were detected and viral titers were determined. Semi-quantitative 
RT-PCR on transcripts purified from CHIKV infected cells showed that Rin 
silencing was efficient (>70%) (Figure 4.6A). To quantify replication levels of 
CHIKV in Rin silenced cells the relative levels of CHIKV genomic RNA were 
measured. CHIKV replication produced equal concentrations of genomic RNA 
in Rin-depleted versus dsLuc transfected cells at both timepoints (Figure 4.6B).
 Structural protein expression of CHIKV was detected in an immunoblot using 
E2 polyclonal antiserum, with no apparent differences between dsRin and 
dsLuc transfected cells, at both timepoints (Figure 4.6C, arrow). Correspondingly, 
the CHIKV titer in Rin-depleted cells was similar to the titer in cells transfected 
with dsLuc RNA (Figure 4.6D). We conclude that Rin depletion in cell culture 
does not affect CHIKV RNA replication, structural protein expression or virion 
production. 
Rasputin silencing limits the CHIKV infection rate and transmissibility 
in Aedes albopictus
As alphavirus nsP3 is a determinant for vector specificity (99) and 
specifically interacts with Rin, we finally investigated the putative role for Rin 
during CHIKV infection in live mosquitoes. Ae. albopictus females (5-day old, 
200 per group) were intrathoracically injected with 500 ng dsRNA against Rin 
or Fluc (day -2). Two days later (day 0), the mosquitoes were offered a blood 
meal containing 107 pfu/ml CHIKV. Six days after blood feeding saliva was 
isolated and the mosquitoes were sacrificed (Day 6)(Figure 4.7A). Silencing of 
Rin mRNA was confirmed in mosquitoes on the day of the blood meal, two days 
post dsRNA injections. Total RNA was isolated and relative Rin mRNA copies 
were quantified. Mean values in relative Rin mRNA copies in the dsRin injected 
mosquitoes were 60% of the dsLuc injected mosquitoes (Figure 4.7B). 
On day six, mosquito saliva was obtained and the mosquito heads were 
separated from their thorax and abdomen, to distinguish between infections 
that were transmissible, fully disseminated or limited to the mosquito body, 
respectively. Mosquito saliva or homogenate from either heads or bodies were 
incubated on Vero cells to determine the presence of CHIKV. CHIKV infected 
75% of the mosquitoes that were injected with dsLuc RNA. In these mosquitoes 
the infection had also disseminated into the head of the mosquito. In addition, 
it resulted in two mosquitoes with infectious saliva (Figure 4.7C, red symbols). 
Injection with dsRin significantly reduced (P<0.05) the number of infected 
mosquito bodies to 40% with identical percentages in mosquito heads and no 
mosquitoes with infectious saliva (Figure 4.7C). In addition, Rin silencing also 
reduced the viral titers in the infected mosquitoes, with significant reductions 
in the mosquito heads (P<0.05, Figure 4.7D). Together, these results show a 
significant effect of Rin silencing on the infection rate and dissemination of 
CHIKV in Ae. albopictus.
Figure 4.6. CHIKV infection is not affected by Rin depletion in cultured mosquito cells. 
In four independent experiments, U4.4 mosquito cells were transfected with dsRNA against Ae. 
albopictus Rin or luciferase. Twenty-four hours later these cells were infected with CHIKV (MOI 
5) and total RNA was isolated at 16 or 24 hpi. A. Rin silencing was determined by semi-quantitative 
RT-PCR on Ae. albopicutus Rin mRNA, normalized for the internal control S7. B. CHIKV genomic 
RNA was quantified with primers that anneal to the nsP1 gene. C. CHIKV structural protein 
expression was determined by immunoblot staining against CHIKV E2 and host cell β-tubulin. 
Protein sizes indicated in kDa. D. At the indicated hpi medium was harvested and the CHIKV 
TCID50/ml was determined in end point dilution essays. A,B,D. Bars represent the mean of four 
independent experiments, normalized to the respective value of dsLuc transfected samples in 
each individual experiment. Error bars represent one standard error of the mean.
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 Structural protein expression of CHIKV was detected in an immunoblot using 
E2 polyclonal antiserum, with no apparent differences between dsRin and 
dsLuc transfected cells, at both timepoints (Figure 4.6C, arrow). Correspondingly, 
the CHIKV titer in Rin-depleted cells was similar to the titer in cells transfected 
with dsLuc RNA (Figure 4.6D). We conclude that Rin depletion in cell culture 
does not affect CHIKV RNA replication, structural protein expression or virion 
production. 
Rasputin silencing limits the CHIKV infection rate and transmissibility 
in Aedes albopictus
As alphavirus nsP3 is a determinant for vector specificity (99) and 
specifically interacts with Rin, we finally investigated the putative role for Rin 
during CHIKV infection in live mosquitoes. Ae. albopictus females (5-day old, 
200 per group) were intrathoracically injected with 500 ng dsRNA against Rin 
or Fluc (day -2). Two days later (day 0), the mosquitoes were offered a blood 
meal containing 107 pfu/ml CHIKV. Six days after blood feeding saliva was 
isolated and the mosquitoes were sacrificed (Day 6)(Figure 4.7A). Silencing of 
Rin mRNA was confirmed in mosquitoes on the day of the blood meal, two days 
post dsRNA injections. Total RNA was isolated and relative Rin mRNA copies 
were quantified. Mean values in relative Rin mRNA copies in the dsRin injected 
mosquitoes were 60% of the dsLuc injected mosquitoes (Figure 4.7B). 
On day six, mosquito saliva was obtained and the mosquito heads were 
separated from their thorax and abdomen, to distinguish between infections 
that were transmissible, fully disseminated or limited to the mosquito body, 
respectively. Mosquito saliva or homogenate from either heads or bodies were 
incubated on Vero cells to determine the presence of CHIKV. CHIKV infected 
75% of the mosquitoes that were injected with dsLuc RNA. In these mosquitoes 
the infection had also disseminated into the head of the mosquito. In addition, 
it resulted in two mosquitoes with infectious saliva (Figure 4.7C, red symbols). 
Injection with dsRin significantly reduced (P<0.05) the number of infected 
mosquito bodies to 40% with identical percentages in mosquito heads and no 
mosquitoes with infectious saliva (Figure 4.7C). In addition, Rin silencing also 
reduced the viral titers in the infected mosquitoes, with significant reductions 
in the mosquito heads (P<0.05, Figure 4.7D). Together, these results show a 
significant effect of Rin silencing on the infection rate and dissemination of 
CHIKV in Ae. albopictus.
Figure 4.6. CHIKV infection is not affected by Rin depletion in cultured mosquito cells. 
In four independent experiments, U4.4 mosquito cells were transfected with dsRNA against Ae. 
albopictus Rin or luciferase. Twenty-four hours later these cells were infected with CHIKV (MOI 
5) and total RNA was isolated at 16 or 24 hpi. A. Rin silencing was determined by semi-quantitative 
RT-PCR on Ae. albopicutus Rin mRNA, normalized for the internal control S7. B. CHIKV genomic 
RNA was quantified with primers that anneal to the nsP1 gene. C. CHIKV structural protein 
expression was determined by immunoblot staining against CHIKV E2 and host cell β-tubulin. 
Protein sizes indicated in kDa. D. At the indicated hpi medium was harvested and the CHIKV 
TCID50/ml was determined in end point dilution essays. A,B,D. Bars represent the mean of four 
independent experiments, normalized to the respective value of dsLuc transfected samples in 
each individual experiment. Error bars represent one standard error of the mean.
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Figure 4.7. Rin silencing reduces the CHIKV infection rate in live Aedes albopictus 
mosquitoes. A. Schematic representation of the experiment. Mosquitoes were injected with 
500ng of dsRin or dsLuc two days prior to blood feeding. On day 0, a subset of mosquitoes was 
sacrificed to determine the level of Rin depletion. Remaining mosquitoes were orally infected 
with CHIKV (107 pfu/ml) and sacrificed six days post infection. B. Total RNA was isolated and 
Rin silencing was determined by semi-quantitative RT-PCR on Ae. albopicutus Rin mRNA, 
normalized for the internal control S7. Bars represent mean Rin mRNA values normalized to 
dsLuc injected mosquitoes. Error bars indicate one standard error of the mean (n=5). C. Heads 
and bodies from the blood fed mosquitoes were separated, homogenized and the presence of 
CHIKV was determined by incubating the homogenate on Vero E6 cells. Bars represent the 
percentage of CHIKV positive mosquito bodies and heads from both dsLuc and dsRin injected 
mosquitoes. Asterisk indicates significant difference (P<0.05 Fisher’s exact test). D. From all the 
CHIKV positive mosquito heads and bodies the viral titers (TCID50/ml) were determined. Data 
points represent one individual mosquito head or body. Asterisk indicates significant difference 
between dsLuc and dsRin injected mosquitoes (P<0.05, Mann Whitney test) and red data points 
indicate mosquitoes with positive saliva.
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Discussion
In this study we investigated the localization of CHIKV nsP3 and its 
interaction with mosquito Rin in insect cells and live mosquitoes. Our results 
show that the intracellular distribution of CHIKV nsP3 is conserved in cells from 
mammalian and insect origin. In mosquito cells, CHIKV nsP3 forms cytoplasmic 
granules, which are highly similar to the nsP3-G3BP granules that inhibit the 
formation of SGs in mammalian cells (159). Removal of the variable domain 
results in the formation of filaments and both the granular or filamentous 
distribution of nsP3 is independent of the N-terminal macrodomain. This 
indicates that multimerization of nsP3 is attributed to the central conserved 
domain. How nsP3 multimerizes into these two diverse cytoplasmic phenotypes 
is unknown, however, removal of the C-terminal variable domain may cause 
a conformational change or affect interactions with host factors which allows 
nsP3 to form long cytoplasmic filaments. Whereas Rin is clearly sequestered 
into nsP3-granules and transient overexpression of Rin may increase the size 
of the nsP3-granules, silencing of Rin and reducing its co-localization with 
nsP3 by mutagenesis shows that Rin is not required for the formation of nsP3-
granules (Figures 4.3, 4.4 and 4.5). The exact structural composition of these 
nsP3 granules and filaments, however, needs further experimentation.
In mammalian cells, nsP3-granule formation and the inhibition of SGs 
is lost when the conserved SH3-domain binding motif is removed from the 
variable domain of nsP3 (159). Similarly, nsP3-d398/406 was diffuse throughout 
insect cells. Amino acid substitutions within the SH3-domain binding motif, 
however, did not affect the formation of nsP3-granules or the sequestration 
of mosquito Rin into granules. Apparently, the amino acid substitutions were 
not sufficient to abrogate the interaction between nsP3 and Rin. Alternatively, 
deletion of the complete SH3-domain binding motif may have disrupted the 
folding of nsP3, rendering a dysfuntional protein that no longer can execute 
its normal function. Indeed, deletion of the entire SH3-domain binding motif 
from a CHIKV replicon yielded a replication-negative phenotype (159).
 G3BP and nsP3 were also shown to interact via two conserved repeats 
in the C-terminal variable domain of nsP3 (166). When we replaced the 
phenylalanine and glycine from either one of the nsP3 C-terminal TFGD repeat 
with alanines there was no apparent change in the co-localization of nsP3 
and Rin. However, the interaction between nsP3 and Rin was completely lost 
when both TFGD repeats were mutated (Figure 4.3C). This suggests a direct 
interaction between these amino acid repeats and Rin and shows that both 
repeats interact with Rin but are exchangeable for the observed phenotype. Ae. 
albopictus Rin was isolated from U4.4 cells. Sequence analysis revealed that 
the N-terminal NTF2-like domain has high homology with other NTF2-like 
domains including human G3BP (Figure 4.4A). The three-dimensional crystal 
structures of the NTF2-like domains from Drosophila Rin and human G3BP 
have recently been resolved, and contain a binding pocket for FxFG containing 
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peptides (167, 168). The NTF2-like domain from Ae. albopictus Rin was modelled 
onto that of Drosophila, showing high resemblance (Figure 4.4B). As expected 
from this model, point mutations in the binding pocket of the Rin NTF2-like 
domain (position F34) greatly reduced the interaction between nsP3 and Rin 
(Figure 4.4C). Although Rin still partly localized to nsP3-granules, this result 
does provide evidence of an interaction between nsP3 and the NTF2-like FxFG 
binding pocket. A recent study has confirmed that this interaction is conserved 
between homologue sites in SFV nsP3 and vertebrate G3BP (169). Additional 
interactions were predicted between FxFG peptides and residues in the NTF2-
like binding pocket of G3BP (167), which could explain the strongly reduced, 
but not completely abolished, interaction with nsP3. 
Rasputin silencing did not affect CHIKV infection in cultured mosquito 
cells (Figure 4.6). This is in agreement with in vitro studies with SINV and 
siRNA-mediated G3BP1/2 silencing (170). However, a recent study that shows 
effective simultaneous knock down of both G3BP1 and G3BP2 resulted in 
decreased CHIKV replication rates, with severely reduced minus strand RNA 
replication (171).  Similarly, depletion of Rin during oral, in vivo infections 
resulted in a marked decrease in CHIKV infected mosquitoes and disseminated 
virus particles in the heads (Figure 4.7). This suggests that Rin is involved in 
the establishment of a productive infection and/or affects CHIKV infections in 
specific tissues. It also suggests that results obtained in cell lines are not always 
a good proxy for results in vivo. Indeed, midgut barriers have been described in 
arthropods that limit arbovirus replication and/or dissemination through the 
organism (64, 65). The interaction between nsP3 and Rin may play a significant 
role in modulating the midgut antiviral responses. Interestingly, exchanging 
the nsP3 genes of CHIKV and ONNV made CHIKV infectious for An. gambiae 
(99). Moreover, replacing only the C-terminal end of CHIKV nsP3, which is 
required for Rin interaction, with that of ONNV was sufficient to orally infect 
An. gambiae with CHIKV. This fragment encompasses the variable domain 
of CHIK nsP3, suggesting a strong role for the C-terminal domain of nsP3 in 
facilitating oral infection in specific vector species.
The decreased infectivity of CHIKV in Rin depleted mosquitoes suggests 
a proviral role for Rin. In Drosophila, Rin is involved in Ras and Rho-mediated 
signaling, cell proliferation and oogenesis (172–174). In mammalian cells, G3BP 
is essential for assembly of SGs, which display many antiviral characteristics 
(89, 175). In response, viruses often inhibit the formation of bona fide SGs 
(reviewed in (89). Poliovirus 3C cleaves G3BP (176), whereas others, including 
alphaviruses, induce viral granules that sequester G3BP and/or other SG factors 
(91, 159, 160, 177, 178). This suggests that viral-granules inhibit bona fide SG 
formation while at the same time utilizing SG components (e.g. G3BP/Rin) 
for their own replication. Indeed, flavivirus and hepatitis C virus infections 
bind SG components which increases their replication efficiency (177, 179). In 
Drospophila, Rin has been suggested to form RNase inhibitor complexes (173), 
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which could protect CHIKV RNA replication during the initial infection in 
the mosquito midgut. Clearly, the molecular details of nsP3 and Rin in live 
mosquitoes should be examined in follow up studies to uncover the exact 
mechanism. 
The interaction of nsP3 with Rin is highly homologous to that of 
nsP3 with G3BP in mammalian cells, which suggests that, in addition to the 
inhibition of SGs, nsP3-G3BP-granules formation can have additional roles to 
increase the infectivity of CHIKV or to evade antiviral responses. Disruption of 
this nsP3-Rin interaction could be of interest as a target for the development of 
compounds that stop the CHIKV transmission cycle.
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Chikungunya virus nsP3 blocks stress 
granule assembly by recruitment of G3BP 
into cytoplasmic foci
Chikungunya virus nonstructural protein nsP3 has an essential but unknown 
role in alphavirus replication and interacts with Ras-GAP SH3 domain-binding 
protein (G3BP). Here, we describe the first known function of nsP3 to inhibit 
stress granule assembly by recruiting G3BP  into cytoplasmic foci. A conserved 
SH3 domain-binding motif in nsP3 is essential for both nsP3-G3BP interactions 
and viral RNA replication. This study reveals a novel role for nsP3 as regulator 
of the cellular stress response.
This chapter has been published as:
Jelke J. Fros, Natalia E. Domeradzka, Jim Baggen, Corinne Geertsema, Jacky Flipse, Just M. Vlak 
and Gorben P. Pijlman. Chikungunya virus nsP3 blocks stress granule assembly by recruitment of 
G3BP into cytoplasmic foci. J. Virol. 86, 10873-9 (2012).
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Main text
Chikungunya virus (CHIKV; family Togaviridae, genus Alphavirus) can 
severely affect human health by causing debilitating disease with symptoms of 
high fever, rash, arthralgia and sometimes death (135). CHIKV is endemic in parts 
of Africa, the Indian Ocean area and Southern Asia (136, 180) and has recently 
been transmitted by the Asian tiger mosquito, Ae. albopictus, in Italy (2007)
(32) and France (2010)(34). CHIKV has a positive-sense, single-stranded RNA 
genome (gRNA) that encodes two polyproteins. The first polyprotein is directly 
translated from the gRNA and produces nonstructural proteins nsP1 to nsP4, 
which are essential for viral replication. The structural proteins are translated 
from a subgenomic RNA, which is transcribed later in infection from the viral 
26S promoter. NsP3 is the most enigmatic of all nsPs, with unclear yet essential 
roles in alphavirus RNA replication (153). NsP3 is highly phosphorylated (151, 
152), is part of the viral replication complex (RC) (146) and has been shown to 
interact with Ras-GAP SH3 domain binding proteins (G3BP1 and G3BP2) in two 
independent coimmunoprecipitation studies (92, 93). Infection with another 
Togaviridae member; Rubella virus, has been shown to alter the distribution of 
host-cell G3BP, suggesting that G3BP plays an important role in the outcome of 
viral infection (181). G3BP is an essential factor in the assembly of stress granules 
(SGs) (182), which  are non-membraneous cytoplasmic focal structures (foci) 
containing cytoplasmic messenger ribonucleoproteins (mRNPs). SGs rapidly 
aggregate in response to different types of environmental stress and lead to 
impaired translation of most mRNAs (90). SGs can have diverse anti- or proviral 
activities (89, 158, 183).
To investigate the relationship between CHIKV replication and SG 
formation, Vero cells were transfected with CHIKV replicon RNA, in two 
independent experiments, as described previously (148). Next, 16 hours 
post-transfection (hpt) cells were either exposed to oxidative stress by using 
arsenite to induce SGs or left untreated. Cells were immunostained for double 
stranded RNA (dsRNA, a replication intermediate of viral RNA replication) 
and/or G3BP (Figure 5.1). Cells that were treated with only transfection reagent 
(mock transfected)(Figure 5.1A,) responded to arsenite induced stress with 
the formation of SGs. G3BP readily localized to these typical SGs, displayed 
as irregularly shaped granules that converge around the nucleus and extend 
from there into the cytoplasm, and are often smaller when located farther away 
from the nucleus (Figure 5.1A, right). In contrast to arsenite-induced SGs, the 
presence of replicating CHIKV replicon RNA (visualized by the dsRNA signal, 
Figure 5.1B) caused G3BP to localize into foci that displayed a more punctate 
morphology and were distributed throughout the cytoplasm in a seemingly 
random manner (Figure 5.1B, top). Exposing cells that harbor replicating 
CHIKV replicon RNA to oxidative stress did not affect the morphology of these 
G3BP foci (Figure 5.1B, bottom left). Cells from the same sample that did not 
harbor replicating CHIKV replicon RNA after transfection were still able to 
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respond to arsenite with the formation of SGs (Figure 5.1B, bottom right).
To investigate the interaction between G3BP and the viral protein nsP3, 
an mCherry reporter protein was incorporated into nsP3 within the CHIKV 
replicon in a way similar to that described for Sindbis virus (92, 184), creating 
CHIKrep-nsP3mC-FlucEGFP (Figure 5.2A) (where FlucEGFP is firefly luciferase-
enhanced green fluorescent protein)(cloning details are available upon 
request). Fluc measurements of two independent experiments indicated that 
CHIKrep-nsP3mC-FlucEGFP RNA was still able to replicate, albeit to lower 
levels than wild-type CHIKrep-FlucEGFP (Figure 5.2B). Immunofluorescence 
analysis revealed nearly complete colocalization between nsP3-mCherry and 
G3BP (Figure 5.2C), indicative of a close interaction between nsP3 and G3BP 
during CHIKV RNA replication. These nsP3/G3BP-foci were indistinguishable 
from G3BP-foci observed in Figure 5.1B in both their morphology and 
unresponsiveness to arsenite-induced stress. Note that only untransfected cells 
were able to form typical arsenite-induced SGs (Figure 5.2C).
Figure 5.1. During CHIKV RNA replication, G3BP localizes to punctate cytoplasmic foci. A. 
Mock transfected Vero cells were left untreated or were treated with sodium arsenite (NaAsO2). 
Cells were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) for 10 min at room 
temperature (RT) and permeabilized with ice-cold acetone-methanol (1:1) for 10 min at -20°C. 
SGs were stained with anit-G3BP (G6046; Sigma). B. Vero cells were transfected with in vitro 
transcribed CHIK replicon RNA (CHIKrep) and stained with J2 anti-dsRNA and anti-G3BP.  B. 
(bottom), displays CHIKrep transfected cells (left) and cells that remained untransfected cells 
from the same sample (right). Where indicated, samples were treated with sodium arsenire (0.5 
mM) for 30 min at 16 hpt.
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To determine whether nsP3 expressed alone also localizes into foci and 
which domain(s) in nsP3 is required for its specific subcellular localization, 
several expression plasmids with an N-terminal EGFP tag fused to nsP3 
(Figure 5.3A) were constructed (cloning details are available upon request) and 
transfected into Vero cells. Expression of EGFP-nsP3 resulted in foci that were 
indistinguishable from those generated during CHIKV replicon RNA replication, 
indicating that subcellular localization in cytoplasmic foci is an intrinsic 
property of nsP3 (Figure 5.3B, top). Deletion of the N-terminal macrodomain 
(nsP3.7, Figure 5.3A), which is conserved among the Togaviridae, Coronaviridae 
and hepatitis E virus (154), did not result in a change in localization (Figure 
5.3B, middle). In contrast, deletion of the  highly variable, C-terminal domain 
(nsP3.8 and nsP3.2, Figure 5.3A) resulted in the formation of filaments instead 
Figure 5.2. During CHIKV RNA replication, nsP3 localizes to punctate cytoplasmic foci 
concurrently with G3BP. A. Schematic representation of the CHIKrep-nsP3mC-FlucEGFP 
replicon expressing nsP3 with an internal mCherry fusion and an FlucEGFP fusion protein from 
the subgenomic promoter. B. Vero cells were transfected with a pRL-TK plasmid constitutively 
expressing Rluc together with either CHIKrep-FlucEGFP or CHIKrep-nsP3mC-FlucEGFP in vitro 
transcribed RNA. Cells were lysed 16 hpt and Fluc/Rluc activities were measured. Luciferase 
activity in mock transfected cells was also measured. The Fluc measurements were normalized 
by Rluc to compensate for differences in transfection efficiency. Depicted values are the average 
of triplicate samples and expressed in the percentage of normalized Fluc activity relative to 
CHIKrep-FlucEGFP. Error bars represent standard deviation. C. CHIKrep-nsP3mC-FlucEGFP in 
vitro transcribed RNA was transfected into Vero cells, 16 hpt cells were fixed and stained with 
G3BP antibodies.  Where indicated, samples were treated with sodium arsenire (0.5 mM) for 30 
min at 16 hpt.
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Figure 5.3. Individually expressed CHIKV nsP3 localizes to small punctate cytoplasmic 
foci that are juxtaposed to P-bodies. A. Schematic representation of N-terminal EGFP-nsP3 
fusion proteins expressing either full length nsP3 (EGFP-nsP3) or truncations of nsP3 missing 
only the macrodomain (EGFP-nsP3.7), both the macro- and variable domain (EGFP-nsP3.8) or 
only the variable domain (EGFP-nsP3.2). B. Plasmids expressing these nsP3 variants from a CMV 
promoter were transfected into Vero cells. Cells were fixed 20 hpt and nuclei were visualized 
by Hoechst staining. C. Vero cells transfected with EGFP-nsP3.8 were fixed 20 hpt and stained 
for tubulin (14-4502; eBioscience). Vero cells expressing EGFP-nsP3 were fixed and stained 
with either SG marker G3BP (D) or P-body marker XRN1 (A300-443A; Bethyl Laboratories) (E) 
antibodies. Arrowheads indicate juxtaposed SGs and PBs. 
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of foci (Figure 5.3B, bottom and data not shown). Since these filaments 
resembled the cytoskeleton, cells expressing nsP3.8 were stained for tubulin 
(Figure 5.3C). No colocalization between nsP3.8 and the cytoskeleton was 
observed, indicating that multimerization is an intrinsic property of the 
conserved, central domain of alphavirus nsP3. 
Next, EGFP-nsP3 transfected cells were stained for SG marker G3BP (Figure 
5.3D) or a marker for processing bodies (PBs), XRN1 (Figure 5.3E). PBs are small 
cytoplasmic foci, and have been shown to be modulated by various RNA viruses 
(91, 158, 183, 185). Here we show for the first time that individually expressed nsP3 
displays complete colocalization with G3BP in Vero (Figure 5.3D) and HEK293T 
(not shown) cells in the absence of viral RNA replication and other CHIKV 
proteins. XRN1 showed a punctate localization in untransfected cells similar 
to that in nsP3-transfected cells (Figure 5.3E). Interestingly, the observed PBs 
did not colocalize but were sometimes juxtaposed to nsP3-foci (Figure 5.3E, 
arrowheads). Juxtaposition of PBs and SGs is a well-known phenomenon (186). 
The observations that nsP3-foci include G3BP and are often juxtaposed to PBs, 
suggest that nsP3/G3BP-foci might be SGs. 
Since nsP3/G3BP-foci have a morphology different from that of bona fide, 
arsenite-induced SGs we set out to elucidate whether or not CHIKV nsP3/G3BP-
foci are indistinguishable from true SGs. In three independent experiments, 
cells expressing EGFP-nsP3 or EGFPns-P3.8, were treated with arsenite and 
subsequently treated with cycloheximide (CHX), before being immunostained 
for G3BP (Figure 5.4ABC). CHX has been shown to disassemble arsenite-
induced, bona fide SGs (Figure 5.4A)(182). Cells that remained untransfected 
in the field (Figure 5.4B) behaved similarly to mock transfected cells (Figure 
5.4A), no longer displaying any bona fide SGs after CHX treatment. Cells 
transfected with EGFP-nsP3 displayed typical nsP3/G3BP-foci, which were 
unaffected by either arsenite or CHX treatment and are therefore different from 
SGs (Figure 5.4B). In contrast, when the same experiment was performed with 
EGFP-nsP3.8, arsenite induction resulted in G3BP-containing granules with 
typical SG morphology (described above)(Figure 5.4C, arrowheads) and CHX 
treatment led to SG disassembly. This experiment indicated an essential role 
for the nsP3 C-terminal variable region in inhibiting bona fide SG assembly.  
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In addition to CHX treatment, another well-known SG marker, eIF3 
(182), was used to assess the composition of the nsP3/G3BP-foci. Similar to 
G3BP, eIF3 readily localized to bona fide SGs and colocalized with G3BP in 
arsenite-treated cells (Figure 5.4D). Cells were transfected with either EGFP-
nsP3 alone (Figure 5.5A) or CHIKV replicon RNA expressing FlucEGFP from its 
subgenomic promoter (Figure 5.5B). Mock-transfected cells (Figure 5.5A, top) 
and cells that remained untransfected (Figure 5.5B, bottom) readily displayed 
arsenite-induced, eIF3-containing, SGs. In contrast, cells transfected with either 
EGFP-nsP3 (Figure 5.5A, bottom) or CHIKrep-FlucEGFP (Figure 5.5B, bottom) 
Figure 5.4. nsP3/G3BP-foci do not disassemble upon cyclohexamide treatment. Vero cells 
were either mock transfected (A) transfected with EGFP-nsP3 (B) or EGFP-nsP3.8 (C). After 16 
h samples were left untreated (top), treated with arsenite for 30 min (middle) or treated with 
arsenite for 30 minutes prior to a cycloheximide (CHX)(10 µg/ml) treatment for 30 min (bottom). 
After treatment samples were fixed and stained for G3BP. Arrowheads show bona fide SGs in cells 
transfected with EGFP-nsP3 variants. D. Untransfected Vero cells were mock treated or treated 
with sodium arsenite, fixed and stained for G3BP and eIF3 (sc-16377; SantaCruz). 
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did not show any eIF3-positive granules, strongly suggesting that nsP3/G3BP-
foci are different from SGs and that the formation of nsP3/G3BP-foci inhibits 
assembly of bona fide, eIF3-positive SGs. 
Since deletion of the nsP3 C-terminal, variable domain inhibited the 
formation of foci, and restored the ability of the host cell to form bona fide SGs, 
we set out to determine the element responsible within this domain. 
Interestingly, a Src homology-3 (SH3) domain-binding motif (PxxPxR) is 
conserved within the variable domains of many, if not all, alphaviruses. This 
element was demonstrated to be important for efficient Semliki forest virus 
replication (187). Deletion of this element from a CHIKV replicon (CHIKrep-
nsP3d398/406-FlucEGFP, Figure 5.6A) rendered it unable to replicate (Figure 5.6B). 
Cotransfection with a second (wild-type) CHIKV replicon in a trans-
complementation experiment, rescued CHIKrep-nsP3d398/406-FlucEGFP 
replication (Figure 5.6B). This confirmed that the RNA of CHIKrep-nsP3d398/406-
FlucEGFP was unable to replicate in the absence of wild-type nsP3. Interestingly, 
nsP3 expressed with the SH3 domain-binding motif deleted (EGFP-nsP3d398/406) 
(Figure 5.6A) no longer localized in foci but was diffusely distributed throughout 
Figure 5.5. nsP3/G3BP-foci do not co-localize with eIF3. A. Vero cells were either mock 
transfected (A, top) or transfected with EGFP-nsP3 (A, bottom), 16 hpt all samples were treated 
with arsenite for 30 min before being fixed and stained for eIF3. B. Vero cells were transfected 
with CHIKrep-FlucEGFP in vitro transcribed RNA and 16 hpt cells were either left untreated 
(top) or treated with arsenite for 30 min (bottom) before being fixed and stained with anti-eIF3 
antibodies.
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Figure 5.6. SH3 domain-binding motif is necessary for CHIK replicon RNA replication 
and the formation of nsP3/G3BP-foci. A. Schematic representation of  the SH3 domain-
binding motif deletion constructs, CHIKrep-nsP3d398/406-FlucEGFP (top) and EGFP-
nsP3d398/406 (middle). The schematic representation of the deleted sequence (bottom) 
depicts both the deleted amino acid sequence and the corresponding nucleotides. The numbers 
indicate the amino acid positions within CHIK nsP3. B. Vero cells were transfected with a pRL-
TK plasmid constitutively expressing Rluc together with in vitro transcribed RNA from either 
CHIKrep-FlucEGFP, CHIKrep-nsP3d398/406-FlucEGFP, CHIKrep-FlucEGFP together with 
CHIKrep-mCherry or CHIKrep-nsP3d398/406-FlucEGFP together with CHIKrep-mCherry. Cells 
were lysed 16 hpt and Fluc/Rluc activities were measured. Luciferase activity in mock transfected 
cells was also measured. The Fluc measurements were normalized by Rluc to compensate for 
differences in transfection efficiency. Depicted values are the average of triplicate samples and 
expressed in the percentage of normalized Fluc activity relative to CHIKrep-FlucEGFP. Error bars 
represent standard deviations. Vero cells were transfected with EGFP-nsP3d398/406 and 16 hpt 
cells were either left untreated (top) or treated with arsenite for 30 min (bottom) before being 
fixed and stained with anti-G3BP (C) or -eIF3 (D) antibodies. 
Chikungunya virus nsP3 blocks stress granule assembly
5
83
the cytoplasm and the nucleus, in two independent experiments. Staining with 
either anti-G3BP (Figure 5.6C) or eIF3 (Figure 5.6D) did not show apparent 
colocalization with EGFP-nsP3d398/406. Treatment with arsenite readily induced 
SGs in both untransfected and EGFP-nsP3d398/406-transfected cells. These results 
indicate that deletion of the SH3 domain-binding motif from nsP3 resulted in 
the complete loss of association with G3BP.
In conclusion, we show that G3BP localizes to CHIKV nsP3-containing 
foci, both in the presence and in the absence of CHIKV RNA replication. 
Although reminiscent of SGs, these nsP3/G3BP-foci differ from bona fide 
SGs in four ways; i.e., (i) they are morphologically different, (ii) they do not 
contain the hallmark SG marker eIF3, (iii) they do not disassemble upon CHX 
treatment, and (iv) they render cells that express these nsP3/G3BP unable to 
form bona fide SGs in response to oxidative stress. The observation that CHIKV 
replication inhibits SG assembly may suggest that SGs have antiviral activity. 
However, it cannot be completely ruled out that G3BP is part of the alphavirus RC, 
although the limited overlap between viral dsRNA and G3BP does not support 
this possibility. Furthermore, deletion of the SH3 domain-binding motif from 
nsP3 restores bona fide SG assembly but abolishes CHIKV RNA replication. We 
propose that nsP3 blocks SG assembly by the sequestration of G3BP into foci 
via an interaction with the SH3 domain-binding motif in nsP3. The nature of 
the binding (direct versus indirect) between G3BP and nsP3 and the relative 
contributions of other nsP3-binding proteins are important avenues for follow-
up studies. This study provides new insights into the function of CHIKV nsP3 
at the molecular level and suggests that its C-terminal variable domain plays 
an important role in modulating SG assembly during CHIKV RNA replication.
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Chikungunya virus nonstructural protein 
2 inhibits type I/II interferon-stimulated 
JAK-STAT signaling
Chikungunya virus (CHIKV) is an emerging human pathogen transmitted by 
mosquitoes. Like other alphaviruses, CHIKV replication causes general host 
shut-off leading to severe cytopathicity in mammalian cells and inhibits the 
ability of infected cells to respond to interferon (IFN). Recent research, however, 
suggests that alphaviruses may have additional mechanisms to circumvent the 
host’s antiviral IFN response. Here we show that CHIKV replication is resistant 
to inhibition by interferon once RNA replication has been established and that 
CHIKV actively suppresses the antiviral interferon (IFN) response by preventing 
IFN-induced gene expression. Both CHIKV infection and CHIKV replicon 
RNA replication efficiently blocked STAT1 phosphorylation and/or nuclear 
translocation in mammalian cells induced by either type I/II IFNs. Expression 
of individual CHIKV nsPs showed that nsP2 was a potent inhibitor of IFN-
induced JAK-STAT signaling. In addition, mutations in CHIKV-nsP2 (P718S) 
and SINV-nsP2 (P726S), which render alphavirus replicons non-cytopathic, 
significantly reduced JAK-STAT inhibition. This host shut-off independent 
inhibition of IFN signaling by CHIKV is likely to have an important role in viral 
pathogenesis.
This chapter has been published as:
Jelke J. Fros, Wen Jun Liu, Natalie Prow, Corinne Geertsema, Maarten Ligten-
berg, Dana L. Vanlandingham, Esther Schnettler, Just M. Vlak, Andreas Suhr-
bier, Alexander A. Khromykh and Gorben P. Pijlman. Chikungunya virus non-
structural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signalling. 
J. Virol. 84, 10877–10887 (2010).
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Introduction
Chikungunya virus (CHIKV) is a mosquito-borne, arthrogenic Alphavirus 
(fam. Togaviridae) causing current epidemics in the Indian Ocean region (180). 
The first reported CHIKV outbreak was in 1952-53 in Tanzania. In the local 
Makonde language, chikungunya means “that which bends up” and refers to 
the body posture of infected individuals who suffer from associated arthralgia 
(188). CHIKV is transmitted mainly by Aedes mosquito species and is endemic 
in most of Central Africa and Southern Asia (30). From 2001 onwards several 
major outbreaks have occurred affecting the islands of Mauritius, Madagascar, 
Mayotte and Reunion Island. On Reunion Island, CHIKV affected up to one 
third of the population and CHIKV-associated deaths were recorded (180). Due 
to an acquired mutation in the viral glycoprotein E1 (43) and the concurrent 
expanding distribution of its novel mosquito vector Aedes albopictus, CHIKV 
is rapidly spreading to other parts of the world including Europe (189). In 2006, 
mainland India suffered a major outbreak resulting in more than 1.4 million 
infected individuals, after which more outbreaks occurred throughout the rest 
of Southern Asia (31).  The first outbreak of CHIKV on the European continent 
occurred in Italy in 2007 (32). Currently, no licensed CHIKV vaccine or effective 
antiviral treatment is available.
CHIKV is a plus-strand RNA virus with a genome of almost 12kb and 
replicates in the cytoplasm of infected cells within virus-induced membranous 
vesicles (190). CHIKV produces two polyproteins, of which the first encodes 
nonstructural proteins (nsPs) 1, 2, 3 and 4. The nsP123 precursor and nsP4 
function in a complex for viral negative strand RNA synthesis, after which 
sequential processing of nsP123 into its individual proteins results in positive 
strand RNA transcription and production of subgenomic RNA (sgRNA). CHIKV 
nsPs encode functions needed for viral replication, e.g. methyltransferase and 
guanylyltransferase (nsP1), protease and helicase (nsP2) and RNA-dependent 
RNA polymerase (nsP4)(191). The second, structural polyprotein is translated 
from this sgRNA and codes for capsid and envelope glycoproteins that 
constitute the virus particle (191). In mosquito cells, alphaviruses can replicate 
in a persistent manner, whereas alphavirus replication in mammalian cells 
usually results in severe cytopathicity, mainly caused by a dramatic shut-off 
of host gene expression resulting in the suppression of innate immunity (28). 
Cellular sensors including the cytoplasmic RNA helicase MDA5 are able 
to detect alphavirus replication in infected mammalian cells (88). Downstream 
signal transduction ultimately leads to interferon regulatory factor (IRF)-3 
activation and interferon (IFN)-β production. After secretion from the infected 
cell, IFN-β binds to the IFN-α/β receptor IFNAR in an auto- or paracrine 
manner to amplify the signal or to prime uninfected cells to establish an 
antiviral state, respectively. Subsequently, the Janus kinases JAK1 and TYK2 
are phosphorylated, which in turn phosphorylate Signal Transducers and 
Activators of Transcription (STAT)1 and STAT2 (192). Heterodimers of STAT1/
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STAT2 are then translocated from the cytoplasm into the nucleus in an IRF9-
dependent manner where they bind IFN Stimulated Response Elements (ISRE). 
STAT1 activation causes cells to produce and secrete IFN-α to further amplify 
the signal via the same signaling cascade. In addition, the expression of an array 
of antiviral proteins, including protein kinase R (PKR), 2’,5’-oligoadenylate 
synthetase (2’5’OAS) and Mx proteins is then induced to ultimately clear the 
infection (192). In addition to the type I IFNs (IFNα/β) expressed by most cells, 
type II IFN (IFN-γ) is also produced early in CHIKV infection, probably by NK 
cells (68), to promote the transition from innate to adaptive immunity. IFN-γ 
activates STAT1 via binding to the IFN-γ receptor, upon which the latter in 
the form of homodimers translocates to the nucleus where they bind Gamma 
Activating Sequence (GAS) elements to transactivate antiviral gene expression 
(192).
Given the potency of IFNs to fight viral infection many viruses have 
evolved specific strategies to counteract or evade the antiviral IFN response 
(192). While alphaviruses are known to cause dramatic host protein synthesis 
shut-off (28), recent research has shown that this alone is not sufficient to 
ensure productive infection and that the IFN response is also antagonized 
in a more direct manner (193). Whether or not CHIKV counteracts the IFN 
response is unknown, however it is clear that robust IFNAR-dependent type 
I IFN-signaling is required to limit CHIKV replication in animals (70, 194). 
IFN-α was recently shown to inhibit CHIKV replication in mice if given before 
infection, but not when given 3 days after infection (68).
In this paper, we show that CHIKV replication is resistant to IFN 
treatment and inhibits IFN-induced JAK-STAT signaling and downstream 
gene transcription independently of host shut-off. We also show for the first 
time that alphavirus nsP2 alone is sufficient for JAK-STAT inhibition. A P726S 
substitution in a conserved region of Sindbis virus (SINV) nsP2 was previously 
reporter to reduce SINV cytopathicity (85). Here we show that this substitution 
and the corresponding P718S in CHIKV reversed the ability of CHIKV and SINV 
replicons to block the JAK-STAT pathway.
Materials and methods
Cells and virus
African green monkey kidney (Vero) and baby hamster kidney BHK-
21J cells were cultured in DMEM (Invitrogen) supplemented with 10% FBS 
(Invitrogen) at 37°C in an atmosphere with 5% CO2 in tissue culture flasks 
(Greiner). Chikungunya virus isolate 06113879 (Mauritius strain) was obtained 
from the Victorian Infectious Diseases Reference Laboratory (VIDRL) and 
supplied via Queensland Health Forensic and Scientific Services (QHFSS) and 
titrated on Vero cells via plaque assay.
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Construction of alphavirus replicons and expression plasmids 
A CHIKV strain 37997 replicon (CHIKrep-EGFP, Figure 6.4A) expressing 
EGFP was constructed by removing the structural genes from CHIKV infectious 
clone 5’-pCHIKic (195) and the insertion of EGFP. Next, a Firefly luciferase (Fluc) 
gene was generated by PCR (Phusion DNA polymerase, Finnzymes) from pGL3 
(Promega) using primers (AscI-Luc-F and BssHII-Luc-R), cloned into CHIKrep-
EGFP, in-frame and upstream of the EGFP gene to generate CHIKrep-FlucEGFP 
(Figure 6.1C). The red fluorescent marker gene mCherry (196) was amplified by 
PCR using primers (AscI-mCherry-F and EcoRI-mCherry-R) and cloned into 
CHIKrep-EGFP in place of EGFP to generate CHIKrep-mCherry (Figure 6.5A). 
A puromycin-acetyltransferase gene fused to the Footh-and-Mouth disease 
virus (FMDV)2A autoprotease was generated by PCR from repPAC-βGal (197) 
using primers (MluI-PAC2A-F/R) and cloned into CHIKrep-EGFP in place of 
EGFP to generate CHIKrep-pac2AEGFP (Figure 6.6A). An MluI fragment from 
CHIKrep-pac2AEGFP was subcloned into pBluescript and reinserted after 
nsP2 was mutated by QuickChange PCR using primers (CHIK-nsP2-P718S-
F/R), generating CHIKrep-pac2AEGFP-nsP2m. Cytopathic, “wildtype” Sindbis 
replicon was generated from the noncytopathic replicon, SINrepGFP (pHY213; 
pToto1101-derivative), by mutating the nsP2 serine at position 726 into a proline 
with primers  (SINnsP2-726P-V426/7) to generate SINrepGFP “wt” (Figure 
6.6A). Individual CHIKV nsPs were PCR amplified from CHIKrep-EGFP using 
AttB1/2 primers listed (Table 1) and cloned in expression plasmids downstream 
of a cytomegalovirus immediate early (CMV) promoter (Figure 6.6A) via 
traditional cloning or Gateway technology using pDONR207 and pcDNA-
DEST40 (Invitrogen). The mCherry gene was fused to FMDV2A using PCR with 
primers (EcoRI-mCherry-F and EcoRI-2A-mCherry-R) and was cloned as an 
EcoRI fragment in-frame and upstream of CHIKV nsPs for live visualization of 
transfected cells (Figure 6.5A). Autocleavage of the red fluorescent mCherry2A 
protein from the nsPs results in expression of CHIKV nsP1-4 with nearly 
authentic N-termini to retain biological activity. All constructs were verified by 
sequencing (Eurofins MWG Operon, Germany).
IFN sensitivity assay
CHIKV: For IFN pre-treatment, Vero cells grown in 24 well plates were 
treated with various doses of IFN-α (I-4276, Sigma), IFN-β (I-4151, Sigma) and 
IFN-γ (I-1520, Sigma) for 6 h. The cells were washed and infected with CHIKV 
at a multiplicity of infection (MOI) of 1 plaque forming unit (pfu) per cell. 
Three hours after viral absorption, the cells were washed and then incubated 
for an additional 21 h.  For IFN post-treatment, Vero cells were infected with 
CHIKV at an MOI of 1 pfu/cell. Four hours after viral absorption, cells were 
treated with various doses of IFN as indicated and left for additional 21 h. The 
supernatants were collected and viral titers were determined by plaque assay 
on Vero cells. CHIKV replicon: In vitro transcribed, capped CHIKrep-FlucEGFP 
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replicon RNA (400 ng/well) was transfected into Vero cells in 96 wells plates, 
using Lipofectamine 2000 (Invitrogen) and OptiMEM medium (Invitrogen) 
according to the manufacturer’s recommendations. The transfection mix was 
removed after 4 h of incubation and replaced with DMEM + 10% FBS. Directly 
after transfection (0 h p.t.) or 24 h p.t., type I IFNs (IFN-α, IFN-β; Calbiochem, 
Nottingham, UK) and type II IFN (IFN-γ; AbD Serotec, Dusseldorf, Germany) 
were added to the wells in increasing concentrations. Two days after transfection, 
cells were lysed in 100 µl passive lysis buffer (Promega Benelux, Leiden, the 
Netherlands) and luciferase expression was measured on a Fluostar Optima 
(BMG Labtech, Germany) using D-luciferin (Synchem OHG, Germany) as a 
substrate basically as described (198). 
IFN reporter assay
Vero cells grown in 24-well plates were cotransfected with 40 ng pRL-TK 
(Promega) plasmid DNA expressing Renilla luciferase (Rluc) and with 200 ng of 
either the IFN-α/β-responsive (ISRE) firefly luciferase (Fluc) reporter plasmid 
p(9-27)4th (–39)Lucter or the IFN-γ responsive (GAS) luciferase reporter 
plasmid p(IRF-1*GAS)6tk (–39)Lucter (199), using Genejammer (Stratagene) 
transfection reagent. Briefly, 24 h p.t., cells were infected with CHIKV at MOI=5 
pfu/cell. Four, 8 and 12 hours post infection (p.i.), cells were treated with 1,000 
international units (IU) of IFN-α (Intron A Redipen) per ml or 100 ng of IFN-γ 
(BD Pharmingen) per ml for 6 h and then assayed for Fluc and Rluc activity 
using the Dual luciferase reporter assay system (Promega) as described (200).
Realtime RT-PCR
Vero cells grown in 24-well plates were infected with CHIKV at MOI=5 
pfu/cell. Healthy or infected cells were subsequently incubated at 4, 8, 12 h 
p.i. with 1,000 IU of IFN-α (Intron A Redipen) per ml (A) or 100 ng of IFN-γ 
(BD Pharmingen) per ml for 10 h. Total RNA was purified using Trizol reagent 
(Invitrogen), and realtime RT-PCR was carried out on a Rotor-Gene 3000 PCR 
machine (Corbett Research) using Superscript III (Invitrogen) and SYBRgreen 
(Invitrogen) basically as described (68). Primers for amplification of OAS2 
transcripts were HuOAS2-F/R, primers for the housekeeping gene RPL13A (201) 
were HuRPL13A-F/R. Each sample was analyzed in duplicate and normalized to 
RPL13A mRNA levels. OAS2 mRNA transcription levels were expressed relative 
to mock-infected, IFN treated samples. 
Immunofluorescence and western blot
CHIKV virus: Vero cells grown on glass cover-slips in 24 wells plates were 
infected with CHIKV at a multiplicity of infection at MOI=1 pfu/cell. Twenty 
four hours after infection, cells were treated with 1,000 IU/ml of IFN-α (I-4276; 
Sigma) or 50 ng/ml of IFN-γ (I-1520; Sigma) for 30 min at 37°C. Cells were fixed 
in 4% formaldehyde in phosphate-buffered saline (PBS) for 10 min at room 
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temperature, permeabilized with ice-cold acetone-methanol (1:1) for 30 min 
at –20°C, and stained sequentially with cross reacting monoclonal antibodies 
specific against CHIKV envelope protein and with polyclonal antibodies 
against STAT1 (SC-345; SantaCruz Biotechnology, Santa Cruz, USA) or STAT2 
(SC-476; SantaCruz) at concentrations of 1 μg/ml essentially as described 
by the manufacturer. Secondary antibodies (GaM-AF546 and GaR-AF488) 
were obtained from Molecular Probes (Invitrogen) and nuclei were stained 
with DAPI. Microscopy was performed using a Zeiss LSM 510 Meta confocal 
microscope. For western analysis, Vero cells in 6 well plates were infected 
with CHIKV at MOI=1 pfu/cell. Twenty four hours p.i., cells were treated with 
either IFN-α (I-4276; Sigma) or IFN-γ (I-1520; Sigma) for 30 min or untreated 
as indicated. Western blot was performed on Vero cell lysates as described 
before (200) using antibodies against phosphorylated STAT1 (pSTAT1) (550428; 
Pharmingen, San Diego, USA), STAT1 (SC-345; SantaCruz) and tubulin (T2200; 
Sigma), and analyzed with an Odyssey Infrared Imaging System (LI-COR 
Biosciences, Lincoln, USA). Replicons and single nsPs: Vero cells grown in 96-
well plates were transfected with capped, in vitro transcribed CHIKrep-EGFP, 
CHIKrep-mCherry, CHIKrep-pac2AEGFP or CHIKrep-pac2AEGFP-nsP2m 
replicon RNA, the four pCMV-nsP constructs or the SINrepGFP construct (400 
ng of RNA or DNA per well) using Lipofectamine 2000 (Invitrogen). Twenty 
four hours later, cells were treated for 30 min with 100 IU IFN-α (Calbiochem), 
2.5 ng IFN-β (Calbiochem) or 1 ng IFN-γ (AbD Serotec) per well (100 l). For the 
host shut-off experiment, cells were transfected with CHIKrep-EGFP replicon 
in normal medium or medium containing 0.5 µg/ml cycloheximide. Twelve 
hours p.t. cells received a similar IFN-β treatment. Cells were fixed with 4% 
paraformaldehyde in PBS and permeabilized with 0.1%SDS in PBS to retain 
EGFP and/or mCherry fluorescence. Nuclei were stained with Hoechst 3342. 
STAT1 nuclear translocation was visualized with primary antibodies anti-
pSTAT1 (phospho-Tyr701; SAB Signalway Antibody, Pearland, USA) with 
secondary antibodies GaR-Rhodamine (Nordic Immunology, Tilburg, the 
Netherlands) or GaR-AF488 (Molecular Probes, Leiden, the Netherlands) or 
primary antibody anti-STAT1 (SC-417; SantaCruz) with secondary antibody 
GaM-AF546 (Molecular Probes), using an Olympus IX71 inverted microscope 
with an X-Cite 120 series lamp.
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Name Sequence 5’-3’ 
AscI-Luc-F TTGGGCGCGCCATGGAAGACGCCAAAAACATAA
BssHII-Luc-R TTGTGCGCGCTCCACGGCGATCTTTCCGCC
MluI-PAC2A-F TTGGACGCGTCATGACCGAGTACAAGCCCACG
MluI-PAC2A-R TTGTACGCGTTCGGGCCCTGGGTTGGACTCG
AscI-mCherry-F CGGGCGCGCCACCATGGTGAGCAAGGGCGAGGAG
EcoRI-mCherry-R CGGAATTCCTTGTACAGCTCGTCCATG
CHIK-nsP2-P718S-F GCTCAAGTCGGGTGGTTCATTACTG
CHIK-nsP2-P718S-R CCACCCGACTTGAGCAGTCTCAGGG
SINnsP2-726P-V426 CTGAATTGTTTAAACCCAGGAGGCACCCTC
SINnsP2-726P-V427 GAGGGTGCCTCCTGGGTTTAAACAATTCAG
attB1-CHIK-nsP1 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGGATC
CCGTGTACGTGG
attB1-CHIK-nsP2 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGGGAA
TAATTGAAACTCCAAGAG
attB1-CHIK-nsP3 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGGCAC
CGTCGTACCGGGTT
attB1-CHIK-nsP4 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGTACA
TATTCTCATCTGACACC
attB2-CHIK-nsP1 
GGGGACCACTTTGTACAAGAAAGCTGGGTACTATGCCCCAGCTCTGT
CTTC
attB2-CHIK-nsP2
GGGGACCACTTTGTACAAGAAAGCTGGGTACTAGCACCCTGCTCGGG
TGG
attB2-CHIK-nsP3 
GGGGACCACTTTGTACAAGAAAGCTGGGTACTACCCACCTGCCCTAT
CTAG
attB2-CHIK-nsP4 
GGGGACCACTTTGTACAAGAAAGCTGGGTACTATTTAGGACCACCGT
ACAG
EcoRI-mCherry-F CGGAATTCACCATGGTGAGCAAGGGCGAGGAG
EcoRI-2A-mCherry-R 
CGGAATTCGGGCCCTGGGTTGGACTCGACGTCGCCGGCCAACTTGAG
CAGGTCAAAGTTAACCTTGTACAGCTCGTCCATG
HuOAS2-F  CGGTGTATGCCTGGGAACAGG
HuOAS2-R GGGTCAACTGGATCCAAGATTAC
HuRPL13A-F CATCGTGGCTAAACAGGTACTG
HuRPL13A-R CGCACGACCTTGAGGGCAGC
Table 6.1. Oligonucleotides used in this study
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Results
CHIKV replication confers resistance to type I/II IFN treatment
Since an intact IFN response is a requirement for limiting CHIKV infection 
in animals (194), it was first investigated to what degree CHIKV replication could 
be inhibited in cells by (pre-)treatment with type I and type II IFNs. Vero cells 
have an intact IFN signaling pathway and respond to IFN treatment, however 
they cannot produce IFN (202) and thus lack the autocrine IFN amplification 
loop. These characteristics allow accurate measurement of the effect of different, 
exogenous IFNs on viral RNA amplification and virus production. When cells 
were primed for 6 h with IFN prior to virus infection, CHIKV production was 
decreased in an IFN concentration dependent manner (Figure 6.1A). IFNα was 
most effectively, followed by IFN-β and IFN–γ. Although pre-treatment with 
10,000 U/ml of IFN-α could reduce virus production approximately 25-fold 
(from 8.1*108 to 6.7*106 pfu/ml), viral titers were not reduced further than 6.7*107 
pfu/ml, indicating that CHIKV was rather insensitive to IFN pre-treatment 
under the experimental conditions used and still replicated to relatively high 
titers. When IFN was applied 4 h p.i., viral titers were not significantly decreased 
(maximum reduction from 1*108 to 7.7*107 pfu/ml) (Figure 6.1B), indicating that 
virus production was thus not overly affected by high concentrations of IFN 
when IFN was added after establishment of infection.  
Next, the effect of IFN treatment on CHIKV viral RNA replication 
independent of virus production and/or secondary infection was tested. 
A CHIKV replicon was constructed with the structural genes replaced by a 
Firefly luciferase (Fluc)-Enhanced Green Fluorescent Protein (EGFP) fusion 
gene (CHIKrep-FlucEGFP, Figure 6.1C). In this way, transfected cells could 
be visualized by fluorescence microscopy and replication measured by 
luminometry. In vitro transcribed, capped CHIKrep-FlucEGFP replicon RNA was 
transfected into Vero cells. Directly after transfection or 24 h post transfection 
(p.t.), type I/II IFNs were added to the wells in increasing concentrations and 
luciferase expression was measured 2 days after transfection. Similarly to the 
results obtained with CHIKV infection, when IFN was added directly after RNA 
transfection (pre-treatment), CHIKV replication was negatively affected in a 
concentration-dependent manner (Figure 6.1D). In the concentrations used, 
IFN-β was most effective (~10% of transgene expression retained), followed by 
IFN-α and IFN-γ. This is similar to what was reported for SINV, another Old 
World alphavirus (203). When IFN was added 24h p.t., however, Fluc expression 
could not be reduced further than approximately 50%, not even with the highest 
IFN concentrations (Figure 6.1E). Collectively, these results suggest that CHIKV 
is insensitive to IFN once viral RNA replication has been established. 
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CHIKV infection inhibits type I/II IFN signaling
Since CHIKV replication is partially sensitive to priming of cells with type 
I IFNs (and to a lesser extent with type II IFN), but is largely resistant to IFN 
treatment after viral RNA replication is well underway, it is likely that CHIKV 
blocks downstream IFN signaling and expression of IFN stimulated genes 
(ISGs) with antiviral activity. To test this hypothesis the effect of CHIKV RNA 
replication on downstream IFN-induced gene transcription was investigated. 
Vero cells were transfected with type I IFN-responsive (ISRE) or type II IFN-
responsive (GAS) firefly luciferase (Fluc) reporter plasmids and subsequently 
infected with CHIKV. Fluc expression was induced by stimulation with type I/
II IFNs at 4, 8 and 12 hpi and normalized to Renilla luciferase (Rluc) activity 
expressed from a constitutive promoter on a co-transfected pRL-TK plasmid 
(Figure 6.2A and 6.2B). Rluc activity decreased approximately 1.5-fold, 2.5-fold 
and 4-fold at 4, 8 and 12 hpi, respectively, as compared to mock-infected cells 
(not shown), indicating that CHIKV infection resulted in some host shut-off 
within this time frame. However, the inhibition by CHIKV of IFN-stimulated 
gene transcription was more pronounced. Relative Fluc expression from the 
ISRE or GAS responsive elements (normalized to Rluc expression) in response 
Figure 6.1. Resistance of CHIKV to type I/II IFN treatment. AB. Sensitivity of CHIKV 
infection to IFN treatment. IFNs were added as indicated to CHIKV infected Vero cells 6 h 
prior to infection (A) or 4 h p.i. (B). Supernatants were collected 24 h p.i. and virus titers were 
determined by plaque assay. Error bars represent standard deviations of duplicates. C. Schematic 
representation of CHIKrep-FlucEGFP replicon expressing an Fluc-EGFP fusion protein. DE. 
Sensitivity of CHIKV replicon RNA replication to IFN treatment. Different concentrations of IFNs 
were added to CHIKV replicon transfected Vero cells in 96 wells plates directly post transfection 
(0 h p.t.) (D) or 24 h p.t. (E), and Fluc activity was measured 48 h p.t. Concentrations of IFN-α 
are denoted in international units (IU) per ml, and IFN-β/γ in ng per ml. Error bars represent 
standard deviations.
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to treatment with IFN-α (Figure 6.2A) and IFN-γ (Figure 6.2B), respectively, was 
substantially inhibited in Vero cells infected with CHIKV. This inhibition was 
apparent at 4 hpi (2-fold), 8 hpi (5-8-fold) and was essentially 100% at 12 hpi 
(Figure 6.2A and 6.2B). In the absence of CHIKV infection, a more than 7-fold 
or 58-fold induction of normalized Fluc expression in response to treatment 
with either IFN-α (Figure 6.2A) or IFN-γ (Figure 6.2B), respectively. These 
results clearly indicated that CHIKV infection efficiently blocks IFN signaling 
beyond the inhibition mediated by host shut-off. 
To illustrate that CHIKV infection also inhibited induction of interferon 
stimulated gene (ISG) expression, an RT-PCR assay was used to monitor the 
expression of 2’-5’-oligoadenylate synthetase 2 (OAS) transcripts.  As expected 
(204), large increases in OAS mRNA levels were seen in Vero cells after treatment 
with IFN-α and IFN-γ (Figures 6.2C and 6.2D, first two bars).  However, in cells 
infected with CHIKV and treated with type I and II IFNs at various time points 
p.i., OAS mRNA levels were substantially reduced relative to the house keeping 
gene, RPL13A (Figures 6.2C and 6.2D).  These results illustrated that CHIKV 
infection efficiently blocks ISG expression beyond that mediated by host shut-
off. 
Figure 6.2. Inhibition of type I/II IFN signaling and ISG induction by CHIKV infection. 
AB. Vero cells were transfected with a pRL-TK plasmid expressing Rluc and either type I IFN-
responsive (ISRE) or type II IFN-responsive (GAS) Fluc reporter plasmids. 24 h p.t., cells were 
infected with CHIKV at MOI=5 pfu/ml. At 4, 8 or 12 hours p.i., cells were treated with IFN-α at 
1,000 IU/ml (A) or IFN-γ at 100 ng/ml (B) for 6 h and then assayed for Fluc and Rluc activity. 
Mock-infected (= uninfected) cells with/without IFN induction were also measured. Fluc was 
divided by Rluc readings to compensate for virus-induced downregulation of transcription/
translation and expressed relative to mock-infected, IFN treated samples. Average values from 
triplicate samples are shown. Error bars represent standard deviations. CD. Vero cells, healthy or 
infected with CHIKV for 4, 8, 12 h were incubated with 1,000 IU of IFN-α (C) or 100 ng of IFN-γ 
(D) per ml for 10 h. Real-time RT-PCR values for IFN stimulated gene OAS2 were normalized 
to the housekeeping gene RPL13A. OAS2 mRNA transcription levels were expressed relative to 
mock-infected, IFN treated samples. Average values from duplicate samples are shown. Error 
bars represent standard deviations.
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CHIKV infection and CHIKV replicon RNA replication block type I/II 
IFN-induced STAT1 nuclear translocation 
In order to investigate whether CHIKV could block IFN signaling by 
specifically interfering with the JAK-STAT pathway, Vero cells were infected 
with CHIKV at MOI=1 pfu/cell and subsequently induced with type I IFN. 
Induction with type I IFNs should result in STAT1/STAT2 phosphorylation/
heterodimerization and subsequent nuclear translocation. As expected, STAT1 
in normal Vero cells was localized in the cytoplasm, but translocated to the 
nucleus upon induction with type I IFN (Figure 6.3A). In contrast, when 
cells were infected with CHIKV 12 h prior to IFN induction, STAT1 nuclear 
translocation was completely blocked (Figure 6.3A). The same result was 
obtained for STAT2 (Figure 6.3B). Similarly, type II IFN stimulation should 
lead to STAT1 phosphorylation/homodimerization and nuclear translocation 
in normal Vero cells, and this was indeed observed in uninfected cells (Figure 
6.3C). Again, CHIKV infection effectively blocked STAT1 nuclear translocation 
(Figure 6.3C). Taken together, these results indicate that CHIKV infection 
blocks both type I and type II IFN-induced JAK-STAT signaling.
It is well known that alphavirus replication leads to host protein synthesis 
shut-off (16). However, based upon the immunofluorescence detection of 
similar levels of endogenous STAT1 and STAT2 in infected and uninfected 
cells (Figures 6.3A-C), it is unlikely that CHIKV infection depletes/degrades 
STAT1/2 proteins. To confirm that the absence of nuclear phospho-STAT1 in 
cells infected with CHIKV was not the result of depletion of STAT1 protein, 
western blot immunodetection was performed to detect endogenous STAT1. 
It is apparent that cells infected with CHIKV (Figure 6.3D, lane 2) have similar 
levels of endogenous STAT1 as compared to uninfected cells (Figure 6.3D, lane 
5), suggesting that CHIKV does not degrade endogenous STAT1 but may act 
via the inhibition of STAT1 phosphorylation and/or nuclear translocation. As 
expected, STAT1 was highly upregulated by IFN induction in uninfected cells, 
likely through signaling via the JAK-STAT pathway (200). In contrast, this was 
not the case in CHIKV infected cells, suggesting that CHIKV also blocks the 
IFN-induced upregulation of STAT1. Importantly, western analysis performed 
with antibodies against phospho-STAT1 showed that CHIKV infection causes a 
major reduction in the amount of phospho-STAT1 in induced cells (Figure 6.3D, 
lanes 3 and 4) when compared to IFN induced, uninfected cells (Figure 3D, lanes 
6 and 7). These data support the observations from the immunofluorescence 
experiments and indicate that CHIKV infection inhibits STAT phosphorylation. 
Some so-called New World alphaviruses need expression of their capsid 
gene to modulate the IFN response (205). CHIKV is an Old World alphavirus 
and therefore is not expected to need capsid expression for suppression of IFN 
signaling. To determine whether RNA replication and expression of CHIKV 
nsPs are sufficient to block the JAK-STAT pathway, a CHIKV replicon was 
constructed in which the structural genes were deleted and replaced by EGFP 
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(CHIKrep-EGFP, Figure 6.4A). In vitro transcribed, CHIKrep-EGFP RNA was 
transfected into Vero cells and the cells were then stimulated with type I and 
type II IFNs 24 h p.t. As expected, in untransfected cells, phospho-STAT1 was 
found in the nuclei of Vero cells after 30 min of induction with IFN-α, and even 
more efficiently with IFN-β or IFN-γ (Figure 6.4B). In contrast, however, the 
cells transfected with CHIKrep-EGFP (green; expressing EGFP) and induced 
with IFN-β or IFN-γ lack nuclear STAT1 (Figure 6.4C, arrowheads), indicating 
that CHIKV replication blocks type I and type II IFN-induced STAT1 
phosphorylation and/or nuclear translocation. 
There is a possibility that the lack of nuclear STAT1 translocation in 
replicon cells could still be due to host shut-off resulting from CHIKV replicon 
RNA replication, although Figure 6.3D showed that endogenous STAT1 levels 
Figure 6.3. CHIKV infection blocks STAT1/STAT2 nuclear translocation without depleting 
endogenous STAT1 levels. Vero cells were infected by CHIKV and treated with IFN-α (AB) or 
IFN-γ (C) for 30 min. Cells were fixed and stained with monoclonal antibodies specific against 
CHIKV envelope protein and STAT1 (AC) or STAT2 (B).  C. Block in nuclear translocation 
of STAT1 in CHIKV infection in response to treatment with IFN-γ. Solid arrows show cells 
negatively infected with CHIKV but with nuclear STAT1/2. D. CHIKV infection blocks STAT1 
phosphorylation in Vero cells in response to IFN treatment. Western blot detection of pSTAT1, 
STAT1 and tubulin in Vero cells infected or mock-infected with CHIKV and untreated or induced 
with type I or type II IFNs. Lane 1; protein size marker (in kDa).
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Figure 6.4. CHIKV replicon efficiently inhibits type I/II IFN-induced JAK-STAT signaling 
independent of host shut-off. A. Schematic representation of CHIKrepEGFP expressing EGFP. 
B. pSTAT1 nuclear translocation in Vero cells upon induction with type I and type II IFNs. C. 
CHIKV replicon blocks pSTAT1 nuclear translocation upon type I/II IFN induction. Vero cells 
were immunostained with anti-pSTAT1 antibody 24 h p.t. D. CHIKV RNA replication but not 
translational shut-off blocks STAT1 nuclear translocation. Vero cells were transfected with 
CHIKrep-EGFP replicon RNA in the absence or presence of cycloheximide. Cells were induced 
for 30 min with IFN-β at 12 h p.t. and stained with anti-STAT1 antibody. Open arrows show 
CHIKV replicon positive cells lacking nuclear STAT1.
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were not decreased by CHIKV infection. To nevertheless rule out this 
possibility, cells were treated with cycloheximide to inhibit translation. This 
method of pharmacologically induced host cell protein synthesis shut-off 
was recently used in experiments with Venezuelan Equine Encephalitis virus 
(VEEV) to show that JAK-STAT signaling was blocked by VEEV and not by 
host shut-off (193). As expected, STAT1 fluorescence in control cells not 
treated with cycloheximide was cytoplasmic with no apparent difference in 
localization or fluorescence intensity between untransfected cells and green 
CHIKV replicon transfected cells (Figure 6.4D, top row). After IFN-β treatment, 
STAT1 was translocated into the nucleus in all cells except those expressing 
the CHIKV replicon (Figure 6.4D, open arrowheads). In cells treated with 
cycloheximide, CHIKV replicon encoded EGFP was absent due to effective 
inhibition of protein synthesis (Figure 6.4D, bottom). However, STAT1 nuclear 
translocation upon IFN-β induction was still clearly apparent despite effective 
inhibition of translation by cycloheximide (Figure 6.4D, bottom). Taken 
together, these experiments clearly show that CHIKV infection and replication 
of CHIKV replicon RNA efficiently inhibit IFN-stimulated JAK-STAT signaling 
independent of host shut-off.
CHIKV nsP2 inhibits IFN-induced STAT1 nuclear translocation
Since the CHIKV replicon could efficiently inhibit JAK-STAT signaling, 
the next question was if any of the CHIKV nsPs could be found to be responsible 
for this activity. Previous reports suggested that alphavirus nsP2 may be an 
important modulator of the IFN response (87, 206), however, direct inhibition 
of the JAK-STAT pathway by individual alphaviral nsP2 has not been reported. 
In order to identify the CHIKV encoded protein responsible for blocking 
STAT1 nuclear translocation, Vero cells were transfected with plasmids 
expressing individual nonstructural proteins fused to self-cleaving mCherry2A 
and as a control transfection with a CHIKV replicon expressing mCherry 
(CHIKrep-mCherry) (Figure 6.5A). Two days p.t., cells were incubated with 
IFN-β and nuclear localization of phospho-STAT1 was visualized using anti-
pSTAT1 antibodies (Please note; pSTAT1 in these pictures is green). IFN-β 
induction of transfected Vero cells showed that STAT1 efficiently translocated 
to the nucleus in cells expressing nsP1, nsP3 and nsP4 (Figure 6.5B, solid 
arrowheads). Only very few cells were found to lack nuclear phospho-STAT1 
(Figure 6.5B, open arrowheads), suggesting that nsP1, -3 and -4 were not capable 
of efficiently blocking STAT1 nuclear translocation. In sharp contrast, however, 
STAT1 nuclear translocation was absent in the vast majority of cells expressing 
nsP2 (Figure 6.5B, nsP2, open arrowheads) and the positive control CHIKrep-
mCherry (Figure 6.5C, open arrowheads). In the few nsP2-expressing cells that 
did display nuclear pSTAT1, the fluorescence intensity was greatly reduced as 
compared to untransfected cells (Figure 6.5B, nsP2, closed arrowheads). As 
expected, the CHIKrep-mCherry transfected cells also showed no nuclear 
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translocation after IFN-β treatment (Figure 6.5C, open arrowheads).These 
results clearly indicate that individually expressed CHIKV nsP2 is capable of 
inhibiting of JAK-STAT signaling.
Mutation of a conserved proline in the C-terminus of nsP2 abolishes the 
inhibitory effect of CHIKV and SINV replicons on JAK-STAT signaling.
Mutations in alphavirus nsP2 can have significant effects on the IFN 
response (87, 206). For example, a mutation of a conserved proline (Figure 
6.6B) at position 726 in SINV was previously shown to result in non-cytopathic 
RNA replication (85) and reduced viral titers associated with higher IFN 
production (206). We hypothesized that this mutation could render the 
Figure 6.5. Inhibition of IFN-β induced STAT1 nuclear translocation by individual CHIKV 
nsPs. A. Schematic representation of pCMV-nsP1-4 expression plasmids and CHIKrep-mCherry 
replicon expressing mCherry. CMV; cytomegalovirus immediate early  promoter, 2A; Footh-
and-Mouth disease virus 2A autoprotease. Bacteriophage SP6 and CHIKV 26S promoters are 
indicated. B. pSTAT1 nuclear translocation  upon IFN-β induction in pCMV-nsP1-4 transfected 
Vero cells. Cells were immunostained with anti-pSTAT1 antibody. C. pSTAT1 nuclear translocation 
upon IFN-β induction in CHIKrep-mCherry transfected Vero cells. Open arrows show nsP1-4 or 
CHIKV replicon positive cells lacking nuclear pSTAT1, solid arrows show nsP1-4 positive cells 
with nuclear pSTAT1.
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replicon unable to block JAK-STAT signaling. This possibility was investigated 
by transfecting Vero cells with cytopathic “wildtype” SINrepGFP-wt (with 
restored proline at position 726) and non-cytopathic SINV replicon SINrepGFP 
(containing nsP2-P726S mutation) (Figure 6.6A). Transfected cells were 
induced 24 h p.t. with IFN-β for 30 min and stained with phospho-STAT1 
antibodies as before. According to the hypothesis, cytopathic “wildtype” SIN 
replicon was able to effectively block STAT1 nuclear translocation, whereas the 
non-cytopathic SIN replicon with nsP2-P726S mutation (85) was not (Figure 
6.6C). 
Figure 6.6. Mutation of a conserved proline in nsP2 abolishes inhibitory effect of CHIKV 
and SINV replicons on JAK-STAT signaling. A. Schematic representation of CHIKrep-
pac2AEGFP and SINrepLuc replicons. NsP2 mutations P718S and P726S are indicated with an 
asterisk. PAC; puromycin acetyltransferase. B. Partial amino acid alignment of alphavirus nsP2. 
RRV; Ross River virus, VEEV; Venezuelan equine encephalitis virus. The conserved Proline and 
amino acid numbers within nsP2 proteins are indicated. C. pSTAT1 nuclear translocation  upon 
type IFN-β induction in SINrepGFP (wildtype and mutant nsP2-P726S) transfected Vero cells. 
Cells were immunostained with anti-pSTAT1 antibody. Open arrows show replicon positive 
cells lacking nuclear pSTAT1, solid arrows show replicon positive cells with nuclear pSTAT1. D. 
phospho-STAT1 nuclear translocation  upon IFN-β induction in CHIKrep-pac2AEGFP (wildtype 
and mutant nsP2-P718S) transfected Vero cells. Cells were immunostained with anti-pSTAT1 
antibody.
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We then investigated for CHIKV whether an analogous mutation of 
the conserved proline in CHIKV-nsP2 at position 718 (Figure 6.6B) could also 
be linked to a reduced ability to block JAK-STAT signaling. A puromycin-
selectable CHIKV replicon designated CHIKrep-pac2AEGFP (Figure 6.6A) 
and the same construct with a nsP2-P718S mutation (CHIKrep-pac2AEGFP-
nsP2m) were constructed and tested for their ability to block the JAK-STAT 
pathway in transient transfection experiment. The replication efficiency in 
Vero cells of CHIKrep-pac2AEGFPnsP2m (5-10 EGFP-expressing cells per 
well in a 96 wells plate) was severely reduced in comparison to CHIKrep-
pac2AEGFP (~10% EGFP-expressing cells). In contrast, replication efficiency 
in BHK-21J cells of CHIKrep-pac2AEGFP-nsP2m as compared to CHIKrep-
pac2AEGFP was only slightly reduced (~10% vs. ~20% EGFP-expressing cells), 
but with notable differences in the induction of cytopathic effect (CPE). BHK-
21J cells transfected with CHIKrep-pac2AEGFP-nsP2m retained normal cell 
morphology, in contrast to cells transfected with CHIKrep-pac2AEGFP, which 
lost adherence and showed cell rounding 48 h p.t. (data not shown). 
In order to investigate the effect of the CHIKV nsP2-P718S mutation 
on JAK-STAT signaling, Vero cells transfected with CHIKrep-pac2AEGFP or 
CHIKrep-pac2AEGFP-nsP2m, were induced with IFN-β at 24h p.t. and stained 
with a-STAT1 antibody as before. Similar to the results obtained with SINV, 
CHIKV replicon expressing nsP2-P718S was indeed unable of blocking IFN-β 
induced STAT1 nuclear translocation, in contrast to its parental “wildtype” 
CHIKV replicon (Figure 6.6D). This observation suggests that SINV and CHIKV 
most likely employ a similar mechanism of blocking the JAK-STAT pathway, 
and that the conserved proline in nsP2 at positions 726 and 718, respectively, is 
essential for this activity.
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Discussion
The IFN response is the first line of defense against invading pathogens 
and therefore it is no surprise that many viruses actively suppress this antiviral 
mechanism to promote virus replication and spread (reviewed by Randall & 
Goodbourn, 2008) (192). In this research we have shown that once established, 
CHIKV replication is largely resistant to treatment with type I and II IFN. While 
IFN-α has been proposed as an antiviral drug to control CHIKV replication 
(207), our results suggest that IFN may have limited use in antiviral therapy. 
Recent experiments in mice support this view illustrating that IFN-α treatment 
before, but not after CHIKV infection inhibits disease and viraemia (68). Next, 
we demonstrated that CHIKV infection and CHIKV replicon RNA replication 
both efficiently blocked IFN-induced JAK-STAT signaling. This activity was 
mapped to the nsP2 gene by expression of nsP2 alone and in the context of 
an attenuated CHIKV replicon harboring an nsP2 mutation from a conserved 
proline to a serine at position 718. 
NsP2 had earlier been recognized as an important player in modulating 
the IFN response associated with host shut-off (208). Recently, it is becoming 
clear that host shut-off and suppression of the IFN response by alphaviruses 
can be regarded as separate activities (193). In Old World alphaviruses, nsP2 
has been found to be the most important viral protein in modulating the IFN 
response, with an additional role for the capsid protein in the New World 
alphaviruses (205, 209). Through the generation of adaptive mutants, nsP2 
has been identified as the main viral factor to establish persistent replication 
in mammalian cells. Non-cytopathic variants of SINV and SFV with different 
mutations in nsP2 display severe defects in counteracting the IFN response (87, 
206) and result in high IFN production. This lead to the hypothesis that nsP2 
has an essential role in modulation of the IFN response, likely via interference 
with downstream JAK-STAT signaling. We show here for the first time that 
alphavirus nsP2 alone is able to block the JAK-STAT pathway. 
Whether or not the other nsPs or their intermediate precursors 
could possible contribute to the activity displayed by nsP2 was not further 
investigated. However, given the potency of individual nsP2 to block STAT1 
nuclear translocation, any contributory activity by other viral proteins may not 
be required to establish a productive infection. Selection of Vero or BHK-21J cell 
lines harboring persistently replicating, attenuated CHIKV replicon RNA was 
unfortunately not accomplished. It might be possible that for CHIKV replicons 
additional mutations in nsP2 or other locations are required to support 
persistent replication in mammalian cells as was previously described for non-
cytopathic SINV (85). 
Previous research has suggested important roles for nsP2 and a host-
encoded, cellular endoribonuclease, RNaseL, to initiate the transition from 
minus- to plus-strand RNA synthesis (210, 211). Since RNaseL is activated by 
OAS, which itself is an interferon stimulated gene (ISG), this seems at odds 
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with the inhibitory role of nsP2 on the JAK/STAT pathway. However, the switch 
from the minus-strand replication complex (RC-) to RC+ occurs at a later stage 
during infection and only after cleavage of the nsP2/3 precursor. In CHIKV-
infected cells, we have observed inhibition of OAS induction by IFN treatment 
at later timepoints (>8 hpi).  This correlates with the current view that nsP2 is 
released in its free form after early replication has been established and creates 
an environment where host transcription/translation is reduced and the IFN 
response is actively suppressed. 
We have shown by several different experimental approaches that 
CHIKV replication blocks the JAK-STAT pathway, yet the exact mechanism at 
the molecular level remains to be elucidated in follow up experiments. We have 
ruled out that the observed blockage of JAK-STAT signaling was due to host 
shut-off, since signaling in these settings was unaffected in cells treated with 
cycloheximide. We have also ruled out that CHIKV reduces endogenous STAT1 
levels, an observation also reported for VEEV- and SINV-infected cells (203).
During dengue virus infection, STAT1 nuclear translocation is inhibited 
by dengue virus nonstructural protein NS5 as an indirect result of preventing 
STAT2 phosphorylation and STAT1-STAT2 heterodimer formation (78, 212). 
Consequently, dengue virus is not capable of inhibiting IFN-γ induced STAT1 
phosphorylation/homodimer formation. In contrast to dengue virus, however, 
incubation with IFN-γ of cells infected with CHIKV or transfected with CHIKV 
replicon demonstrates that STAT1 activation is blocked (Figures 6.3C and 6.4C), 
suggesting that the inhibitory mechanism in the case of CHIKV is different. 
The increased STAT1 levels upon IFN induction in normal but not in 
CHIKV infected cells (Figure 6.3D) may be the result of signal transduction 
via JAK-STAT pathway as was suggested earlier (200). In this scenario, STAT1 
upregulation in CHIKV-infected cells is  prevented by active inhibition of 
JAK-STAT signaling, which is supported by the observed decreased luciferase 
production from the IFN responsive plasmids in infected cells (Figure 6.2).
We showed that a SINV replicon containing nsP2 with a serine at position 
726 was not able to efficiently block phospho-STAT1 nuclear translocation, 
in contrast to the “wildtype” SINV replicon containing nsP2 with a restored 
proline at position 726. Others have previously claimed that wildtype SINV 
infection does not impair the ability to respond to IFN-α as judged by similar 
levels of STAT1 phosphorylation in infected as compared to uninfected cells 
(75). The reason for this apparent discrepancy in results is not clear, but an 
explanation may be the timing of the experiment or the genetic background 
of the SINV constructs. In our studies, we induced Vero cells with IFN 24 h p.t. 
with a pToto1101 derived replicon (213), whereas Lin et al. (2006) (75) used a 
dsTE12Q recombinant Sindbis vector (214) and induced Vero cells with IFN 6 h 
p.i.. It would be interesting to map the putative differences between these SINV 
vectors, within nsP2 or elsewhere in the genome, and identify the domain(s) or 
amino acid(s) responsible. 
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Taken together, the inability of alphaviruses with mutated nsP2 
proteins to efficiently block STAT1 nuclear translocation may now provide an 
explanation for the reported overall increased IFN production by such mutants. 
In this light it is interesting to note that in preliminary studies Ross River virus 
(RRV), another arthrogenic alphavirus and a close relative to CHIKV, does not 
appear to antagonize STAT1 activation (215) although this awaits confirmation. 
In future research, it may be interesting to investigate whether this apparent 
difference between CHIKV and RRV could be due to differences of their 
respective nsP2 proteins. Mapping the functional domains within CHIKV 
nsP2 and deciphering the exact mechanism how nsP2 blocks the JAK-STAT 
pathway, possibly by preventing STAT1 phosphorylation and/or prohibiting 
nuclear import of phosphorylated STAT1, is the focus of future studies in our 
laboratories. Our results may also provide insights into the development of 
live-attenuated vaccines to control CHIKV and other alphavirus infections. 
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The C-terminal domain of chikungunya 
virus nsP2 independently governs viral 
RNA replication, cytopathicity, and 
inhibition of interferon signaling
Alphavirus non-structural protein (nsP)2 has pivotal roles in viral RNA 
replication, host cell shut-off and inhibition of antiviral responses. Mutations 
that individually rendered other alphaviruses non-cytopathic were introduced 
into chikungunya virus nsP2. Results show that (i) nsP2 mutation P718S only 
in combination with KR649AA or adaptive mutation D711G allowed non-
cytopathic replicon RNA replication, (ii) prohibiting nsP2 nuclear localization 
abrogates inhibition of antiviral interferon-induced JAK-STAT signaling (iii) 
nsP2 independently affects RNA replication, cytopathicity and JAK-STAT 
signaling.
This chapter has been published as:
Jelke J. Fros, Erika van der Maten, Just M. Vlak and G. P. Pijlman. The C-termi-
nal domain of chikungunya virus nsP2 independently governs viral RNA replica-
tion, cytopathicity, and inhibition of interferon signalling. J. Virol. 87, 10394–400 
(2013).
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Main text 
Chikungunya virus (CHIKV) is a member of the Alphavirus genus within 
the Togaviridae family. In humans, infection by this mosquito-borne virus can 
result in the development of a high fever, rash and incapacitating, sometimes 
chronic, arthralgia. The last decade CHIKV outbreaks occurred throughout the 
Indian ocean region, including La Reunion infecting up to one third of the 
human population, before infecting millions of people in India and Southern 
Asia (3, 31). CHIKV is a positive-strand RNA virus that replicates in the 
cytoplasm of infected cells. The genome contains four non-structural proteins 
(nsP1-4) that are directly translated from the genomic RNA (gRNA). The viral 
structural proteins are translated later in infection from subgenomic mRNA 
(sgRNA)(191). 
NsP1 is a methyltransferase and is associated with cellular membranes 
(145), nsP3 is a phosphoprotein that recruits host factor G3BP and consequently 
inhibits the formation of cellular stress granules (160, 216) and nsP4 is the 
viral RNA-dependent RNA polymerase (191). NsP2 contains the viral helicase, 
protease and a putative C-terminal methyltransferase domain, associates with 
many host proteins and can effectively shut down host cell protein synthesis 
(217–221). Alphavirus nsP2 also contains a nuclear localization signal (NLS) 
in its C-terminal domain (CHIKV nsP2 KR649-650) (Figure 7.1A, top). NsP2 
from related Semliki Forest (SFV) and Sindbis viruses (SINV) has been shown 
to translocate to the nucleus (222–224) as specific mutations within the NLS 
retained SFV nsP2 in the cytoplasm and reduced its cytopathicity (225). In 
the nucleus, nsP2 of Old World alphaviruses (SFV, SINV, CHIKV) has been 
reported to inhibit host cell mRNA transcription via degradation of a subunit 
of DNA-directed RNA polymerase II (RPB1)(149). Mutation of a conserved 
proline residue in a site homologous to CHIKV nsP2 P718 (Figure 7.1A, bottom) 
rendered SINV non-cytopathic and alleviated the transcriptional inhibition via 
RPB1 (85, 149, 226).
In addition, alphavirus nsP2 has been shown to antagonize the hosts 
main antiviral response, the interferon(IFN)-response in two ways: (i) IFN-β 
transcription via global host shut-off and (ii) downstream type I/II IFN-induced 
Janus kinase/signal transducers and activators of transcription (JAK-STAT) 
signalling (87, 148, 149, 193, 206). Upon activation, phosphorylated STAT1/2 
proteins translocate as dimers into the nucleus to activate the transcription of 
antiviral genes, bringing the cell in an antiviral state (192). Inhibition of STAT1 
phosphorylation and/or nuclear translocation are important determinants of 
alphavirus virulence (193, 227).
Previously, we showed that CHIKV replication is sensitive to pre-
stimulation of cells with IFNs, but becomes largely resistant to IFNs once 
replication has been established (148). In addition, we showed that individually 
expressed CHIKV nsP2 is a potent inhibitor of IFN downstream signaling 
by blocking STAT1 nuclear translocation. In the context of CHIKV replicon 
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RNA replication, the mutation P718S within the nsP2 gene abrogated the 
inhibitory effects of nsP2, re-allowing STAT1 to translocate to the nucleus upon 
stimulation with IFN (148). Since the C-terminal domain of nsP2 appears to be 
highly multifunctional and is associated with host cell shut-off and cytopathic 
effect (CPE), the inhibition of JAK-STAT signaling, viral replication and with 
nuclear translocation of nsP2, we set out to determine whether or not these 
characteristics of nsP2 are intrinsically connected. 
We began by investigating the cellular distribution of CHIKV nsP2. EGFP 
was fused within the N-terminus of nsP2 (essentially as described for SINV 
(224)), in a CHIKV replicon expressing mCherry from the 26S subgenomic 
promoter (148) creating CHIKrep-nsP2EGFP-mCherry (Figure 7.1B, bottom). 
Mutations in the NLS (KR649AA) or P718 (P718S) were introduced creating 
CHIKrep-nsP2EGFPKR649AA-mCherry  and CHIKrep-nsP2EGFPP718S-mCherry, 
respectively. Transfection of in vitro transcribed CHIKrep-nsP2EGFP-mCherry 
RNA into Vero cells showed that nsP2EGFP not only translocates from the 
cytoplasm to the nucleus, but also supports functional viral RNA replication and 
sgRNA expression as indicated by mCherry expression (Figure 7.1C, top panel). 
Both the mutated replicons were hardly detectable when the same exposure 
time was used as with wild type CHIKrep-nsP2EGFP-mCherry. However, longer 
exposure times revealed that nsP2EGFPKR649AA was exclusively localized to the 
cytoplasm and that the mCherry signal was barely detectable (Figure 7.1C). 
Although overall protein levels were much lower, nsP2EGFPP718S distribution 
and the mCherry signal resembled that of the wild type replicon (Figure 7.1C).
Since these mutations in the C-terminus of alphavirus nsP2 clearly 
affect viral protein expression we introduced both the mutations in the NLS 
(KR649AA) or P718S into a plasmid that individually expressed nsP2-EGFP 
from a cytomegalovirus (CMV) promoter (Figure 7.1B, top) creating pnsP2-
EGFP,  pnsP2-EGFPKR649AA and pnsP2-EGFPP718S, respectively.  As expected 
and similar to expression from replicon (Figure 7.1C), individually expressed 
nsP2EGFP fusion proteins localized to both the cytoplasm and the nucleus 
(Figure 7.1D, top panels). In line with what was found for SFV, disruption of 
the NLS in CHIKV nsP2 blocked nuclear localization and retained nsP2 in 
the cytoplasm (Figure 7.1D, middle panels)(222, 225). In contrast, the P718S 
mutation still allowed nuclear translocation and displayed a distribution of 
the nsP2EGFP fusion protein similar to wild type nsP2 (Figure 7.1D, lower 
panels). In the context of replicon RNA replication (Figure 7.1C), the fraction 
of nsP2EGFP in the nucleus was somewhat smaller compared to individually 
expressed nsP2EGFP (Figure 7.1D). Most likely, more nsP2 is retained in the 
cytoplasm when it interacts with other nsPs to form replication complexes. 
These results demonstrate that CHIKV nsP2 is present in the nucleus during 
RNA replication and upon individual expression but requires an intact NLS for 
nuclear translocation. 
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Figure 7.1. CHIKV nuclear localization depends on an intact NLS. A. Partial amino acid 
alignment of alphavirus nsP2s. RRV, Ross River virus; VEEV, Venezuelan equine encephalitis 
virus. Arrows indicate the conserved amino acids lysine (K) and arginine (R) in the NLS at CHIKV 
nsP2 position 649 (top) and the conserved proline (P) at position 718 (bottom). B. Schematic 
representation of pnsP2EGFP (top) and pCHIKrep-nsP2EGFP-mCherry (bottom). EGFP has been 
inserted between amino acid 8/9 as indicated. Asterisks indicate the  location of conserved site 
mutations (KR649 and P718). C. Vero cells were transfected with in vitro transcribed CHIKrep-
nsP2EGFP-mCherry wild type RNA and the KR649AA and P718S mutants. After 24 h the cells 
were fixed in 4% paraformaldehyde in phosphate-buffered saline for 10 min at room temperature 
and nuclei were visualized by Hoechst 33342 staining (10 ng/ml). All samples were visualized 
with identical exposure times prior to being overexposed. D. Vero cells were transfected with 
pCMV-nsP2EGFP, nsP2EGFPKR649AA or nsP2EGFPP718S. After 24 h cells were fixed and stained 
with Hoechst and visualised with a Zeiss Axio Observer Z1m inverted microscope in combination 
with an X-Cite 120 series lamp.
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Since alphavirus nsP2 causes shut down of host cell protein synthesis 
and is cytotoxic (85, 218, 225) we investigated the effect of the mutations in 
the C-terminus of CHIK nsP2 on host cell protein synthesis. CMV promoter-
driven expression plasmids (21) encoding nsP2KR649AA and nsP2P718S mutants were 
transfected into Vero cells together with a plasmid, constitutively expressing 
Renilla luciferase (Rluc). Cells transfected with a control plasmid expressing 
EGFP were either left untreated or treated with cycloheximide (CHX), to 
inhibit protein synthesis. Both CHX treatment and wild type nsP2 expression 
reduced the amount of translated Rluc considerably, whereas both mutants did 
not decrease Rluc protein synthesis (Figure 7.2A). Surprisingly, nsP2KR649AA even 
seemed to increase Rluc synthesis (Figure 7.2A). Although alphavirus nsP2 
is known to modulate host cell translation, possible mechanisms that could 
enhance general translation have not been reported (85, 218, 225, 226, 228).
Subsequently, the level of cytotoxicity induced by CHIKV nsP2 and its 
mutants was investigated in cell viability and apoptosis assays. Vero cells were 
transfected with either the control plasmid or with plasmids encoding one 
of the nsP2 mutants. Cells transfected with the control plasmid were either 
left untreated or treated with actinomycin D (ActD) to induce CPE through 
transcriptional inhibition (229). Both treatment with ActD and transfection 
with nsP2 resulted in severe CPE and thus reduced the total cell viability 
(Figure 7.2B). In sharp contrast, expression of either the nsP2KR649AA or nsP2P718S 
mutants did not induce any CPE over the course of the experiment. In a parallel 
experiment, the level of nsP2-induced apoptosis was determined by measuring 
effector caspase 3/7 activity  (Figure 7.2C).  The presence of either ActD or nsP2 
resulted in a significant induction of caspase activity compared to the mock. 
In line with results from the cell viability assay, both mutant nsP2 proteins did 
not induce any caspase activity. Together, these results indicate that mutation 
of the NLS (KR649) or the conserved proline at P718 abrogates host cell shut-
off and significantly decreases the cytotoxicity of nsP2 and the subsequent 
induction of apoptosis.   
Previously, we reported that in the context of CHIKV RNA replication, 
nsP2P718S allows STAT1 nuclear translocation, whereas wild type nsP2 is a potent 
inhibitor of JAK-STAT signalling (148). Because residues P718, but also KR649 
are important for viral replication, host cell shut-off and associated CPE, we 
investigated whether or not there is a connection with the inhibition of JAK-
STAT signaling by individually expressed nsP2. Vero cells were transfected with 
either wildtype pCMV-nsP2, -nsP2KR649AA or -nsP2P718S. Since nsP1 alone did not 
have any effect on STAT1 nuclear translocation, pCMV-nsP1 was used as a 
control (Figure 7.2D, left)(148). At 24 h post transfection, STAT1 phosphorylation 
was induced with IFN-β. Immuno-staining with phosphoSTAT1 antibodies 
showed that nsP2 wild type clearly inhibits STAT1 nuclear translocation (Figure 
7.2D, middle left). The NLS mutant nsP2KR649AA completely lost the ability to 
inhibit STAT1 nuclear translocation, indicating that a functional NLS in nsP2 
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may be required for blocking the JAK-STAT pathway (Figure 7.2D, middle 
right). Unexpectedly, given the previously observed abrogation of JAK-STAT 
inhibition by a CHIKV replicon with a P718S mutation in nsP2, the individually 
expressed nsP2P718S mutant still inhibited STAT1 nuclear translocation to the 
same extent as wild type nsP2 (Figure 7.2D, right). 
Figure 7.2. Mutations in CHIKV nsP2 differentially influence host shut-off mediated 
cytopathicity and the inhibition of JAK-STAT signaling. ABC. Vero cells were transfected 
with either a control plasmid pEGFP-N1 (Clontech) or CMV-nsP2, CMV-nsP2KR649AA or 
CMV-nsP2P718S. A. In addition to the nsP2 plasmid cells were co-transfected with plasmid 
constitutively expressing Renilla luciferase (pRL-TK, Promega). Control cells were either left 
untreated or treated with CHX (0.5μg/ml) for 24 h, before Rluc expression was measured. Values 
are depicted as the average duplicate samples from two individual experiments. Error bars 
represent one standard error and asterisk indicate a significant difference compared to the mock 
(Tukey HSD test, P<0.05. BC. Cells were transfected with the nsP2 variants or control plasmid. 
Controls were either treated with ActD (2µg/ml) for 48 h or left untreated. After 48 h cell viability 
(B) or caspase activity (C) were measured with a luminescent based assays (CelltiterGLO and 
Caspase-GLO 3/7 assays, Promega). Values are depicted as the average of triplicate samples from 
three individual experiments and relative to the mock. Error bars represent one standard error 
and asterisk indicate a significant difference compared to the mock (Tukey HSD test, P<0.05). D. 
Vero cells were transfected with the indicated mutants of pCMV-nsP2. After 24 hours cells were 
fixed and permeabilized with 0.1% sodium dodecyl sulfate (SDS) in PBS. Nuclei were stained with 
Hoechst 3342. STAT1 nuclear translocation was visualized with anti-pSTAT1 primary antibody 
(phospho-Tyr701; SAB Signalway Antibody) and the secondary antibody GaR-AF488 (Molecular 
Probes). Open arrowheads indicate the nuclei of nsP2 positive cells that lack the signal for 
pSTAT1. Solid arrowheads indicate nsP2 positive cells with nuclear pSTAT1
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We therefore hypothesized that reduced RNA replication of the CHIKV 
replicon carrying the P718S mutation could explain the observed lack of 
inhibition of JAK-STAT signaling in our earlier study (148). We set out to 
determine what the (combined) effects of the NLS and P718S mutations were on 
CHIKV RNA replication and cytopathicity. In a puromycin  selectable CHIKV 
replicon which was described previously (148), we engineered both mutations 
either separately or together, creating: CHIKrep-nsP2KR649AA-pac2AEGFP, 
CHIKrep-nsP2P718S-pac2AEGFP and CHIKrep-nsP2KR649-P718S-pac2AEGFP, 
respectively. In vitro transcribed RNA was transfected into BHK cells and 
puromycin selection was started 24 hpt (Figure 7.3A). The double mutant 
(CHIKrep-nsP2KR649-P718S) proved easily selectable (Figure 7.3A, e) and is similar 
to a recently described non-cytopathic CHIKV replicon that acquired a 5 amino 
acid insertion of unknown origin that disrupted the NLS (226). However, 
multiple attempts to select cells that expressed replicons with single nsP2 
mutations were unsuccessful (Figure 7.3A, cd). In one of these experiments, 
however, a single colony of the CHIKrep-nsP2P718S–pac2AEGFP mutant survived 
and grew out to a stable, CHIKrep-pac2AEGFP expressing cell line. Sequencing 
of the nsP2 gene revealed that nsP2 had acquired a second-site mutation, D711G. 
To exclude the possibility that additional adaptive mutations outside nsP2 were 
acquired we engineered a replicon with only the D711G and P718S mutations 
(CHIKrep-nsP2D711G-P718S-pac2AEGFP). Transfection into BHK cells displayed a 
non-cytopathic phenotype and as a result these cells were readily selected with 
puromycin (Figure 7.3A, f). 
To investigate whether reduced cytopathicity was due to nsP2 related host 
cell modulation and/or affected replication efficiency we measured CHIKrep 
RNA replication in a time course experiment. BHK cells were transfected with 
either wild-type CHIKrep-pac2AEGFP  (Figure 7.3B, b), a replication-defective 
variant lacking its 3’UTR  (CHIKrep-pac2AEGFP-Δ3’UTR) (Figure 7.3B, a) or 
one of the above described mutants (Figure 7.3B, c-f). Cells were harvested at 
different times post transfection and the relative copy numbers of CHIKrep 
gRNA and sgRNA were quantified by qRT-PCR via amplification of parts of  the 
nsP1 and the pacEGFP genes, respectively. At 15 hpt all replicons had reached 
peak RNA copy numbers (Figure 7.3C). The transfected cells were not subjected 
to puromycin selection, making it likely that the observed decrease after 15 h 
was caused by proliferation of untransfected cells and/or cell death induced 
by CHIKV RNA replication. At 15 hpt, wild type CHIKrep displayed a ~30-
fold increase in relative copy numbers of gRNA (Figure 7.3C, left) and a ~60-
fold increase of sgRNA (Figure 7.3C, right). The gRNA levels of the KR649AA 
mutant were similar to wild type (Figure 7.3C, left). The primers used to amplify 
sgRNA also amplify the corresponding fragment from the gRNA. Since the level 
of sgRNA amplification was comparable to that of gRNA, this indicates that 
the actual production of sgRNA was severely impaired (Figure 7.3C, right). 
The lack of mCherry production during CHIKrep-nsP2EGFPKR649AA-mCherry 
The C-terminal domain of chikungunya virus nsP2
7
115
Figure 7.3. CHIKV nsP2 requires multiple mutations to establish non-cytopathic 
replication, independently of STAT1 nuclear translocation. AB. BHK cells were transfected 
with in vitro transcribed RNA of the various mutants of CHIKrep-pac2AEGFP (a-f). A. Twenty 
four hpt cells were selected for non-cytopathic replicon replication expressing the puromycin 
resistance gene (pac) by adding puromycin (5 ng/ml) to the medium. Pictures were taken at 
9 h (B) and 5 d (A) post transfection. C. Vero cells were transfected with in vitro transcribed 
RNA of the indicated mutants of CHIKrep-pac2AEGFP. At indicated times post transfection 
total RNA was harvested (Maxwell, LEV16 simplyRNA cell kit, Promega) and reverse transcribed 
(SuperScriptIII, Invitrogen) using random primers. Genomic RNA replication was measured 
using semi-quantitative PCR (IQ SYBRgreen, Bio-rad). Depicted is a representative of 2 
independent experiments. Values represent the average from duplicate samples, after being 
normalized for a non-replicating replicon (lacking the 3’UTR) and relative to input RNA at 0 h 
post transfection. Error bars represent one standard deviation. D. Vero cells were transfected with 
nsP2D711G-P718S and fixed and stained for pSTAT1. Open arrowheads indicate the nuclei of nsP2 
positive cells that lack the signal for pSTAT1. E. Vero cells were transfected with the indicated 
mutants of pCMV-nsP2 and immunostained with pSTAT1 24 hpt. Values represent manual cell 
counts of STAT1 positive nuclei, relative to nsP1. Values within brackets represents population 
size. Asterisks indicate significant decrease from nsP1 (binomial test, P<0.01). F. Model of the 
C-terminal domain of CHIKV nsP2. Loop structures 1-4 and residues KR649 (magenta), D711 
(blue) and P718 (red) are indicated.
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replication confirms the reduction in sgRNA production (Figure 7.1C). The 
P718S mutant had a very low level of gRNA replication (Figure 7.3C, left) with 
a respective ~3-fold increase of sgRNA at 15 hpt. (Figure 7.3C, right). Reduced 
replication rates of both mutant replicons correspond to what was found for 
other alphavirus replicons that carry mutations at homologous sites (225, 226). 
The severely diminished sgRNA production of CHIKrep-nsP2EGFPKR649AA has 
not been reported previously. These observations and those presented by 
others, indicate that various mutations at these sites can differentially affect the 
efficiency of alphavirus replicon RNA replication, depending on the alphavirus 
species (225, 226). The replicon with both the KR649AA and P718S mutations 
has an intermediate phenotype, resulting in low level production of  gRNA 
and sgRNA (Figure 7.3C). Interestingly, RNA replication of the D711G-P718S 
replicon was partly rescued by this novel adaptive mutation as observed by 
increased gRNA (~7-fold) and sgRNA (~12-fold) levels at 15 hpt (Figure 7.3C).  
 These results indicate that, unlike other alphaviruses, CHIKV replicons 
require multiple mutations in the C-terminus of nsP2 for establishment of non-
cytopathic replication. Since the mutations KR649AA and P718S completely 
reduced the cytotoxicity of nsP2 when it was individually expressed (Figure 
7.2BC), the inability to select both CHIKrep-nsP2KR649AA-pac2AEGFP and 
CHIKrep-nsP2P718S-pac2AEGFP replicons is likely to be the result of reduced 
production of sgRNA messenger and gRNA replication, respectively (Figure 
7.3C). The reduced replication efficiencies of replicons with the P718S mutation 
(Figures 7.1C and 7.3C) explain the absence of inhibition of STAT1 nuclear 
translocation observed in our previous study (148). In addition, we identified 
a novel combination of mutations (D711G-P718S) that allows non-cytopathic 
replication combined with relatively high sgRNA levels. This replicon may 
be an attractive tool for biotechnology applications where high level protein 
expression from non-cytopathic viral vectors is desired. In addition, this novel 
replicon carrying combined D711G and P718S mutations allowed us to investigate 
whether or not the inhibition of JAK-STAT signaling is intrinsically linked to 
non-cytopathic RNA replication. We introduced the D711G mutation in pCMV-
nsP2P718S to create pCMV-nsP2D711G-P718S. When STAT1 localization was assayed in 
the presence of this novel double mutant it proved to be a potent inhibitor of 
JAK-STAT signaling (Figure 7.3D). A manual count of cells displaying STAT1 
nuclear translocation in the presence of either nsP1, wild type nsP2 or one of 
the described nsP2 mutants clearly showed that only nsP2KR649AA was no longer 
able to inhibit STAT1 nuclear translocation (Figure 7.3E). This shows that non-
cytopathic RNA replication is independent from JAK-STAT signaling and that a 
functional NLS is a prerequisite for the inhibition of STAT1 nuclear localization. 
In conclusion, we show that host cell shut-off and associated CPE induced 
by CHIKV RNA replication are caused by CHIKV nsP2 (Summarized in Table 
1). The shutoff caused by overexpression of nsP2 has been clearly described by 
others and is a result of transcriptional arrest via degradation of DNA-directed 
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RNA polymerase II (149). Mutations that rendered other alphavirus replicons 
non-cytopathic (KR649AA, P718S) completely restored host cell protein 
synthesis and efficiently prevented nsP2-induced CPE. Unlike the situation in 
other alphaviruses, multiple mutations in the C-terminus of nsP2 are required 
to establish non-cytopathic CHIKV RNA replication in mammalian cells. Here 
we show that directed mutagenesis of the NLS (KR649AA) in combination with 
the P718S mutation is sufficient to sustain non-cytopathic RNA replication and 
selection of replicon cell lines. Moreover, we also identified a second combination 
of mutations including a novel adaptive second-site mutation (D711G-P718S) 
not affecting the NLS and resulting in higher sgRNA synthesis than the other 
mutations. Interestingly, neither P718S alone, nor in combination with this 
novel adaptive mutation reverted the inhibition of STAT1 signaling, when 
nsP2 was individually expressed. Disruption of the NLS, however, abolished 
the inhibition of STAT1 nuclear translocation, indicating that a functional 
NLS within nsP2 is a pivotal determinant for inhibition of STAT1 nuclear 
translocation. Whether the lack of nuclear nsP2 re-allows STAT1 to translocate 
to the nucleus or that a mutation within the NLS disrupts an additional 
function of the nsP2 C-terminal domain will be subject of future investigation. 
The three-dimensional structure of the C-terminal domain of CHIKV nsP2 
reveals that the residues KR649-650 and P718 are both located at the tips of 
externalized loop structures (loop 2 and 4 respectively), whereas the novel 
adaptive mutation at amino acid D711 is located within the alpha-helix at the 
base of loop 4 (Figure 7.3F). Interestingly, this region of the C-terminus of nsP2 
has been shown to directly bind nsP3 in the viral replication complex of SINV 
(156). Modifications in the nsP2-nsP3 interaction could explain the differential 
replication efficiencies of the mutant CHIKV replicons. Taken together, these 
results show that the C-terminus of nsP2 is a truly multifunctional domain 
distinctly involved in the regulation of RNA replication, cytopathicity and the 
inhibition of IFN-induced JAK-STAT signaling.   
Level for strain:
Characteristic Figure(s) Wildtype KR649AA 
mutant
P718S 
mutant
KR649AA-
P718S mutant
D711G-P718S 
mutant
Nuclear localization 1C and D + - + NT NT
CPE 2B and C + - - - -
gRNA replication 3C + + - - +/-
sgRNA production 3C ++ - +/- - +
JAK-STAT signaling 
inhibition
2D, 3D 
and E
+ - + NT +
Table 7.1. Summary of Data a
a Symbols and abbreviations: -, negative, +/-, intermediate, +, postitive, ++, strongly positive, 
NT, not tested.
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Chikungunya virus nsP2-mediated host 
shut-off disables the unfolded protein 
response
The unfolded protein response (UPR) is a cellular defense mechanism against 
high concentrations of misfolded protein in the endoplasmic reticulum (ER). 
In the presence of misfolded proteins, ER-transmembrane proteins PERK 
and IRE1α become activated. PERK phosphorylates eIF2α leading to a general 
inhibition of cellular translation, while the expression of transcription factor 
ATF4 is upregulated. Active IRE1α splices out an intron from XBP1 mRNA, 
to produce a potent transcription factor. Activation of the UPR increases the 
production of several proteins involved in protein folding, degradation and 
apoptosis. Herein we demonstrate that transient expression of chikungunya 
virus (CHIKV) (Togaviridae, genus Alphavirus) envelope glycoproteins induced 
the UPR and that CHIKV infection resulted in the phosphorylation of eIF2α and 
partial splicing of XBP1 mRNA. However, infection with CHIKV did not increase 
the expression of ATF4 and known UPR target genes (GRP78/BiP, GRP94 and 
CHOP). Moreover, nuclear XBP1 was not observed during CHIK infection. 
Even upon stimulation with tunicamycin, the UPR was efficiently inhibited in 
CHIKV infected cells. Individual expression of CHIKV non-structural proteins 
(nsP) revealed that nsP2 alone was sufficient to inhibit the UPR. Mutations 
that render nsP2 unable to cause host-cell shut-off prevented nsP2-mediated 
inhibition of the UPR. This indicates that initial UPR induction takes place in 
the ER, but that expression of functional UPR transcription factors and target 
genes is efficiently inhibited by CHIKV nsP2.
This chapter has been published as:
Jelke J. Fros, Lee D. Major, Florine E. M. Scholte, Joy Gardner, Martijn J. van 
Hemert, Andreas Suhrbier and Gorben P. Pijlman. Chikungunya virus nsP2-me-
diated host shut-off disables the unfolded protein response. J Gen Virol. 96, 580–
589 (2015).
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Introduction
Many newly translated proteins, including those of viral origin, are 
translocated into the endoplasmic reticulum (ER) for post-translational 
modifications (e.g. glycosylation) and proper folding, before being secreted 
or transported to various cellular organelles. Several stimuli can disrupt the 
homeostasis in the ER, including viral infections that result in high expression 
of viral glycoproteins (95). An increase in the concentration of unfolded and 
misfolded proteins in the ER lumen results in ER stress. To cope with ER stress, 
eukaryotic cells have the ability to sense unfolded protein levels and regulate the 
transcriptional and translational machinery to reduce general protein synthesis 
and to increase the protein folding capacity of the ER. The mechanisms by 
which cells respond to ER stress are collectively called the unfolded protein 
response (UPR). The initial responses of the UPR aim to reduce ER stress and 
aid in cell survival. However, prolonged activation of the UPR results in the 
induction of apoptosis (230–232). The UPR is initiated when Ca2+-dissociated 
heavy-chain binding protein (BiP), also known as glucose-regulated protein 78 
(GRP78), dissociates from three distinct ER trans-membrane UPR sensors to 
bind misfolded proteins in the ER lumen (233, 234). 
Dissociation of GRP78/BiP from double-stranded RNA-dependent 
protein kinase (PKR)-like ER kinase (PERK), allows PERK to phosphorylate 
the alpha subunit of the eukaryotic translation initiation factor-2 (eIF2α). 
Phosphorylation renders eIF2α unable to be recycled back into its active, GTP-
bound state, reducing the general level of translation and thereby reducing the 
protein load in the ER lumen (235). Under conditions of eIF2α phosphorylation, 
activating transcription factor 4 (ATF4) is selectively translated (236). ATF4 
causes up-regulation of UPR target gene transcription, including redox and 
metabolism regulatory proteins and pro-apoptotic protein DNA damage-
inducible protein C/EBP-homologous protein 10 (CHOP or GADD153)(237).
Dissociation of GRP78/BiP from inositol-requiring 1α (IRE1α) results 
in the oligomerization and trans-autophosphorylation of the kinase domain 
of IRE1α, which activates its cytoplasmic RNase activity. This results in the 
removal of a 26 base pair long intron from X-box-binding protein 1 (XBP1) 
mRNA, allowing translation of the full-length transcription factor (238). In 
the nucleus XBP1 promotes the transcription of genes that increase (i) protein 
folding capacity, (ii) chaperone protein entry to the ER, and (iii) ER-associated 
degradation (239–241). 
The third unfolded protein sensor is activating transcription factor 
6 (ATF-6). After the ER-luminal domain of ATF-6 has sensed the unfolded 
protein load and disassociates from GRP78/BiP, ATF-6 is cleaved and acts as a 
potent transcription factor for the expression of many ER-chaperones as well as 
XBP1 (242, 243). The three arms of the UPR form a highly cross-linked network, 
as specific interactions between ATF-6 and XBP1 have been reported and the 
transcription of CHOP and GRP78/BiP can be induced via all three arms of the 
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UPR (241, 244, 245).
To facilitate their replication, viruses manipulate many processes within 
their host cells. Enveloped viruses often rely on the ER for the maturation of 
their glycoproteins and transport of the glycoproteins to the plasma membrane. 
Many viruses inhibit, modulate or exploit arms of the UPR. For instance, 
human cytomegalovirus and Semliki Forest virus (SFV) induce XBP1 mRNA 
splicing (246, 247), whereas hepatitis C virus and herpes simplex virus induce 
ATF-6 cleavage (248, 249). West Nile virus infection initiates both XBP1 mRNA 
splicing and ATF-6 cleavage (250). The induction of the IRE1α and/or ATF-6 
arms of the UPR may help to maintain ER homeostasis by increasing protein 
folding capacity, thereby facilitating viral glycoprotein maturation and host 
cell survival. In contrast, most viruses block activation of the PERK pathway 
and the downstream phosphorylation of eIF2α, thereby avoiding translational 
inhibition and the subsequent induction of apoptosis via CHOP (249–251). 
Herein we explored the impact of CHIKV on the UPR. CHIKV is a re-
emerging mosquito transmitted alphavirus that causes sporadic epidemics of 
primarily rheumatic disease, with the largest epidemic ever recorded starting 
in 2004 in Africa and spread across Asia (3) and recently reached Oceania (252) 
affecting millions of people. The recent explosive outbreak in the Caribbean 
(35) was the first on the Western Hemisphere and has even reached the United 
States (253). The structural proteins of CHIKV are expressed as a polyprotein 
that results from translation of the viral subgenomic RNA. After autocatalytic 
cleavage of the capsid protein, the remaining polyprotein translocates to the ER. 
In the ER the polyprotein is cleaved by host signalases into precursor E2 and E1, 
which are N-linked-glycosylated before being transported to the Golgi network 
(163, 254). We investigated whether CHIKV envelope glycoproteins induced the 
UPR and whether CHIKV replication affects UPR target gene expression and the 
expression of ATF4. Furthermore, we analyzed the activation and localization 
of XBP1 and conclude that host cell shut-off, mediated by viral non-structural 
protein (nsP2) was responsible for modulating the UPR.   
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Materials and methods 
Ethics statement
All animals were handled in strict accordance with good animal practice 
as defined by the National Health and Medical Research Council of Australia. 
All animal work was approved by the QIMR Berghofer Medical Research 
Institute animal ethics committee.
Cells and virus isolates
Vero cells (ATCC number CRL-1586) and murine embryonic fibroblasts 
from C57 BL/6 mice (MEFs) were cultured in RPMI 1640 medium (GIBCO-
invitrogen) supplemented with 5% fetal calf serum (FCS) at 37 oC, 5% CO2. 
Murine splenic macrophages were obtained by homogenizing a spleen in RPMI 
1640 with 10% FCS. Tissue was pelleted and resuspended in 3 ml of ACK lysis 
solution (150 mM NH4Cl, 1 mM Na2-EDTA [pH 7.3]) for 3 minutes to remove 
any erythrocytes. Cells were washed and pelleted twice with RPMI 1640, 10% 
FCS, before being plated and left to attach overnight. Medium was replaced by 
RPMI 1640, 10% FCS containing 30% of Langerhans cell conditioned medium 
(LCCM). Cells were left to incubate over 3 days before being washed again with 
RPMI 1640, 10% FCS, 30% LCCM. The chikungunya virus isolate (LR2006-
OPY1) is a primary isolate from the recent outbreak in Reunion Island (268) 
and CHIKV LS3 (Scholte et al., 2013) is an infectious clone-derived virus. 
Reagents
The UPR reporter constructs consisted of a pGL-3 basic backbone with the 
promoter region of either GRP78/BiP (pGL-3 basic GRP78P(-132)-luc), GRP94 
(pGL-3 basic GRP94P(-363)-luc controls, respectively. CHIKV (S27) envelope 
cassette was expressed from a pcDNA/Dest40 backbone (pcDNA-envelope) 
and the plasmids expressing individual nsPs were described previously (147, 
148). GeneJammer (Agilent Technologies) and Lipofectamine2000 (Invitrogen) 
were used as transfection reagents and tunicamycin (tm) (Sigma-Aldrich) was 
used to activate the UPR in a concentration of 5 μg/ml.
XBP1 mRNA splicing
Activation occurs via the removal of a 26 base pair intron from XBP1 
mRNA, which contains a PstI restriction site. Total RNA extraction from cell 
cultures was performed using Trizol reagent (Invitrogen). Female C57BL/6 
mice were inoculated with CHIKV LR2006-OPY1 (104 CCID50) subcutaneously 
into the ventral side of each hind foot as described previously (68). For the 
extraction of total RNA from mouse feet, each foot was placed in a snaplock 
Eppendorf tube with 1.5 ml Trizol reagent and two, 3 mm tungsten carbide 
beads (QIAGEN). Tissue was homogenised at 25 HZ in a tissue lyser (QIAGEN). 
Samples were spun down for 10 min at 12,000 rpm at 4 ○C. The supernatant 
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(1 ml) was used for further Trizol RNA extraction. To remove genomic DNA, 
all RNA samples were DNase treated (TURBO DNA-free Applied Biosystems). 
The RNA from murine splenic macrophages and mouse feet was reverse 
transcribed using random primers. Murine RPL13A, spliced and unspliced 
XBP1 and CHIKV RNA were quantitated by real-time PCR, using platinum 
SYBR Green (Invitrogen), using a Rotor Gene RG-3000 (Corbett Research). 
Primers used in this assay were mXBP1 Fwd, mXBP1 U Rev and mXBP1 S 
Rev with the respective sequences: 5’-AAACAGAGTAGCAGCGCAGACTGC-3’, 
5’-GCTGCAGAGGTGCACATAGTCTGA-3’ and 5’-GCCTGCACCTGCTGCGGACTC-3’. 
Murine RPL13A was used as an internal control, mRPL13A 
Fwd. 5’-GAGGTCGGGTGGAAGTACCA-3’and mRPL13A Rev. 
5’-TGCATCTTGGCCTTTTCCTT-3’. CHIKV RNA was detected using Fwd. 
5’-AGCTCCGCGTCCTTTACC-3’ and Rev. 5’-CAAATTGTCCTGGTCTTCCTG-3’ 
primers.  mRNA from Vero cells was reverse transcribed (Superscript 
III, Invitrogen) using random hexamers (Roche) and XBP1 was PCR 
amplified using XBP1 F 5’-CCGGAGCTGGGTATCTCAAAT-3’ and XBP1 R 
5’-CCGTATCCACAGTCACTGTAGCA-3’ primers. Amplicons were digested with 
PstI and loaded on an agarose gel (250).
Dual luciferase assay
One day after transfection with the respective UPR reporter plasmids, 
Vero cells were infected and/or tm-treated as indicated. At the end point of 
each experiment cells were lysed in passive lysis buffer (Promega) and cellular 
debris were pelleted by centrifugation (6 min, 5000 rpm). Fluc and Rluc 
luminescence was measured using the dual-luciferase reporter assay system 
(Promega). Supernatants (25 to 50 μl) were transferred into a white Greiner 
F-bottom 96-wells plate and scanned for luciferase luminescence in a POLARstar 
OPTIMA (BMG Labtech) plate reader. Significant differences (P<0.05) between 
two samples were tested using a student’s T-test and significant differences 
between multiple samples with a Tukey honestly significant difference [HSD] 
test. 
Immunostaining
Protein expression of CHIKV E2 and eIF2α were analysed by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Mock 
infected and infected cells were washed once with PBS and lysed in RIPA buffer 
(PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS supplemented with 
Complete Protease Inhibitor Cocktail (Roche), 1 mM NaF and 1 mM Na3VO4) 
and clarified by centrifugation for 10 min at 13,000 rpm. After electrophoresis, 
denatured proteins were transferred to an Immobilon membrane (Millipore) 
for analysis by Western blot (WB). Membranes were blocked in 3% skimmed 
milk in PBS-0.05% Tween-60 (PBST) for 1h at RT. Membranes were washed 3×5 
min with PBST and subsequently incubated for 1h at RT with rabbit polyclonal 
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anti-E2 (1 20,000)(163), anti-P-eIF2α (ab32157, 1:500) and anti-beta-Tubulin 
(ab6046, 1:4000) in PBST, respectively. Membranes were washed and treated 
with alkaline phosphatase (AP) conjugated, goat anti-rabbit IgG monoclonal 
antibodies (Sigma), 1 3000 times diluted in PBST, for 45 min at RT. Membranes 
were washed 2×5 min with PBST and 1×10 min with AP-buffer (100 mM NaCl, 
5 mM MgCl2, 100 mM Tris-HCl, 0.1% Tween 20, pH 9.5). Proteins were detected 
by NBT/BCIP staining (Roche).
 To determine the expression of CHIKV-E2, Vero cells were transfected 
with pcDNA-envelope. After 24 hours, the cells were washed with PBS and 
fixed with 4% paraformaldehyde in PBS for 10 minutes at room temperature 
(RT). Cells were washed twice with PBS and permeabilized with 0.1% SDS 
in PBS for 10 minutes at RT. Samples were washed and incubated with PBS 
containing 5% FBS and 1 5000 diluted rabbit α-E2 polyclonal antibodies, for 1h 
at RT. Cells were washed 3× with PBS and treated with 1 2000 diluted goat-anti-
rabbit Alexa fluor 488 (Invitrogen) for 1h at RT. Finally, cells were washed and 
treated with 10µg/ml Hoechst stain for 5 min at RT. Cells were analyzed using 
a Zeiss Axio Observer Z1m inverted microscope in combination with an X-Cite 
120 series lamp.
The subcellular localization of XBP1 was determined with indirect 
immunofluorescence microscopy as described previously (255). Double-
stranded RNA was detected using mouse monoclonal antibody J2 (English 
& Scientific Consulting, #10010500). Rabbit polyclonal antibody was used to 
detect XBP-1 (Santa Cruz, #sc-17160). Primary antibodies were detected with 
Cy3- or Alexa488-conjugated secondary antibodies (Jackson/Life technologies). 
Nuclei were visualized with Hoechst 33342. The coverslips were analyzed using 
a Leica TCS SP5 confocal microscope and LAS AF Lite software (Leica).
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Results
Effect of Chikungunya virus infection on UPR activation
CHIKV replication in cell culture is relatively fast and cytopathic, with 
the production of progeny virus and clear expression of structural proteins 
from 6 hours post infection (255). To determine whether CHIKV infection leads 
to the activation of the UPR, the induction of three well-known ER-stress 
related proteins, CHOP, GRP78/BiP and GRP94 (256), was investigated. Vero 
cells were co-transfected with a plasmid containing the promoter region and 
5’untranslated region (UTR) of one of these target genes upstream of a firefly 
luciferase (Fluc) gene and a plasmid constitutively expressing renilla luciferase 
(Rluc). Given that CHIKV infection induces host shut-off and reduces RNA 
polymerase II driven transcription (149, 218), we studied the induction of UPR 
reporter genes using a luciferase-based assay in which all Fluc values were 
normalized for constitutive Rluc expression. One day after transfection, cells 
were infected with CHIKV at a multiplicity of infection (MOI) of 15. Sixteen 
hours post infection (hpi) the induction of three UPR target genes was measured 
(Figure 8.1A). As a positive control, uninfected cells were treated with 
tunicamycin (tm) for 6 hours. Tm is a microbial toxin, commonly used to 
induce the UPR by blocking N-linked glycosylation. Treatment with tm resulted 
in a 2, 6 and 2.5-fold upregulation of CHOP, GRP78/BiP and GRP94 reporters, 
respectively. In contrast, CHIKV infection did not upregulate the activity of any 
of these UPR reporters (Figure 8.1A).  Because prolonged CHIKV infection 
induces host shut-off, we studied the UPR at an earlier time point as well. 
However, also at six hours post CHIKV infection additional expression of the 
UPR reporter genes was not induced (Figure 8.1B).    
Both PKR and PERK have been reported to be activated early during 
alphavirus infection (228, 257–260). To confirm the activation of the PERK-
eIF2α-ATF4 branch of the UPR we analyzed the phosphorylation status of 
eIF2α (Figure 8.1C). A time course experiment indicated that CHIKV infection 
in Vero cells resulted in a marked increase in p-eIF2α within eight hours post 
infection. The phosphorylation of eIF2α was concurrent with the expression 
of CHIKV envelope proteins, as indicated by the presence of E2 and precursor 
E3E2 (Figure 8.1C). Phosphorylation of eIF2α limits general translation and 
selectively upregulates the translation of transcription factor ATF4 (236). A 
plasmid containing the promoter and 5’UTR of ATF4 upstream of a Fluc gene 
was transfected into Vero cells concurrently with a plasmid that constitutively 
expresses Rluc. Treatment with tm resulted in a respective 4- and 5-fold 
upregulation of the ATF4 reporter, whereas CHIKV infection for 6 or 16 
hours did not induce ATF4 reporter activity (Figure 8.1D), indicating that the 
expression of viral glycoproteins and the phosphorylation of eIF2α by CHIKV 
infection does not effectively stimulate the PERK arm of the UPR.
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Figure 8.1. CHIKV infection does not activate the UPR. ABD. Vero cells were co-transfected 
with plasmids constitutively expressing Rluc and either CHOP-, GRP78/BiP- or GRP94-Fluc 
reporter plasmids. Cells were not infected (mock) or infected with CHIKV (MOI 15). The UPR 
was induced with tunicamycin (tm)(5 µg/ml) for 6 hours. Cells were assayed for dual-luciferase 
expression sixteen (A and D) or six (B and D) hours hpi. Values are depicted as fold change 
of Fluc normalized for Rluc relative to the untreated mock. Error bars represent standard 
deviation. C. Vero cells infected with CHIKV (MOI 10) for 8, 16 and 24 hours were harvested 
and immunostained for CHIKV E2, p-eIF2α and β-tubulin. E. Vero cells were not infected 
(mock) or infected with CHIKV (MOI 10). Total RNA was harvested and XBP1 mRNA was reverse 
transcribed and PCR amplified. Samples were split into two, from which one subset was digested 
with PstI. Both digested and undigested amplicons were loaded on a 1.5% agarose gel. Numbers 
within the brackets are the volume intensity of the XBP1(U), normalized to XBP1(T) and relative 
to mock.
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Results
Effect of Chikungunya virus infection on UPR activation
CHIKV replication in cell culture is relatively fast and cytopathic, with 
the production of progeny virus and clear expression of structural proteins 
from 6 hours post infection (255). To determine whether CHIKV infection leads 
to the activation of the UPR, the induction of three well-known ER-stress 
related proteins, CHOP, GRP78/BiP and GRP94 (256), was investigated. Vero 
cells were co-transfected with a plasmid containing the promoter region and 
5’untranslated region (UTR) of one of these target genes upstream of a firefly 
luciferase (Fluc) gene and a plasmid constitutively expressing renilla luciferase 
(Rluc). Given that CHIKV infection induces host shut-off and reduces RNA 
polymerase II driven transcription (149, 218), we studied the induction of UPR 
reporter genes using a luciferase-based assay in which all Fluc values were 
normalized for constitutive Rluc expression. One day after transfection, cells 
were infected with CHIKV at a multiplicity of infection (MOI) of 15. Sixteen 
hours post infection (hpi) the induction of three UPR target genes was measured 
(Figure 8.1A). As a positive control, uninfected cells were treated with 
tunicamycin (tm) for 6 hours. Tm is a microbial toxin, commonly used to 
induce the UPR by blocking N-linked glycosylation. Treatment with tm resulted 
in a 2, 6 and 2.5-fold upregulation of CHOP, GRP78/BiP and GRP94 reporters, 
respectively. In contrast, CHIKV infection did not upregulate the activity of any 
of these UPR reporters (Figure 8.1A).  Because prolonged CHIKV infection 
induces host shut-off, we studied the UPR at an earlier time point as well. 
However, also at six hours post CHIKV infection additional expression of the 
UPR reporter genes was not induced (Figure 8.1B).    
Both PKR and PERK have been reported to be activated early during 
alphavirus infection (228, 257–260). To confirm the activation of the PERK-
eIF2α-ATF4 branch of the UPR we analyzed the phosphorylation status of 
eIF2α (Figure 8.1C). A time course experiment indicated that CHIKV infection 
in Vero cells resulted in a marked increase in p-eIF2α within eight hours post 
infection. The phosphorylation of eIF2α was concurrent with the expression 
of CHIKV envelope proteins, as indicated by the presence of E2 and precursor 
E3E2 (Figure 8.1C). Phosphorylation of eIF2α limits general translation and 
selectively upregulates the translation of transcription factor ATF4 (236). A 
plasmid containing the promoter and 5’UTR of ATF4 upstream of a Fluc gene 
was transfected into Vero cells concurrently with a plasmid that constitutively 
expresses Rluc. Treatment with tm resulted in a respective 4- and 5-fold 
upregulation of the ATF4 reporter, whereas CHIKV infection for 6 or 16 
hours did not induce ATF4 reporter activity (Figure 8.1D), indicating that the 
expression of viral glycoproteins and the phosphorylation of eIF2α by CHIKV 
infection does not effectively stimulate the PERK arm of the UPR.
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Figure 8.1. CHIKV infection does not activate the UPR. ABD. Vero cells were co-transfected 
with plasmids constitutively expressing Rluc and either CHOP-, GRP78/BiP- or GRP94-Fluc 
reporter plasmids. Cells were not infected (mock) or infected with CHIKV (MOI 15). The UPR 
was induced with tunicamycin (tm)(5 µg/ml) for 6 hours. Cells were assayed for dual-luciferase 
expression sixteen (A and D) or six (B and D) hours hpi. Values are depicted as fold change 
of Fluc normalized for Rluc relative to the untreated mock. Error bars represent standard 
deviation. C. Vero cells infected with CHIKV (MOI 10) for 8, 16 and 24 hours were harvested 
and immunostained for CHIKV E2, p-eIF2α and β-tubulin. E. Vero cells were not infected 
(mock) or infected with CHIKV (MOI 10). Total RNA was harvested and XBP1 mRNA was reverse 
transcribed and PCR amplified. Samples were split into two, from which one subset was digested 
with PstI. Both digested and undigested amplicons were loaded on a 1.5% agarose gel. Numbers 
within the brackets are the volume intensity of the XBP1(U), normalized to XBP1(T) and relative 
to mock.
The IRE1a-XBP1 arm of the UPR has been shown to be activated during 
infection with other viruses (246, 247, 250). To investigate whether CHIKV 
infection induces XBP1 mRNA splicing, Vero cells were either mock infected, 
infected with CHIKV, or treated with tm in a time course experiment. In 
uninfected cells most of the XBP1 mRNA remained in its unspliced form (U) 
(Figure 8.1E, left lane). When treated with tm, nearly all XBP1 mRNA was 
spliced (S) (Figure 8.1E, second lane). During CHIKV infection, part of the XBP1 
mRNA was spliced and some remained unspliced between 14 and 22 hours post 
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infection (Figure 8.1E, lanes 3-5). When the amount of XBP1(U) mRNA was 
quantified and normalized for total XBP1(T), the relative amount of XBP1(U) 
during CHIKV infection was 30 to 55% of the mock untreated and tm treated 
controls (Figure 8.1E). These data suggest that CHIKV infection results in 
partial XBP1 activation; however, a substantial amount of XBP1 remains in its 
inactive unspliced form. 
CHIKV infection does not induce XBP1 splicing in mice
Next, we analyzed XBP1 mRNA splicing in vivo in an adult wild-type mouse 
model of CHIKV arthritis. To increase the sensitivity of the XBP1 splicing assay, 
we designed a semi-quantitative reverse transcriptase PCR assay to measure 
the relative levels of spliced and unspliced XBP1 mRNA. To validate the XBP1 
B 
Mock 0 1 2 3 6 14 21 29
0.0
0.5
1.0
1.5
2.0
CHIKV infection (dpi)
Fo
ld
 c
ha
ng
e
XB
P1
  s
pl
ic
in
g
Days post infection 
C 
0
100
200
300
400
500
NTC 0 1 2 3
Fo
ld
 c
ha
ng
e 
(X
10
00
) 
C
H
IK
V 
R
N
A
 
Fo
ld
 c
ha
ng
e 
XB
P1
 s
pl
ic
in
g 
 
A 
0
2
4
6
8
10
12
14
Mock Tm Mock Tm
Mφ MEF 
      m ck    t      m      t  
B 
Mock 0 1 2 3 6 14 21 29
0.0
0.5
1.0
1.5
2.0
CHIKV infection (dpi)
Fo
ld
 c
ha
ng
e
XB
P1
  s
pl
ic
in
g
Days post infection 
C 
0
100
200
300
400
500
NTC 0 1 2 3
Fo
ld
 c
ha
ng
e 
(X
10
00
) 
C
H
IK
V 
R
N
A
 
Fo
ld
 c
ha
ng
e 
XB
P1
 s
pl
ic
in
g 
 
A 
0
2
4
6
8
10
12
14
Mock Tm Mock Tm
Mφ MEF 
      m ck    t      m      t  
Figure 8.2. XBP1 mRNA splicing in murine cells and in a mouse model. A. Isolated murine 
splenic macrophages and MEFs were mock treated or tm treated. B. Mouse feet were infected 
with CHIKV and harvested at the indicated days post infection. Values are depicted as fold 
induction of spliced divided by unspliced XBP1 mRNA, normalized to RPL13A and relative to 
the mock. Error bars represent one standard deviation. C. CHIKV RNA copies harvested from 
infected mouse feet at the indicated days post inoculation.
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mRNA splicing assay in murine cells, XBP1 mRNA splicing was measured 
in murine splenic macrophages and mouse embryonic fibroblasts (MEF). 
Treatment with tm resulted in a respective 6- and 12-fold increase in mouse 
embryonic macrophages and MEFs (Figure 8.2A). In the in vivo experiment, 
C57BL/6 mice were either mock infected or infected with CHIKV as described 
previously (68). Tissue samples from mouse feet were collected at the indicated 
days post infection and XBP1 mRNA splicing was measured (Figure 8.2B). The 
infected mouse feet displayed all the signs of CHIKV specific inflammation, 
with maximum foot-swelling at day 6 post infection and ample CHIKV RNA 
replication in the first three days post infection (68, 139, 261, 262)(Figure 8.2C 
and data not shown). However, XBP1 mRNA splicing could not be detected in 
these tissues (Figure 8.2B). Taken together, these results indicate that although 
CHIKV infection did induce XBP1 mRNA splicing in Vero cells in vitro, XBP1 
splicing remained undetectable in mouse feet during an in vivo infection. 
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Figure 8.3. Overexpression of CHIKV envelope glycoproteins induces the UPR. Vero cells 
were transfected with plasmids expressing either EGFP (mock) of CHIKV envelope proteins 
(E) together with constitutively expressing RLuc and either ATF4-Fluc or GRP78-Fluc reporter 
plasmids. 24 hours post transfection cells were either fixed, permeabilized and immunostained 
for CHIKV E2 (A) or lysed in passive lysis buffer and assayed for dual luciferase activity (B and 
C). Values are depicted as average of three individual experiments. Error bars represent one 
Standard error of the mean.
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Chikungunya virus glycoproteins stimulate the UPR
Since we observed signs of induction during the early steps of the UPR, 
but no upregulation of the UPR target proteins in response to CHIKV infection, 
we determined whether overexpression of the CHIKV envelope proteins outside 
the context of viral replication activates the UPR. Vero cells were transfected 
with a plasmid expressing either GFP or the CHIKV envelope glycoproteins 
(E3E26KE1) under the control of a CMV promoter. The expression of CHIKV 
envelope glycoproteins was confirmed by immunofluorescence microscopy 
(Figure 8.3A). To measure the effects of the CHIKV envelope glycoproteins 
on UPR target gene expression and the PERK arm of the UPR, GRP78/BiP 
and ATF4 Fluc reporter plasmids were co-transfected with constitutive Rluc 
and either a GFP-expressing plasmid or the plasmid expressing the CHIKV 
envelope glycoproteins. After 24 hours, the overexpression of CHIKV envelope 
proteins resulted in a moderate but consistent upregulation of both ATF4 and 
GRP78/BiP expression (Figure 8.3B and C). Treatment with tm 24 hours post 
transfection resulted in an enhancement of ATF4 and GRP78/BiP expression 
compared to tm treatment or CHIKV envelope expression alone (Figure 8.3B 
and C). These data suggest that CHIKV envelope protein expression results in 
UPR activation.  
Chikungunya virus replication prevents effective activation of the UPR
 Since the expression of viral envelope glycoproteins, in the absence of 
viral RNA replication and non-structural proteins (nsP1-4), induced the UPR, 
we investigated whether the lack of UPR activation during CHIKV infection was 
the result of active inhibition by the virus. Vero cells were either mock infected 
or infected with CHIKV, and 4, 8 or 12 hours later they were treated with tm (10 
hours)(Figure 8.4A). The UPR target reporters CHOP, GRP94 and GRP78/BiP 
were induced by tm in the mock infected cells. However, this induction was 
reduced in infected cells that were treated with tm at 4 hpi and was completely 
absent in infected cells that were treated with tm at 8 or 12 hpi (Figure 8.4B). 
In a similar experiment,  tm-mediated induction of ATF4 was also completely 
inhibited when cells were infected with CHIKV 12 hours prior to tm treatment 
(Figure 8.4C). 
 In a time course experiment (Figure 8.4A), UPR induction using tm 
resulted in the splicing of almost the entire XBP1 mRNA pool (Figure 8.4D, lane 
2). Treatment with tm 4 hpi with CHIKV also resulted in the splicing of all XBP1 
mRNA (Figure 8.4D, lane 3). However, tm treatment at 8 or 12 hours post CHIKV 
infection no longer induced complete XBP1 mRNA splicing (Figure 8.4D, lanes 
4 and 5). Interestingly, CHIKV infection with (Figure 8.4D) and without (Figure 
8.1D) tm treatment resulted in a gradual increase in the total amount of 
unspliced XBP1 mRNA during these experiments. Next, we determined the 
subcellular localization of XBP1 protein to investigate whether the spliced XBP1 
mRNA was translated in the functional XBP1 transcription factor in CHIKV 
infected cells. When uninfected Vero cells were treated with tm (6 hours) and 
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Chikungunya virus glycoproteins stimulate the UPR
Since we observed signs of induction during the early steps of the UPR, 
but no upregulation of the UPR target proteins in response to CHIKV infection, 
we determined whether overexpression of the CHIKV envelope proteins outside 
the context of viral replication activates the UPR. Vero cells were transfected 
with a plasmid expressing either GFP or the CHIKV envelope glycoproteins 
(E3E26KE1) under the control of a CMV promoter. The expression of CHIKV 
envelope glycoproteins was confirmed by immunofluorescence microscopy 
(Figure 8.3A). To measure the effects of the CHIKV envelope glycoproteins 
on UPR target gene expression and the PERK arm of the UPR, GRP78/BiP 
and ATF4 Fluc reporter plasmids were co-transfected with constitutive Rluc 
and either a GFP-expressing plasmid or the plasmid expressing the CHIKV 
envelope glycoproteins. After 24 hours, the overexpression of CHIKV envelope 
proteins resulted in a moderate but consistent upregulation of both ATF4 and 
GRP78/BiP expression (Figure 8.3B and C). Treatment with tm 24 hours post 
transfection resulted in an enhancement of ATF4 and GRP78/BiP expression 
compared to tm treatment or CHIKV envelope expression alone (Figure 8.3B 
and C). These data suggest that CHIKV envelope protein expression results in 
UPR activation.  
Chikungunya virus replication prevents effective activation of the UPR
 Since the expression of viral envelope glycoproteins, in the absence of 
viral RNA replication and non-structural proteins (nsP1-4), induced the UPR, 
we investigated whether the lack of UPR activation during CHIKV infection was 
the result of active inhibition by the virus. Vero cells were either mock infected 
or infected with CHIKV, and 4, 8 or 12 hours later they were treated with tm (10 
hours)(Figure 8.4A). The UPR target reporters CHOP, GRP94 and GRP78/BiP 
were induced by tm in the mock infected cells. However, this induction was 
reduced in infected cells that were treated with tm at 4 hpi and was completely 
absent in infected cells that were treated with tm at 8 or 12 hpi (Figure 8.4B). 
In a similar experiment,  tm-mediated induction of ATF4 was also completely 
inhibited when cells were infected with CHIKV 12 hours prior to tm treatment 
(Figure 8.4C). 
 In a time course experiment (Figure 8.4A), UPR induction using tm 
resulted in the splicing of almost the entire XBP1 mRNA pool (Figure 8.4D, lane 
2). Treatment with tm 4 hpi with CHIKV also resulted in the splicing of all XBP1 
mRNA (Figure 8.4D, lane 3). However, tm treatment at 8 or 12 hours post CHIKV 
infection no longer induced complete XBP1 mRNA splicing (Figure 8.4D, lanes 
4 and 5). Interestingly, CHIKV infection with (Figure 8.4D) and without (Figure 
8.1D) tm treatment resulted in a gradual increase in the total amount of 
unspliced XBP1 mRNA during these experiments. Next, we determined the 
subcellular localization of XBP1 protein to investigate whether the spliced XBP1 
mRNA was translated in the functional XBP1 transcription factor in CHIKV 
infected cells. When uninfected Vero cells were treated with tm (6 hours) and 
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marker for CHIKV replication.
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immunostained for XBP1, XBP1 localized to the nucleus as expected (Figure 
8.4E). In contrast, during CHIKV infection XBP1 remained predominantly 
cytoplasmic even when the cells were treated with tm (Figure 8.4E). Taken 
together these results demonstrate that CHIKV infection inhibits the functional 
expression and/or subcellular localization of transcription factors ATF4 and 
XBP1 respectively, and effectively prevents the induction of UPR target genes. 
Non-structural protein 2 inhibits the upregulation of UPR target genes     
Overexpression of CHIKV glycoproteins activated the UPR, but CHIKV 
infection did not (Figures 8.1-8.4), suggesting that one or more of the CHIKV 
non-structural proteins are able to inhibit activation of the UPR. Plasmids 
expressing individual CHIKV nsPs (147, 148), were co-transfected with Fluc UPR 
reporter plasmids and a plasmid constitutively expressing Rluc. Sixteen hours 
post transfection the cells were treated with tm. CHIKV nsP2 clearly inhibited 
the tm-mediated induction of both ATF4 and GRP78/BiP reporters (Figure 
8.5A and B). Since CHIKV nsP2 is a multifunctional protein, with clear roles 
in host shut-off (149, 217), nsP2 mutants that do not inhibit cellular protein 
synthesis were analyzed for their ability to inhibit tm-mediated UPR induction. 
Mutations in the nuclear localization site (KR649) or proline 718, both known 
to abolish host transcriptional shut-off activity (147), rendered nsP2 unable to 
inhibit tm-induced ATF4 and GRP78/BiP reporter activity (Figure 8.5C and D). 
These data suggest that CHIKV infection inhibits the UPR via nsP2-mediated 
host shut-off. 
Chikungunya virus nsP2-mediated host shut-off disables the UPR
8
133
GRP78/BiP
0
1
2
3
Fo
ld
 c
ha
ng
e 
(R
LU
)
ATF4
mock nsP1 nsP2 nsP3 nsP4
0
1
2
3
4
5
Fo
ld
 c
ha
ng
e 
(R
LU
)
GRP78/BiP
mock nsP1 nsP2 nsP3 nsP4
0
1
2
3
4
Fo
ld
 c
ha
ng
e 
(R
LU
)
  mock      nsP2      nsP2       nsP2 
                              KR649AA        P718S 
  mock      nsP2      nsP2       nsP2 
                              KR649AA        P718S 
ATF4
0
1
2
3
4
Fo
ld
 c
ha
ng
e 
(R
LU
)
* 
* 
* 
A B 
C D 
* 
* 
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Chapter 8
134
Discussion
Alphavirus infection has been reported to induce several key components 
of the UPR. PERK is activated early during SINV and CHIKV infections 
and XBP1 mRNA splicing is initiated during SFV infection (247, 259, 258). 
Herein we demonstrate that, although eIF2α is phosphorylated and part of 
the XBP1 mRNA pool is spliced, XBP1 is not present in the nucleus and the 
upregulation of ATF4 and UPR target genes is completely inhibited in CHIKV-
infected cells. Transient  expression studies of nsPs demonstrated that nsP2 
is responsible for preventing an effective UPR. In addition to PERK, eIF2α 
can be phosphorylated by a number of other kinases, including PKR, which 
recognizes (viral) dsRNA (235). To allow the translation of viral proteins, most 
viruses prevent the phosphorylation of eIF2α (249–251). Although inhibition of 
eIF2α phosphorylation via CHIKV nsP4 has been reported (259), we and others 
have found that alphaviruses are exceptional in allowing the phosphorylation 
of eIF2α during productive infection (228, 263, 264, 258). In our experiments, 
CHIKV infection resulted in the phosphorylation of eIF2α within 8 hours post 
infection (Figure 8.1C). The translation of alphaviral structural proteins from 
their subgenomic messenger is unaffected by the phosphorylation of eIF2α. A 
stable hairpin loop structure in the 26S promoter of the subgenomic mRNA 
from SINV was shown to stall the ribosome on the correct AUG providing 
resistance to eIF2α phosphorylation (263). Surprisingly, the translational shut-
off during alphavirus infection has been shown to be independent of eIF2α 
phosphorylation, indicative of an additional mechanism by which alphaviruses 
modulate the translational machinery of the host(228, 264). In agreement with 
this hypothesis, the phosphorylation of eIF2α during CHIKV infection did 
not result in an increased expression of the eIF2α phosphorylation insensitive 
transcription factor ATF4 (Figure 8.1D) nor did it upregulate the induction of 
known UPR target genes GRP78/BiP, CHOP and GRP94 (Figure 8.1A and B). In 
fact, when the UPR was induced with tm in the context of a CHIKV infection, 
the expression of UPR target gene reporters and transcription factor ATF4 was 
clearly inhibited (Figure 8.4B,C and D). 
SFV replication was shown to induce the UPR only when the envelope 
proteins were expressed during RNA replication (247), an observation 
consistent with our results that shows the ability of CHIKV envelope proteins to 
induce GRP78/BiP and ATF4. The addition of tm to cells expressing the CHIKV 
envelope proteins resulted in an enhanced induction of the UPR (Figure 
8.3B and C). These results indicate that CHIKV envelope proteins expressed 
outside the context of viral infection do induce the UPR, with the presence of 
these glycoproteins markedly increasing tm-mediated activation of the UPR. 
However, no stimulation of the UPR target genes was observed during CHIKV 
replication, not even when cells were  treated with tm (Figures 8.1 and 8.4). This 
clearly indicates that, despite the ability of the envelope proteins to activate 
the UPR, the induction of transcription factor ATF4 and UPR target genes is 
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effectively inhibited during CHIKV infection.  
Previous studies showed that the IRE1α-XBP1 arm of the UPR was 
activated during SFV infection (247). In agreement with this finding, our in 
vitro experiments did show a moderate level of XBP1 mRNA splicing during 
CHIKV infection (Figures 8.1E). A time course experiment (Figures 8.4D) 
revealed that four hours post infection, tm induction induced complete XBP1 
mRNA splicing. Interestingly, XBP1 mRNA splicing upon tm induction at eight 
hours post CHIKV infection was partly inhibited. In addition, CHIKV infection 
of mice did not induce detectable levels of XBP1 mRNA splicing (Figures 8.2B). 
Thus, although CHIKV infection activates the IRE1α-XBP1 arm of the UPR in 
certain cell types, progressive CHIKV infection does severely limit the extent 
to which XBP1 mRNA is spliced. Immunostaining of XBP1 protein at twelve 
hours post CHIKV infection showed that the nuclear accumulation of XBP1 is 
completely inhibited, even when cells are treated with tm (Figures 8.4E). These 
data illustrate that although some XBP1 mRNA splicing is induced by CHIKV 
infection in certain cell types, XBP1 proteins are absent from the nucleus of an 
infected cell.  
Using a combination of independent PCR-based assays, dual-luciferase 
reporter systems, immunofluorescence and Western blot, we have shown 
that the IRE1α/XBP1 and PERK arms of the UPR are effectively suppressed by 
CHIKV infection. Expression of individual CHIKV non-structural proteins 
revealed that nsP2 is responsible for the inhibition of ATF4 and UPR target 
gene induction (Figures 8.5A and B). NsP2 is a multifunctional protein with 
an active protease and helicase domain, and NTPase activity (29, 217, 265). In 
addition, it causes host cell transcriptional shut-off via the degradation of a 
catalytic subunit of RNA polymerase II (149), and also inhibits the JAK-STAT 
signaling pathway of the IFN response (147, 148). Here we show that point 
mutations in nsP2 that render the protein non-cytopathic by eliminating its 
function in host shut-off (KR649AA or P718S)(147, 149) reversed the nsP2-
mediated inhibition of the UPR (Figures 8.5C and D). Alphaviruses carrying 
these mutations at homologous sites are effectively attenuated in cell culture 
(85, 225), perhaps in part due to a failure to constrain the UPR. It would be 
informative to investigate how CHIKV replication and the UPR influence one 
another in light of these attenuating mutations.  We postulate that the host-cell 
shut-off, which is governed by CHIKV nsP2, is responsible for the inhibition of 
the UPR, by preventing the upregulated expression of ATF4, active XBP1 and 
additional UPR target genes.
The diminished UPR activation during CHIKV infection suggests that 
anti-viral effects, elicited by the UPR, could hamper CHIKV propagation. 
This provides a rationale for why CHIKV induced host shut-off has evolved 
to also inhibit the UPR. In addition, immune responses directed against viral 
infections can be augmented by the UPR (reviewed by (266)). Replication of 
several RNA viruses, including SINV, was shown to be inhibited by a small 
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molecule deubiquitinase inhibitor that functions via the activation of the UPR 
(98, 267). This indicates that alphaviruses are sensitive to the effects of the UPR 
and that activating the UPR may have potential as an antiviral strategy.
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General Discussion
The outbreaks of arboviruses West Nile virus (WNV) and chikungunya 
virus (CHIKV) in recent years and their effect on the human population 
emphasize the need for new strategies to control the transmission of these 
viruses and to prevent or mitigate the disease they cause (Chapter 1)(3, 100). 
Classical broad spectrum antivirals (e.g. interferons (IFN)) proved unsuccessful 
and the need for novel, more specific, compounds has increased. In addition, 
transmission cycles with alternating vertebrate and invertebrate hosts and 
possible enzootic cycles complicates arbovirus control and risk assessments, 
but at the same time provides unique opportunities for innovative novel 
intervention strategies. This thesis addresses the questions how arboviruses 
secure effective transmission between invertebrate and vertebrate hosts and 
how these two biologically very different hosts cope with arbovirus infections. 
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Arbovirus transmission
The mosquito vector
Most arboviruses are transmitted by a small number of mosquito 
species. The proximity between susceptible vectors and amplifying hosts and 
the feeding behaviour of these vectors are important factors that often drive 
evolution towards a narrow virus-vector host range. CHIKV is transmitted in an 
urban cycle involving humans and two specific mosquito species Aedes aegypti 
and Aedes albopictus, or in a sylvatic cycle involving non-human primates and 
closely related forest-dwelling Aedes species (269). In contrast, WNV is rather 
unusual as more than 60 mosquito species have been reported as vectors, 
many of which belong to the Culex genus (9, 270, 271). In addition, WNV also 
replicates in a broad range of vertebrate species. Most amplifying hosts are bird 
species, but also several reptile and rodent species can develop high viral titers 
(>106 pfu/ml) (272–274), which is sufficient to infect Culex mosquitoes (275). 
Interestingly, when WNV infected mice were fed to birds of prey and alligators 
or when these animals were housed in close vicinity of one another WNV was 
readily transmitted (273, 276, 277). Although the exact biological relevance of 
these findings is unknown, it is possible that these alternative transmission 
routes contribute to sustained endemic WNV activity over time. 
During the epidemic sweep of WNV that engulfed North America in the 
early 2000s, the virus  was transmitted by several main Culex species: Culex 
pipiens, (38), Culex quinquefasciatus (39) and  Culex tarsalis (278). Southern 
Europe currently suffers from annual WNV outbreaks and field studies have 
detected both WNV and the related flavivirus Usutu virus (USUV) in a large 
number of mosquito species, but most often in the northern house mosquito 
Cx. pipiens (41). Not only southern European mosquitoes can transmit WNV, as 
Cx. pipiens from WNV-free, north-western Europe (NWE) now appears to be a 
highly competent vector for lineage 1 and 2 WNV, and USUV (Chapter 2 and 3). 
The species Cx. pipiens is further classified into two biotypes (Cx. pipiens pipiens 
and Cx. pipiens molestus). For both biotypes, different feeding preferences on 
either avian or mammalian hosts have been reported (113). Hybrids between 
both biotypes are considered less ornithophilic and more likely to feed on 
other vertebrates, including humans, which may contribute to the incidence 
of human WNV disease. These hybrids are considered to be relatively common 
in North America, but not in north-western Europe (113). However, a more 
recent study detected substantial numbers of hybrids in Germany, suggesting 
that more continuous mosquito surveillance is necessary to determine the 
exact distribution of these dynamic mosquito populations (279).  Other Culex 
species could also contribute to the distribution of WNV and USUV. In North 
and Central Europe, Cx. torrentium is a very common mosquito (42), but it is 
poorly characterized how effectively these different Culex species or Cx. pipiens 
biotypes can vector either WNV or USUV. In southern France, Cx. modestus 
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was found highly competent for a local lineage 1 WNV isolate (106). Thus, in 
order to establish more reliable risk projections for WNV transmission, the data 
presented in Chapters 2 and 3 can be augmented by a more detailed picture of 
the distribution of these Culex populations and their competence to circulating 
arboviruses. 
WNV activity in Europe has thus far remained localized to the 
Mediterranean basin, which could be explained by a higher number of WNV 
refractory mosquitoes in more northern parts of Europe e.g. Cx. torrentium 
with currently unknown competence to WNV. However, the distribution 
of USUV does extend further into central and northern Europe (280). The 
localized activity of WNV is therefore somewhat surprising as Cx. pipiens 
mosquitoes from north-western Europe (NWE) are competent vectors for 
both lineage 1 and 2 WNV (Chapter 2) as well as for USUV (Chapter 3). In 
parts of southern Europe, WNV and USUV co-circulate but it is unknown 
whether these viruses can co-infect the same vector. Laboratory infections of 
Cx. quinquefasciatus with either WNV or St Louis encephalitis virus (SLEV), 
however, reduced the infectivity of a subsequent second flavivirus infection 
(281). In addition, insect-specific flaviviruses (e.g. Culex flavivirus), which are 
vertically transmitted among insects without transmission to vertebrates, are 
widely distributed and infections in mosquito populations can also reduce the 
vector competence of infected mosquitoes to other flaviviruses (282). Finally, 
flavivirus activity generally decreases when substantial numbers of amplifying 
hosts have previously been exposed to a related flavivirus. Thus, infections 
with related flaviviruses, e.g. SLEV in North America and USUV in Europe, 
may reduce secondary flavivirus infections in both invertebrate and vertebrate 
hosts (114). Exactly how co-circulating flaviviruses influence the seroconversion 
rates in the diverse and dynamic populations of (avian) amplifying hosts is still 
poorly characterized.  
Intrinsic factors that determine vector competence
North American (NA) and NWE Cx. pipiens mosquitoes were competent 
vectors for an American isolate of lineage 1 WNV (NY’99)(Chapter 2). 
Interestingly, the transmission rate of lineage 2 WNV was significantly lower 
in NA compared to that in NWE mosquitoes (Chapter 2). That these two 
geographically separated Cx. pipiens populations have a significantly different 
vector competence for lineage 2 WNV, but not lineage 1 WNV, indicates a 
high degree of genotype-genotype specificity in the interaction between virus 
and vector. In North America, lineage 1 WNV has evolved within a few years 
from the introduced NY’99 isolate into genotypes that all have an adaptive 
mutation in the viral envelope (V159A). This WN02 genotype allows more 
effective transmission by North American Culex species and has completely 
replaced the original NY’99 strain (40). The lower transmission rates of lineage 
2 WNV by NA mosquitoes could be explained by purifying selection that takes 
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place in the mosquito midgut (283). However, sequencing of small RNAs from 
lineage 2 WNV infected NWE and NA Cx. pipiens mosquitoes both resulted 
in the expression of 21 nucleotide long RNA molecules, suggesting that both 
viruses are subjected to an antiviral RNAi response. Mapping of these virus-
derived RNA molecules to the viral reference genomes resulted in identical 
distributions when allowing either 0 or 1 mismatch per RNA (data not shown). 
This suggests that there was no selection for single nucleotide changes in the 
consensus genome sequences. Thus, the obtained transmission rates are the 
direct result of infections with the respective WNV isolates in both NWE and 
NA mosquitoes. The generation of recombinant inbred lines between both 
mosquito populations may ultimately provide a molecular explanation for the 
observed differences in vector competence. However, the Cx. pipiens genome 
has not been completely sequenced (yet), and simultaneously maintaining 
numbers of different mosquito colonies is very time-consuming and elaborate 
as Cx. pipiens eggs cannot be stored for later use. Both these factors complicate 
this approach. More feasible is to locate the viral elements that are responsible 
for the differential vector competence using oral infection experiments with 
chimeric viruses. Once identified, this also allows a more specific search for the 
host factors that determine vector competence. 
Extrinsic factors that directly influence vector competence
The presence of highly WNV competent vector species and susceptible 
amplifying hosts in WNV-free areas suggests that other, extrinsic factors 
may play a role in limiting WNV activity. Incubation at higher temperatures 
significantly increased the infectivity of both WNV and USUV in Cx. pipiens 
(Chapter 2 and 3). While this provides a rationale for the current WNV activity 
in southern Europe, it fails to explain the more northern distribution of USUV. 
Infection and transmission rates of lineage 1 WNV in North American Culex 
species were also shown to be influenced by the incubation temperature and in 
North America, WNV has already adapted to certain climatic conditions (105, 
284).  
An interesting observation is that the transmission and infection rates of 
USUV were substantially higher in NWE Cx. pipiens mosquitoes compared to 
those of WNV when incubated at 28°C, but not at temperatures <23°C (Chapter 
3). The average summer temperatures in northern and central Europe, however, 
are generally well below 23°C (108). Both viruses infect the same amplifying 
hosts; therefore similar vector competence in their main vector would infer that 
also WNV has the potential to extend its distribution into Central and the North 
of Europe. However, the influence of daily temperature fluctuations on vector 
competence should not be neglected. For example, the vector competence 
of Ae. aegypti for dengue virus (DENV) increases or decreases, depending 
on whether incubation temperatures fluctuate around low or high mean 
temperatures, respectively (134). Temperatures in North and Central Europe 
Chapter 9
142
can reach daily highs that are well above 23°C, and as USUV is more infectious 
than WNV at these temperatures, this could provide an explanation for the 
current, more northern, distribution of USUV. To test this hypothesis, USUV 
and WNV infected mosquitoes can be incubated at fluctuating temperatures 
that represent the normal diurnal temperature range around a specific mean 
and can be compared to mosquitoes that are kept at an identical, but constant, 
mean temperature.        
These complex interactions between the virus, vector and environment 
observed for WNV also introduce large diversity into the vector competence 
of Ae. albopictus for CHIKV. Aedes albopictus populations, collected from 
six separate global sites, have highly diverse transmission rates for two 
isolates of CHIKV. In some of these mosquito populations, the two CHIKV 
isolates displayed large differences in transmission rates within one mosquito 
population and showed a high variation in response to two distinct incubation 
temperatures (162). The intricate relationships between temperature, virus 
and vector genotypes that determine vector competence imply that arbovirus 
outbreaks will remain largely unpredictable.  
Vectorial capacity
The multiple ecological traits that should be taken into account when 
assessing the risk levels of an arbovirus outbreak add one more layer of 
complexity. The vectorial capacity (VC) includes traits of the vector population, 
providing a better measure of the capacity of a mosquito population to transmit 
a pathogen and follows from
  
VC = m·a2·b·pn/-loge(P)
where VC is the vectorial capacity, m is the number of female mosquitoes 
per host, a the daily blood feeding rate, b the vector competence or transmission 
rate, p the daily mosquito survival rate (from 0-1.0), and n the extrinsic 
incubation period. The lineage 2 WNV transmission rate in European Culex 
pipiens mosquitoes is three times higher as compared to that in North American 
mosquitoes (Chapter 2). This indicates that under similar environmental 
circumstances the vectorial capacity is also three times larger. Additionally, the 
extrinsic incubation period is shorter for lineage 2 WNV, which enhances the 
VC even further. However, mosquito numbers, blood feeding behavior and the 
mosquito survival rate can also influence the vectorial capacity significantly. In 
addition, temperature and rainfall may severely influence mosquito numbers. 
For example, the resurgence of WNV disease in 2012 in the United States was 
partly attributed to a wet spring and hot summer, which provided suitable 
microclimates that led to high numbers of mosquito vectors, coinciding with 
dense local bird populations (20). Finally, virus-induced behavioral changes, 
such as the increased locomotive activity and probing behavior of DENV 
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infected  Ae. aegypti (285, 286), adds to the already complex interplay between 
virus, vector, and environmental factors. 
Taken together, the presence of WNV and USUV competent mosquitoes 
in currently WNV-free areas in Europe clearly indicates a risk for WNV 
transmission in these areas. Climatic conditions that favor mosquito numbers 
or increase their vector competence are likely the main factors that determine 
the distribution of these arboviruses. It is clear that vector competence is a 
highly complex trait and a better understanding of the possible vector species, 
co-circulating arboviruses, seroconversion rates of amplifying hosts, and 
environmental risk factors will increase the effectiveness and accuracy of 
arbovirus surveillance and risk assessments. 
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Molecular determinants of arbovirus infections
Antiviral RNAi and viral counter defense
Arboviruses establish a permanent infection in the vector and although 
effects on fecundity have been reported (287) the infection does not obstruct 
the invertebrate ‘s ability to find and feed on subsequent vertebrate hosts. 
After the vector has fed on a viraemic vertebrate host, the ingested arbovirus 
must first infect the midgut epithelial cells. Both WNV and USUV have a 
high infection rate in Cx. pipiens, suggesting limited involvement of a midgut 
infection barrier (MIB) (Chapter 2 and 3).  Once inside the midgut epithelial 
cells the Toll, immune deficiency (IMD), Janus kinase signal transducer and 
activator of transcription (JAK-STAT) and RNA-mediated gene silencing 
pathways can influence arbovirus infections in the midgut (44). Both WNV and 
USUV infections in Cx. pipiens mosquitoes elicit an RNAi response as small 
(21 nt) viral RNA products are expressed as a result of dicer2/AGO2 dependent 
cleavage of double stranded RNA replication intermediates (Chapter 3). Larger 
RNA products (24-30 nt) were detected in CHIKV and DENV infected Aedes 
mosquitoes and suggest antiviral activity of the PIWI-interacting RNA pathway 
(56, 57). Although reported as an antiviral response in several insect species, 
the apparent lack of PIWI-interacting RNA pathway specific products suggests 
that this pathway is not involved in the systemic defense against flaviviruses in 
Culex mosquitoes (Chapter 3).      
Although inhibitors of RNAi from an arboviral origin have not been 
extensively described, introducing strong heterologous viral suppressors of 
RNAi (VSR) in Sindbis virus (SINV) has resulted in reduced siRNA expression, 
increased viral replication and reduced mosquito survival (63). This suggests 
that arboviruses are subjected to the RNAi response only to some extent to 
ensure an optimal balance between viral replication and antiviral responses 
that ultimately results in effective arbovirus transmission. Flaviviruses possess 
a potent RNAi suppressor during in vitro replication, which maps to the 3’ 
untranslated region (UTR) (288). The 3’UTR of flaviviruses is highly structured 
and is able to stall the 5’ exoribonuclease (pacman/XRN1) that normally 
degrades RNA molecules (289, 290). This results in the accumulation of large 
quantities of short (~500 nt) non-coding subgenomic flavivirus RNA (sfRNA) 
(289). Besides inhibiting the RNAi response, sfRNA also modulates the 
mammalian interferon (IFN) response and is essential for the cytopathicity and 
pathogenicity of WNV (289, 291). The fact that insect-specific flaviviruses also 
produce sfRNA in high quantities suggests a specific, conserved interaction 
with the arthropod host. Specific mutations in the pseudoknots of the 3’UTR 
can abrogate the production of sfRNA (292) by altering the structure that would 
normally stall the exoribonuclease (293). Introducing mutations in a full-length 
infectious WNV clone will result in a virus that is unable to produce sfRNA and 
its infectivity can then be compared to wild type WNV in vivo. When sfRNA 
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also has in vivo VSR activity these modified viruses are likely to have reduced 
infection and/or transmission rates in live mosquitoes. Reducing the activity of 
the RNAi pathway by silencing crucial components (e.g. AGO2) can potentially 
restore viral replication and dissemination. Experiments such as these can 
provide valuable insights into the role of sfRNA as an RNAi suppressor in vivo. 
A recent study showed that knock down of RNAi (e.g. AGO2) increases 
CHIKV replication in Ae. aegypti (53). Although RNAi is likely the most potent 
antiviral defense strategy invertebrates possess, O’nyong nyong virus (ONNV) 
infections in Anopheles gambiae showed that the exogenous RNAi pathway did 
not play any role during the initial midgut infection, but only limited systemic 
viral infections. In contrast, the JAK-STAT and IMD signaling pathways did 
affect viral infection of the midgut. Moreover, ONNV partly inhibited the IMD 
and JAK-STAT pathway. Naturally high infection rates also required a natural 
gut microbiome (294). This suggests that ONNV infection in the mosquito 
vectors encounters different antiviral responses during the course of infection, 
which should be taken into account when studying the mosquito antiviral 
responses against other arboviruses.  
Chikungunya virus nsP3 and Rasputin/G3BP
The interactions between viral and host products involved in vector 
specificity are not well understood, but are beginning to become elucidated. 
ONNV is effectively transmitted by Anopheles mosquitoes. Interestingly, when 
CHIKV non-structural protein 3 (nsP3) was replaced with nsP3 of ONNV 
inserted in a chimeric CHIKV infectious clone, it enabled CHIKV to infect 
An. gambiae (99). This suggests that alphavirus nsP3 has a specific function 
that determines the outcome of infection in the mosquito vector. Alphavirus 
nsP3 interacts with the homologous proteins Rasputin (Rin) and Ras-GTPase-
activating SH3-domain binding protein (G3BP1/2) in mosquito and mammalian 
cells, respectively (93). In both invertebrate and vertebrate cells nsP3 forms 
cytoplasmic granules with Rin/G3BP (Chapters 4 and 5). In mammalian cells, 
these nsP3-G3BP-granules inhibit the cell’s response to environmental stress, 
as G3BP is a crucial component of stress granules (SG) (Figure 9.2)(Chapter 
5). SGs contain mRNPs and stalled translation initiation complexes, and often 
form during viral infections. Many viruses, however, counteract the formation 
of SGs, suggesting antiviral activity (reviewed by (89)). In fact, a recent study 
showed that the formation of SGs is associated with the antiviral protein, 
protein kinase R (PKR)-induced phosphorylation of eukaryotic translation 
initiation factor 2α (eIF2α), which inhibits general translation (295). Moreover, 
a specific interaction between the PxxP domain of G3BP and PKR is known to 
activate PKR, suggesting that G3BP is an antiviral protein itself (175). Other 
antiviral RNA binding proteins, e.g. retinoic acid-inducible gene I (RIG-I) and 
melanoma differentiation-associated gene 5 (MDA5) also localize to SGs (296, 
297). These proteins have been recognized as some of the most potent antiviral 
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cytoplasmic pattern recognition receptors (PRRs) (192). Together this suggests 
that the formation of SGs is intertwined with (the activation of) innate antiviral 
responses.  
In both insect and mammalian cells, Rin and G3BP are sequestered into 
nsP3-granules via an interaction between the conserved N-terminal NTF2-like 
domain of Rin/G3BP and two conserved repeats in the C-terminal variable 
domain of alphavirus nsP3, that closely resemble the amino acid residues 
normally bound by NTF2-like domains (Chapter 4)(166). The central domain 
of nsP3 forms multimers, independent of the N-terminal macrodomain or the 
C-terminal variable domain. However, the variable domain is required for a 
granular localization (Chapter 4 and 5), but the formation of these cytoplasmic 
nsP3-granules does not require Rin (Chapter 4).  
Further investigation of these nsP3-granules in mammalian cells revealed 
that these granules were devoid of other typical SG components (e.g. eIF3) 
and did not respond to chemical stimulations that either induce (arsenite) or 
disassemble (cycloheximide) normal SGs (Chapter 5). These results indicate 
that the interaction between Rin/G3BP and CHIKV nsP3 inhibits the formation 
of bona fide SGs. 
Considering the growing evidence that SGs augment innate antiviral 
responses, it is not surprising that CHIKV has evolved a way to inhibit SG 
formation. Paradoxically, silencing of G3BP1 and G3BP2 in mammalian cell 
culture decreased levels of CHIKV RNA replication, CHIKV protein expression 
and progeny virus titers (57). Although subjected to some controversy, SINV 
replication was also affected by the simultaneous depletion of G3BP1/2 (57, 58). 
Rin depletion in insect cells in vitro did not alter levels of CHIKV replication 
and/or protein expression (Chapter 4). Depletion of Rin in live Ae. albopictus 
mosquitoes, however, significantly reduced CHIKV infection rates (Chapter 4), 
suggesting that the interaction between nsP3 and Rin elicits proviral effects 
in vivo. The decreased CHIKV infection rate and viral titers in vivo but not in 
vitro during Rin silencing in Ae. albopictus, suggests that Rin helps to establish 
a productive infection and/or affects CHIKV replication in specific insect 
tissues, possibly the midgut. It also suggests that results obtained in these 
cell lines cannot always be extrapolated to an in vivo model. Furthermore, 
siRNA-mediated gene silencing may not completely abolish the presence of 
Rin/G3BP, which could also explain the discrepancy between the results from 
the in vitro and in vivo experiments. Introducing mutations in the Rin/G3BP 
binding domains of nsP3 in the context of viral replication can provide more 
insights into the role that Rin/G3BP-nsP3 granules play during an alphavirus 
infection. Deletion of the C-terminal 30 amino acids, that contain the G3BP 
binding domains, severely reduced Semliki forest virus (SFV) replication (165), 
strengthening the hypothesis that the interaction between nsP3 and Rin/
G3BP has a positive effect on viral replication. The exact mechanism of how 
Rin/G3BP enhances viral replication in both vertebrates and invertebrates 
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is unknown, however G3BPs are not directly involved in the translation of 
incoming genomes, nor genome replication. This suggests that G3BPs support 
the switch between viral non-structural polyprotein translation and negative-
strand RNA replication (57). 
Besides alphaviruses, several other viruses, including flaviviruses, 
induce cytoplasmic granules that sequester essential SG factors (91, 177, 178). 
The interaction of flaviviruses and hepatitis C virus with SG components 
even increased their replication efficiency (177, 179, 298). The exact effects of 
flavivirus infection on the composition and formation of SGs has not been 
properly characterized. SG components T cell intracellular antigen-1 (TIA-1) and 
TIA1-related protein (TIAR) did not localize to SGs during WNV infection even 
when SGs were induced with oxidative stress (91). In contrast, G3BP-containing 
granules formed during flavivirus infection (299). These contradicting results 
actually suggest that viral-G3BP granules inhibit the formation of bona fide (TIA-
1 and TIAR containing) SGs. In co-ordinance with this hypothesis, flavivirus 
sfRNA was shown to bind SG components G3BP1 and G3BP2 and CAPRIN1 
which repressed innate immune responses (297). Experiments using infectious 
WNV clones that no longer produce sfRNA, as described above, combined with 
transient expression of transcripts that contain sequences from flavivirus 3’UTR 
can reveal in more detail how flaviviruses modulate the formation of SGs. 
In summary, this suggests that viral-Rin/G3BP-granules inhibit the 
formation of bona fide SGs, and that this strategy has been adopted by multiple 
unrelated viruses, which utilize different mechanisms. In addition, viruses may 
utilize SG components in viral-granules (e.g. Rin/G3BP) to increase their own 
productivity. In Drosophila, Rin has been suggested to form RNase inhibitor 
complexes (173), which could protect CHIKV RNA replication during the initial 
infection in the mosquito midgut. SGs are triage centres of RNA binding proteins 
and AGO2 has also been found to localize to SGs (158, 300). It is tempting 
to speculate that arboviruses modulate the SG response in invertebrates to 
decrease but not completely abolish the effects of RNAi and possible other 
antiviral pathways to balance appropriate levels of viral replication and fitness 
of the vector. These observations also suggest that small molecule modulators 
of the stress response could be used as antiviral treatment by stimulating 
antiviral responses, but perhaps more effectively by reducing viral replication 
rates. In addition, the interaction between nsP3 and Rin can provide a novel 
target to interfere with the CHIKV transmission cycle.
Chikungunya virus nsP2 and the vertebrate IFN-response
It is becoming increasingly clear that SGs have an antiviral role, as PRRs 
(e.g. RIG-I, MDA5 and PKR) that can activate other antiviral innate immune 
responses localize to bona fide SGs (297, 301, 302). The IFN response is arguably 
the most potent innate antiviral response that vertebrates possess. PRRs 
recognize viral elements resulting in the expression and secretion of IFNs. IFNs 
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activate neighboring cells via transmembrane receptors, which signal through 
the JAK-STAT pathway. STAT1/2 dimers are activated by phosphorylation and 
translocate to the nucleus, resulting in the up regulation of IFN-stimulated 
(antiviral) genes (ISG). Modulation of the IFN-response is absolutely 
essential for flaviviruses and alphaviruses to establish productive infections in 
mammalian hosts (Figure 1.6)(68–73).  
Flaviviruses inhibit the IFN response by interfering with the recognition 
by PRRs, IFN-β production, and multiple steps during JAK-STAT signaling 
(reviewed by (303)). A group of old world alphaviruses, which includes CHIKV, 
are notorious for the suppression of host gene expression and the induction of 
cytopathic effects in cell culture (83, 209). General host cell shut-off is induced 
by nsP2 and was reported to affect the expression of IFNs and ISGs (218). 
CHIKV infected cells no longer respond to exogenous stimulation with 
IFNs, as viral titers and CHIKV replicon RNA replication were unaffected 
and ISG expression was inhibited. However, when treated with IFNs prior to 
infection, ISGs were readily expressed and virus replication was severely reduced 
(Chapter 6). Interestingly, IFNs did not induce the nuclear translocation of 
STAT dimers when cells were infected with CHIKV. The absence of nuclear 
phosphorylated STAT (pSTAT) in these cells was independent of general host 
shut-off as cellular levels of STAT1 were unaffected by CHIKV RNA replication 
and complete inhibition of protein synthesis with cycloheximide did not affect 
STAT nuclear translocation during the course of the experiments (Chapter 6). 
Transient expression of individual CHIKV nsPs revealed that nsP2 inhibited 
JAK-STAT signaling (Chapter 6). 
NsP2 is a multifunctional protein that contains the protease that 
processes the non-structural polyprotein (304), has RNA helicase activity (305), 
NTPase activity (306) and RNA triphosphatase activity (307). Recently, nsP2 
was shown to induce the ubiquitination and degradation of RNA polymerase 
II subunit RPB1, which results in general host cell transcriptional shut-off and 
cytopathic effects in mammalian cells, but not in insect cells (149). A single 
amino acid change in the C-terminal domain of SINV nsP2 no longer induced 
the degradation of RPB1, abolished the cytotoxicity of nsP2 and enabled 
persistent infection in mammalian cells (85, 149). A homologous mutation 
in a CHIKV replicon reinstated the nuclear translocation of pSTAT in cells 
induced with IFNs (Chapter 6). However, when mutated CHIKV nsP2 was 
transiently expressed in mammalian cells, nuclear accumulation of pSTAT1 was 
still inhibited (Chapter 7). Further investigations revealed that this mutation 
decreases general host shut-off and the cytotoxicity of transiently expressed 
nsP2, but also severely reduced CHIKV RNA replication (Chapter 7). Reduced 
RNA replication and subsequent viral protein expression of this less cytopathic 
CHIKV replicon is likely what allowed the observed nuclear accumulation of 
pSTAT (Chapter 6). 
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In contrast to SINV, additional amino acid changes were necessary 
to establish persistent CHIKV replication in mammalian cells (Chapter 7)
(226). These mutations in CHIKV nsP2 all mapped to the homologous region 
of SINV nsP2 that directly binds nsP3 in the SINV replication complex (RC)
(156). Changing the interaction with nsP3 could reduce the functionality of the 
CHIKV replication complex and therefore reduce CHIKV replication. Reduced 
RNA replication was necessary to establish persistent CHIKV RNA replication 
in mammalian cells; however, one second site mutation partly restored CHIKV 
replicon RNA replication. Cells expressing stable CHIKV or SFV replicon RNA 
replication have already been developed into an assay for the identification of 
inhibitors of alphavirus entry and replication (226). Finally, introducing these 
attenuating mutations in an infectious full-length CHIKV virus holds potential 
for the development of a live attenuated vaccine. 
One of the mutations that contributed to the attenuation of CHIKV 
replicon RNA replication was  inside the putative nuclear localization signal 
(NLS) within nsP2 (KR649-650)(223). Interestingly, substituting these residues 
for alanines not only kept nsP2 out of the nucleus, but also completely re-
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Figure 9.1. Nuclear localization of the C-terminal domain of nsP2 reduces nuclear STAT1. 
A. schematic representation of EGFPnsP2. Indicated are the NLS within nsP2 (KR649) and an in 
frame fusion with the Simian virus 40 NLS (SV40). Helicase and Protease domains were deleted 
and the C-terminal domain was fused in frame with EGFP. BC. NsP2 variants were transiently 
expressed in Vero cells and 20 hours post transfection cells received a 30 min stimulation with 
IFN-β (25 ng/ml). Cells were fixed permeabilized and stained for STAT1. C. cells were either mock 
treated (grey bars) or treated with 20nM of Leptomycin B (LMB) for 3 h (black bars) prior to IFN 
stimulation. Bars represent the percentage of cells with visible nuclear STAT1 relative to mock 
transfected IFN-induced samples. Asterisk indicates significant difference from the mock (B) or 
LMB induced (C) samples (P<0.01, binominal test). 
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instated the JAK-STAT signaling pathway upon stimulation with IFNs (Chapter 
7). These results indicated that the inhibition of JAK-STAT signaling either 
occurs inside the nucleus, or is a direct consequence of mutations in the nsP2 
NLS. Transiently expressed nsP2-KR649AA with an additional classical NLS 
fused to the C-terminus (Figure 9.1A) was redirected into the nucleus and 
effectively inhibited the nuclear accumulation of pSTAT upon stimulation 
with IFNs (Figure 9.1B). Moreover, N-terminal truncations of nsP2 revealed 
that only the C-terminal domain is required for the inhibition of JAK-STAT 
signaling (Figure 9.1B). 
Only as a dimer two STAT proteins display an NLS at the STAT-STAT 
interface, which results in active nuclear translocation via importin-α (308). 
The STAT dimer has a relatively high affinity for the IFN-stimulated response 
element (ISRE), which promotes the transcription of down-stream ISGs. STAT 
proteins that are not bound to DNA are actively exported out of the nucleus 
by chromosome region maintenance 1 (CRM1) (309). This suggests that the 
JAK-STAT signaling assay, based on immunofluorescence of pSTAT proteins in 
fixed mammalian cells, was unable to detect nuclear pSTAT as STAT had been 
redirected back into the cytoplasm (Figure 9.2). Indeed, when nuclear export 
was chemically blocked by leptomycin B a large increase in nuclear STAT1 in 
nsP2 expressing IFN induced cells was observed (Figure 9.1C). These results 
indicate that, in the nucleus, the C-terminal domain of CHIKV nsP2 somehow 
induces the nuclear export of STAT. 
The C-terminal domain of CHIKV nsP2 has a SAM-dependent 
methyltransferase fold (Chapter 7)(310), but methyltransferase activity has not 
been reported. Interestingly, IFN-stimulated gene expression can be silenced 
by hypermethylation of the promoter region (311). Genomic DNA isolation 
followed by sodium bisulfite treatment and PCR amplification can identify 
whether nsP2 expression results in alternative methylation patterns in the DNA 
binding sites of pSTAT dimers. Alternatively, demethylation of phosphorylated 
STAT1 would result in increased affinity of protein inhibitors of activated STAT1 
(PIAS1) for STAT1, also reducing the binding affinity of STAT dimers (312).       
In addition, CHIKV nsP2 is a highly connected and multifunctional 
protein, which induces nsP2-mediated ubiquitination of RPB1 (149, 217). NsP2 
is associated with ubiquitin ligases RCHY1, WWP1 and a regulator of ubiquitin 
activity ubiquilin 4 (217). The DNA binding affinity of STAT dimers is increased 
by a number of co-factors, including IFN-response factor 9 (IRF9). Inducing 
the ubiquitination of co-factors may also decrease the DNA binding affinity 
of STAT dimers and consequently induce nuclear export of STAT. Similarly, 
rotavirus NSP1 inhibits STAT nuclear accumulation upon IFN stimulation 
(313). Rotavirus NSP1 also induces the proteasomal degradation of multiple 
IRFs, including IRF9 (314), however, both findings appear to be unrelated (315). 
Taken together, these results indicate that the C-terminal domain of CHIKV 
nsP2 specifically inhibits IFN signaling by inducing the nuclear export of STAT 
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proteins (Figure 9.2). Additionally, these results provide a rationale for the 
ineffectiveness of IFN-treatment during CHIKV infections.    
Chikungunya virus nsP2 and the vertebrate unfolded protein response
Once the initial cellular antiviral responses have been overcome and 
viral replication is underway, the vast amounts of CHIKV progeny virus that is 
produced poses another problem. As one of the final steps in the viral replication 
cycle, large amounts of viral glycoproteins are expressed which mature in the 
endoplasmic reticulum (ER)(Fig. 1.7). The expression of alphavirus glycoproteins 
Figure 9.2.CHIKV modulation of the vertebrate host-cell. SG formation: Interaction between 
nsP3 and G3BP inhibits the formation of SG and  contributes to effective viral replication (Chapter 
4 and 5)(270). JAK-STAT signaling: STAT dimers are formed and translocate to the nucleus, but 
are quickly exported upon the nuclear presence of the C-terminus of nsP2. Host shut-off: RPB1 
is tagged for degradation inhibiting RNA pol II transcription (145). UPR:CHIKV infection and 
envelope (E) proteins in the ER activate the UPR, which results in XBP1 mRNA splicing and 
eIF2α phosphorylation. nsP2 inhibits transcription of UPR target genes and translation of UPR 
transcription factors.
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disrupts the homeostasis in the ER which in turn results in activation of the 
unfolded protein response (UPR) (Chapter 8)(97). There is growing evidence 
that the UPR enhances inflammatory and innate immune pathways (266). 
The UPR also increases the production of several proteins involved in protein 
folding, degradation and apoptosis, whilst inhibiting general protein synthesis 
via the phosphorylation of eIF2α in an effort to restore homeostasis in the ER 
(230). Most viruses prevent the phosphorylation of eIF2α to allow and promote 
the translation of viral proteins (249–251). Alphaviruses, however, allow the 
phosphorylation of eIF2α during productive infection (228, 263, 264, 258). A 
stable hairpin loop structure in the 26S promoter of the subgenomic mRNA 
from SINV stalls the ribosome on the correct AUG providing resistance to eIF2α 
phosphorylation (263). When the UPR was induced with a chemical inhibitor 
of N-linked glycosylation, in the context of a CHIKV infection or transient 
expression of CHIKV nsP2, the expression of UPR target genes and the eIF2α 
phosphorylation insensitive activating transcription factor 4 (ATF4) was clearly 
inhibited. In addition, UPR transcription factor X-box binding protein 1 (XBP1) 
was initially activated, but was not found in the nucleus (Figure 9.2)(Chapter 
8). Whether the lack of nuclear XBP1 results from a similar mechanism as STAT 
proteins is unknown, but investigating the subcellular distribution of activated 
XBP1 in cells that transiently express nsP2 and the variants thereof can provide 
a first indication.
The translational shut-off during alphavirus infection is independent 
of eIF2α phosphorylation (228, 264), and could explain the lack of UPR 
transcription factors during alphavirus infection. Point mutations in nsP2 
that abolish host cell (transcriptional) shut-off reversed the nsP2-mediated 
inhibition of the UPR. This suggests that the host-cell shut-off, governed 
by CHIKV nsP2, is responsible for the inhibition of the UPR. Although the 
mechanism of alphavirus-induced translational shut-off is not well understood, 
previous reports suggest SINV translational shut-off is independent of 
transcriptional shut-off, but both can be relieved by mutations in nsP2 (218). 
It is thus unclear whether indirect effects of nsP2-mediated transcriptional 
shut-off contribute to the observed eIF2α-independent translational shut-off 
or whether there is a specific mechanism that blocks cellular translation and 
subsequently downstream activation of the UPR. A better understanding of the 
mechanisms by which alphaviruses inhibit transcription and translation will 
allow better understanding of how these inhibitory effects impact intracellular 
signaling pathways, including the UPR.
What does become apparent now is that CHIKV has evolved efficient 
ways to prevent or inhibit antiviral responses in vertebrates and delay apoptosis 
to maximize virus replication, during a rapid and lytic infection. This suggests 
that activating the UPR or IFN-response to treat CHIKV infections are unlikely 
to be effective, pressing the need for compounds that directly inhibit viral 
replication or alternative approaches to interrupt viral transmission cycles.           
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Significance and concluding remarks 
In recent years, CHIKV and WNV have caused substantial outbreaks of 
human arthritogenic and encephalitic disease. The spread of invasive CHIKV 
vector species has closely been followed by CHIKV outbreaks. After the first 
reported autochthonous transmission on the American continent in 2013, 
more than a million CHIKV infections have been reported by the end of 2014. 
Similarly, WNV swept through the USA after its initial introduction to the 
continent, because it was effectively transmitted by local mosquito species. 
This thesis describes the epidemic potential of two pathogenic lineages of 
WNV within Europe and compares it to that of USUV, a related flavivirus 
that has only recently emerged in Europe. The results presented in chapter 2 
and 3 show that European Cx. pipiens mosquitoes from WNV-free areas are 
intrinsically effective WNV and USUV vectors. This clearly indicates a risk for 
further spread of these arboviruses. In addition, changing climatic conditions 
and the adaptive nature of these small RNA viruses suggests that arbovirus 
outbreaks will continue to emerge. The data presented in this thesis will 
increase the effectiveness and accuracy of arbovirus risk assessments and calls 
for intensified surveillance of flavivirus activity in regions that are currently 
virus-free and increased awareness in clinics throughout Europe. 
The molecular interactions that determine effective viral replication 
throughout the mosquito vector are still poorly characterized and strong 
inhibitors of mosquito antiviral responses (e.g. RNAi) have not been described. 
Arbovirus infections in the invertebrate vector are persistent and seem almost 
symbiotic, with little to no fitness costs for the vector. In sharp contrast, 
arbovirus pathogenesis in vertebrate hosts can be relatively severe and acute, 
which finally results in either the death of the vertebrate host or clearance of the 
viral infection. This is also reflected by the amount of vigorous countermeasures 
that arboviruses have evolved against vertebrate antiviral responses, compared 
to the limited and mild modulations that have been reported against the vectors 
antiviral responses. This thesis further describes the identification of novel 
molecular interactions between viral and host proteins that enable CHIKV to 
successfully infect both the vertebrate and invertebrate hosts (Figure 9.3).  
Currently there are no vaccines or antiviral compounds available for 
human uses that are effective against WNV and CHIKV infections. These 
viruses are, however, readily cleared by an operational vertebrate innate 
immune response in vivo, which produces large amounts of IFNs (135). When 
IFNs are administered prior to (or very early during) infection they do effectively 
protect against WNV and CHIKV disease in experimental animal models (68, 
71, 72, 316). IFNs are regularly used as antiviral treatment during chronic viral 
infections, however lack effectiveness when used to treat acute infections (e.g. 
WNV or CHIKV infections) (317). The results presented in Chapters 6 and 7 
provide a rationale for the ineffectiveness of IFN treatment in response to 
clinical (acute) CHIKV infections. The combined effects of CHIKV nsP2 
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induced general host shut-off and the inhibition of JAK-STAT signaling are 
particularly effective, shutting down both general antiviral gene transcription 
(including the production of IFNs) and downstream signaling that is initiated 
by IFNs produced by other cells of the infected organism. The UPR has been 
proposed to strengthen and specify the IFN-response (266). This explains why 
CHIKV induced host shut-off has evolved to also inhibit the UPR. Indeed, the 
replication of several RNA viruses, including SINV, was inhibited when the 
UPR was activated with a small molecule deubiquitinase inhibitor (98, 267). 
However, these authors activated the UPR prior to infection, while our data 
indicate that downstream activation of the UPR is effectively inhibited during 
CHIKV infection. This suggests that activating either the UPR or the IFN-
response (and possibly other antiviral pathways) is an ineffective strategy in the 
fight against these fast replicating and adaptive arboviruses. In fact, most 
arboviruses have adopted a similar transmission strategy, often with analogous 
solutions to inhibit vertebrate antiviral responses (66, 318).  
Specifically counteracting the CHIKV-induced inhibition of either the 
IFN-response or the UPR can provide a more effective strategy for antiviral 
treatments. Alternatively, compounds that directly interfere with viral 
replication, virion assembly or virus entry are also likely to be effective. The 
interaction between CHIKV nsP3 and G3BP/Rin, described in Chapters 4 and 
5, may provide such a target as this interaction not only inhibits the antiviral 
Figure 9.3. Schematic representation of the CHIKV transmission cycle with CHIKV nsP2 
and nsP3 and their effect on host responses indicated. CHIKV nsP2 inhibits vertebrate RNA 
pol II RNA transcription in vertebrates but not in invertebrates (145). In addition it effectively 
inhibits the UPR and JAK-STAT signaling in vertebrates. CHIKV nsP3 interacts with vertebrate 
G3BP or homologous mosquito Rin, forming viral Granules and inhibiting the formation of 
bona fide SGs, with a positive, proviral effect on CHIKV replication. The respective chapters that 
describe these interactions are indicated within brackets and arrows indicate respective up or 
down regulation. 
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stress granule response, but also exerts a positive effect on viral replication 
both in vertebrate cells and the mosquito vector (Chapters 4 and 5)(171). 
Compounds that disturb the interaction between G3BP and CHIKV nsP3 have 
the potential to increase the antiviral response by re-establishing a functional 
SG response, while at the same time reducing viral replication rates. The 
homologous interaction between nsP3 and mosquito Rin may also provide a 
novel target to interfere with the CHIKV transmission cycle, e.g. by disrupting 
the interaction between virus and vector. It will be interesting to determine 
whether the interaction between alphavirus nsP3 and Rin is in fact a molecular 
determinant of vector competence and whether other arboviruses and RNA 
viruses in general, also utilize G3BP/Rin for their propagation.   
 This thesis thus adds to the collective knowledge of arbovirus 
transmission cycles by describing the risk for WNV and USUV transmission 
in Europe and the climatic factors that are involved. Additionally, this thesis 
provides novel molecular data, which suggests directing future antiviral drug 
development to more specific compounds that directly interfere with viral 
replication and transmission.
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Summary 
Two highly pathogenic arthropod-borne (arbo)viruses, West Nile virus (WNV) 
and chikungunya virus (CHIKV), recently (re-)emerged in both Europe and 
the Americas. This resulted in large-scale epidemics of severe encephalitic 
and arthritogenic human disease, respectively. Both viruses replicate in their 
vertebrate hosts and mosquito vectors to complete their respective transmission 
cycles. In mosquitoes, arbovirus infections lead to relatively high viral titres 
without causing notable disease symptoms or fitness costs, whereas virus 
replication in the vertebrate host initiates strong antiviral responses and can be 
highly pathogenic and sometimes deadly. 
WNV is a flavivirus (family Flaviviridae; genus Flavivirus), that finds its 
origin in Africa. The introduction of lineage 1 WNV into North America in 1999 
caused the largest outbreak of human neuroinvasive disease to date. In southern 
Europe, a highly pathogenic lineage 2 strain has recently established itself in 
2010, causing annual outbreaks. Additionally, the related flavivirus Usutu virus 
(USUV), has also emerged in Europe. Both WNV and USUV are transmitted by 
mainly Culex mosquitoes between avian amplifying hosts, but also frequently 
infect humans and horses. USUV and WNV co-circulate in parts of southern 
Europe, but the distribution of USUV extends further into central and north-
western Europe. 
In this thesis the potential spread of both WNV lineages through Europe is 
investigated by determining how effectively north-western European common 
house mosquitoes (Culex pipiens) transmit WNV. The results were compared 
to the transmission rates of USUV. North-western European mosquitoes were 
found to be highly competent vectors for both pathogenic lineages of WNV, 
which underscores the epidemic potential of WNV in Europe. Interestingly, 
American Culex pipiens only efficiently transmitted WNV lineage 1 but not 
the European lineage 2, which indicates a high degree of genotype-genotype 
specificity in the interaction between virus and vector. Furthermore, by 
comparing blood meal infection with intrathoracic injection of mosquitoes 
with WNV, the differential transmission rates of WNV lineage 2 could be 
attributed to infection barriers at the midgut level. In the vector competence 
studies, European mosquitoes were also found to be highly competent for USUV 
transmission. Interestingly, at higher temperatures USUV infected significantly 
more mosquitoes as compared to WNV. This indicates that mosquitoes from 
WNV-free areas are intrinsically capable of transmitting both pathogenic WNV 
lineages and explains the current localized WNV activity in southern Europe. 
In addition, the infection rates of WNV and USUV were both enhanced 
at higher temperatures. This implies further epidemic spread of WNV and/
or USUV during periods with favourable climatic conditions. Finally, as both 
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viruses utilize the same vector and reservoir species, the higher infection rate of 
USUV suggests that this virus may precede WNV transmission in Europe. This 
presses the need for intensified surveillance of virus activity in current WNV-
free regions and warrants increased awareness in the clinic throughout Europe
In contrast to WNV, CHIKV (Family Togaviridae; genus Alphavirus) 
is transmitted in an urban transmission cycle involving humans and two 
major mosquito species: Aedes aegypti and Aedes albopictus. These invasive, 
originally African and Asian mosquito species are the drivers of the recent 
CHIKV outbreaks in Europe and the Americas. The first autochthonous CHIKV 
transmission on the American continent was detected in late 2013 and by the 
end of 2014 over a million people were diagnosed with a CHIKV infection. In 
humans, CHIKV can cause high fever and incapacitating arthralgia. There are no 
vaccines or antiviral compounds available for human use against either CHIKV 
(or WNV) and broad-spectrum antiviral treatments have proven ineffective. To 
develop novel strategies that interrupt the CHIKV transmission cycle, it is key 
to understand how CHIKV replicates in both vertebrates host and the mosquito 
vector. The molecular mechanisms that determine effective viral replication in 
mosquitoes are largely unknown. By studying the intracellular localization of 
CHIKV non-structural protein 3 (nsP3) in insect cells, an interaction between 
nsP3 and the endogenous mosquito protein Rasputin was uncovered and 
elucidated. Both proteins were found to interact via two short amino acid 
repeats within the C-terminus of nsP3 and the NTF2-like domain of Rasputin, 
forming cytoplasmic nsP3-Rin granules. Silencing of endogenous Rasputin in 
live Ae. albopictus mosquitoes revealed that this protein is essential for CHIKV 
to effectively establish transmissible infections. This is the first reported 
function of mosquito Rasputin in arbovirus infection. 
Vertebrate cells express two proteins that are homologue to mosquito 
Rasputin, namely Ras-GAP SH3 domain-binding protein (G3BP) 1 and 2. G3BP 
proteins are crucial components of mammalian stress granules (SG), which are 
RNA triage centers that form during environmental stress, leading to impaired 
translation of most mRNAs. In co-localization studies in mammalian cells it 
is shown how CHIKV nsP3 sequesters G3BP into viral nsP3-G3BP granules. By 
making G3BP unavailable, nsP3 inhibits a bona fide SG response. The evidence 
obtained in these studies contributes to the growing evidence that cellular SGs 
possess antiviral activity, yet at the same time indicate a novel, proviral role for 
Rasputin during infection of the mosquito vector. 
In mammalian cells, cytoplasmic pattern recognition receptors (PRR) 
localize to SGs. These PRRs recognize specific viral molecular patterns and 
upregulate the expression of interferon (IFN), activating the most potent 
vertebrate antiviral response, the IFN-response. The IFN-response is sufficient 
to clear most arbovirus infections, but administering IFN in response to CHIKV 
infections is ineffective. Experiments in this thesis show that CHIKV replication 
is resistant to IFN once RNA replication has been established, because CHIKV 
actively prevents IFN-induced gene expression via the inhibition of the down-
stream JAK-STAT signaling pathway. In response to extracellular IFNs, this 
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pathway activates STAT proteins, which then dimerise and translocate to the 
nucleus to activate antiviral gene transcription. WNV and other flaviviruses 
have evolved specific mechanisms to evade and inhibit the IFN-response, while 
alphaviruses such as CHIKV cause general host shut-off to prevent antiviral 
gene expression. Clear evidence is now obtained that in addition to general host 
shut-off, CHIKV nsP2 inhibits the JAK-STAT signaling pathway in a specific 
manner. Genetic evidence is presented which reveals that nsP2 independently 
affects RNA replication, CHIKV induced host shut-off and cytopathicity, and 
JAK-STAT signaling. Additional data shows that the activation and nuclear 
translocation of STAT is unaffected by nsP2, but that the C-terminal domain of 
nsP2 within the nucleus is sufficient to quickly redirect STAT dimers out of the 
nucleus. This host shut-off-independent inhibition of IFN signaling by CHIKV 
nsP2 is likely to have an important role in viral pathogenesis.
In the final phase of viral replication, viral envelope proteins mature 
in the endoplasmic reticulum (ER) before they translocate to the plasma 
membrane. When the ER-protein folding load becomes too high, unfolded and 
misfolded proteins in the ER will activate the unfolded protein response (UPR). 
Transient expression of CHIKV envelope glycoproteins are now shown to have 
the potential to induce the UPR. The UPR aims to reduce general protein 
synthesis and increase the protein-folding capacity of the ER. CHIKV infection 
resulted in the phosphorylation of eukaryotic translation initiation factor 2, but 
did not increase the expression of well-known UPR target genes. In addition, 
functional X-box-binding protein 1 did not translocate into the nucleus during 
CHIKV infection. Individual expression of CHIKV nsPs revealed that nsP2 
alone was sufficient to inhibit the UPR. Mutations that rendered nsP2 unable to 
cause host-cell shut-off prevented nsP2-mediated inhibition of the UPR. This 
indicates that initial UPR induction takes place in the ER but that expression 
of functional UPR transcription factors and target genes is efficiently inhibited 
by CHIKV nsP2.
Finally, this thesis describes how effectively potential mosquito vectors 
transmit the flaviviruses WNV and USUV and provides novel insights on the 
underlying molecular mechanisms that enable CHIKV to accomplish successful 
infections in both its human host and mosquito vector. The effective inhibition 
of the JAK-STAT signaling pathway, combined with host shutoff, induced by 
nsP2 provides a rationale for the ineffectiveness of broad-spectrum antivirals 
against acute arbovirus infections and suggests directing future antiviral drug 
development to more specific compounds that directly interfere with viral 
replication and transmission. The uncovered interaction between CHIKV nsP3 
and Rasputin/G3BP may provide such a target as disturbing this interaction 
could potentially re-instate cellular stress responses and interfere with viral 
replication and transmission. 
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Samenvatting
Het Westnijl virus (WNV) en het chikungunya virus (CHIKV) zijn twee humaan 
pathogene virussen die hun oorsprong vinden in Afrika, en recentelijk grote 
uitbraken hebben veroorzaakt op de Europese en Amerikaanse continenten. 
Deze door muggen overgedragen virussen kunnen in mensen respectievelijk 
hersen(vlies)ontsteking en artritis veroorzaken. Om succesvol verspreid te 
kunnen worden, vermenigvuldigen deze virussen zich in de mug tot hoge 
concentraties, zonder ogenschijnlijke ziekteverschijnselen te veroorzaken. 
Echter, virusvermenigvuldiging in mensen en andere gewervelde dieren wekt 
een sterke antivirale afweer op, gaat samen met ziekteverschijnselen en kan 
soms de dood tot gevolg hebben. 
 WNV is een flavivirus (familie Flaviviridae; genus flavivirus) en is onder 
te verdelen in een aantal stammen (of lineages). In 1999 werd WNV voor het 
eerst aangetroffen op het Amerikaanse continent. Een lineage 1 WNV isolaat 
begon in New York (VS) en verspreidde zich al snel over het gehele continent, 
wat resulteerde in de grootste uitbraak van hersen(vlies)ontsteking ooit 
waargenomen. In 2010 kreeg een pathogeen lineage 2 WNV isolaat definitief 
voet aan de grond in Zuid Europa, waar het sindsdien voor jaarlijkse uitbraken 
zorgt. Een ander flavivirus, Usutu virus (USUV) heeft zich recentelijk gevestigd 
in Centraal Europa. USUV en WNV circuleren beiden tussen muggen van 
het Culex genus en vogels. Naast vogels dragen geïnfecteerde muggen beide 
virussen regelmatig over naar mensen en andere gewervelde dieren, waarvan de 
(soms dodelijke) gevolgen vooral merkbaar zijn in paarden en mensen. USUV 
en WNV co-circuleren in delen van Zuid Europa, maar alleen USUV vertoont 
regelmatige activiteit in Centraal en Noordwest Europa. 
 Dit proefschrift begint met het onderzoeken van de potentiële 
verspreiding van WNV richting Noordwest Europa door te meten hoe effectief 
de Nederlandse huissteekmug (Culex pipiens) is in de overdracht van WNV. 
Deze resultaten werden vergeleken met die van USUV. De resultaten laten 
zien dat Nederlandse huissteekmuggen erg goed in staat zijn beide pathogene 
lineage 1 en 2 WNV isolaten over te dragen. In tegenstelling waren Amerikaanse 
muggen alleen geschikt voor de overdracht van het Amerikaanse lineage 1 WNV 
isolaat en niet het Europese lineage 2 WNV isolaat. Dit impliceert dat specifieke 
virus-vector genotype-genotype interacties aan dit verschil ten grondslag 
liggen. De eerste cellen van de mug die geïnfecteerd moeten worden zijn de 
endotheelcellen van de maagwand. Wanneer infectie van deze cellen werd 
omzeild door virus direct in het lichaam van de mug te injecteren, resulteerde 
100% van alle virus-vector combinaties in een volledige infectie die zich door de 
mug verspreidde tot in de speekselklieren. Dit impliceert dat de verschillen in 
ineffectiviteit van de geteste mug-virus combinaties in het abdomen veroorzaakt 
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worden. Naast WNV bleek de Nederlandse huissteekmug ook in staat om USUV 
effectief over te dragen. Beide virussen werden beter overgedragen wanneer 
de geïnfecteerde muggen geïncubeerd werden bij hogere temperaturen. Bij 
deze hogere temperaturen was USUV effectiever in het infecteren van Culex 
muggen vergeleken met WNV. Deze resultaten kunnen verklaren waarom 
WNV activiteit vooralsnog gelokaliseerd is gebleven in Zuid Europa. Het 
impliceert ook dat deze virussen zich in de toekomst verder zouden kunnen 
verspreiden wanneer de weersomstandigheden gunstig zijn. Omdat USUV 
en WNV dezelfde vogelreservoirs en muggensoorten kunnen gebruiken voor 
hun respectievelijke transmissiecycli, maar USUV bij hogere temperaturen de 
vector effectiever kan infecteren, heeft USUV een potentieel groter bereik dan 
WNV. Daarom kan de prevalentie van USUV als voorbode gezien worden voor 
toekomstige WNV activiteit. Het feit dat muggen uit een momenteel WNV-vrije 
zone (c.q. Noordwest Europa) effectieve vectoren voor WNV zijn benadrukt het 
risico op WNV uitbraken buiten Zuid Europa en accentueert de noodzaak voor 
goede controles op WNV activiteit en symptoombewustzijn in de klinieken. 
      In tegenstelling tot WNV wordt CHIKV (family Togaviridae; genus 
alphavirus) hoofdzakelijk overgedragen door de Aziatische tijgermug (Aedes 
albopictus) en de gelekoortsmug (Aedes aegypti) in een transmissiecyclus 
tussen muggen en mensen. Deze respectievelijk Aziatische en Afrikaanse 
muggensoorten waren ook de vectoren tijdens recente CHIKV uitbraken op 
het Europese en Amerikaanse continent. De eerste autochtone transmissie 
van CHIKV op het Amerikaanse continent is waargenomen in 2013. Eind 2014 
waren er al meer dan een miljoen diagnoses van CHIKV infecties geteld. CHIKV 
veroorzaakt onder andere hoge koorts en hevige gewrichtspijnen. Er zijn op dit 
moment geen vaccins of antivirale middelen tegen CHIKV beschikbaar terwijl 
generieke antivirale middelen ontoereikend zijn gebleken. Het is daarom van 
belang om nieuwe strategieën te ontwikkelen die de transmissiecyclus kunnen 
onderbreken, waarbij kennis van de replicatiecyclus in menselijke maar ook 
muggen cellen van waarde is. Voornamelijk de moleculaire mechanismen die 
het lot van een virus bepalen in het insect zijn nog grotendeels onbekend. 
Dit proefschrift laat zien hoe het niet-structurele eiwit 3 (nsP3) van 
CHIKV een interactie aangaat met het endogene muggeneiwit genaamd 
Rasputin. Beide eiwitten lieten een interactie met elkaar zien middels twee 
korte aminozuurvolgordes in de C-terminus van nsP3 en het NTF2 (nucleair 
transport factor 2)-like domein van het Rasputin eiwit. CHIKV infecties 
in levende Aedes albopictus muggen waren minder effectief wanneer de 
hoeveelheid beschikbaar Rasputin eiwit in deze muggen was verminderd. Dit 
impliceert dat de interactie tussen nsP3 en Rasputin een cruciale functie heeft 
tijdens CHIKV replicatie in de mug. 
Cellen van mensen en andere gewervelde dieren brengen eiwitten tot 
expressie die homoloog zijn aan Rasputin, genaamd Ras-GAP SH3 domain-
binding protein (G3BP) 1 en 2. Deze G3BP eiwitten zijn cruciale componenten 
van stress granula (SG). In stressvolle situaties reageert de cel door 
cytoplasmatische granula te vormen van RNA bindende eiwitten zoals G3BP, 
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mRNAs en translatie initiatie factoren. Het resultaat hiervan is een afname 
van de vertaling  van de meeste mRNAs. CHIKV nsP3 zorgt ervoor dat G3BP 
weliswaar naar granula migreert samen met nsP3, echter deze granula bevatten 
geen translatie initiatie factoren en gedragen zich niet als functionele SG. Deze 
experimenten laten zien dat er een antivirale rol bestaat voor SG die geremd 
wordt door CHIKV nsP3, maar ook dat de interactie met homoloog Rasputin 
een gunstig effect heeft op virale replicatie. 
In SG in cellen van gewervelden bevinden zich ook receptoren die 
specifieke patronen van pathogenen herkennen. Na activatie zorgen deze 
receptoren voor de activatie van de aangeboren immuniteit via de expressie 
van interferon (IFN). De IFN-respons is uiterst effectief als afweermechanisme 
tegen vele virussen inclusief CHIKV en WNV, maar de toediening van IFN 
gedurende een infectie heeft vaak weinig tot geen effect. Dit proefschrift 
laat zien dat CHIKV RNA replicatie-resistent is tegen IFN wanneer dit wordt 
toegediend na infectie en dat dit wordt veroorzaakt door onderdrukking van 
de JAK-STAT (Janus kinase-signal transducer and activator of transcription) 
signaaltransductie route door CHIKV. In een niet-geïnfecteerde cel wordt de 
JAK-STAT signaal transductieroute geactiveerd door IFNs en leidt dit normaliter 
tot de expressie van vele antivirale genen. Alphavirussen zoals CHIKV staan er 
om bekend de algemene genexpressie van de gastheer te verminderen. Hier 
laten we zien dat het nsP2 eiwit van CHIKV ook specifiek de JAK-STAT signaal 
transductieroute uitschakelt. Bovendien verschaffen we genetisch bewijs dat 
de C-terminus van CHIKV nsP2 een onafhankelijke  rol speelt in CHIKV RNA 
replicatie, de inhibitie van gastheer genexpressie en de blokkade van de JAK-
STAT signaal transductie route. Ook laten we zien dat de activatie en nucleaire 
translocatie van STAT eiwitten niet wordt aangetast door nsP2, maar dat de 
aanwezigheid van de C-terminus van nsP2 in de celkern voldoende is om STAT 
eiwitten voortijdig weer de celkern uit te sturen. Deze inhibitie speelt daarom 
hoogstwaarschijnlijk een grote rol in the pathogenese van CHIKV infecties. 
Tijdens de laatste fase van virale replicatie vinden de laatste modificaties 
aan de virale glycoproteïnen plaats in het endoplasmatisch reticulum (ER), 
alvorens deze naar het celmembraan getransporteerd worden. Het ER 
assisteert onder andere in de correcte vouwing van deze eiwitten. Wanneer er 
te veel eiwitten het ER moeten passeren, kunnen verkeerd gevouwen eiwitten 
accumuleren in het ER en de ‘ongevouwen eiwit respons’ (UPR, unfolded 
protein response) activeren. Alphavirus glycoproteïnes kunnen de UPR ook 
activeren. In een poging het aantal eiwitten in het ER te verminderen wordt dan 
algemene translatie verminderd met uitzondering van bepaalde eiwitten die 
assisteren bij vouwing. CHIKV infectie resulteerde in verminderde translatie 
via de fosforilatie van translatie initiatie factor eIF2α, maar zorgde niet voor 
de activatie van UPR-specifieke transcriptiefactoren en remde de expressie van 
UPR-specifieke genen. Individuele expressie van CHIKV eiwitten toonde aan 
dat nsP2 op zichzelf in staat was om de UPR te remmen. Door het aanbrengen 
van mutaties in nsP2 werd duidelijk dat het inhiberen van de genexpressie van 
de gastheer hieraan ten grondslag ligt. Samengevat laat dit zien dat de UPR in 
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eerste instantie geactiveerd wordt door CHIKV, maar dat nsP2 de downstream 
effecten van de UPR efficiënt weet te remmen. 
Concluderend beschrijft dit proefschrift in welke mate potentiële 
muggenpopulaties WNV en USUV kunnen overdragen en geeft het nieuwe 
inzichten in de moleculaire interacties die ervoor zorgen dat CHIKV succesvol 
zijn transmissiecyclus kan doorlopen. De effectieve uitschakeling van de 
JAK-STAT signaal transductie route, in combinatie met het inhiberen van 
de gastheer genexpressie verklaart waarom generieke antivirale middelen 
ineffectief zijn tegen CHIKV infecties. Dit suggereert dat de ontwikkeling van 
nieuwe antivirale middelen beter gericht kan worden op verbindingen met een 
meer specifieke werking. De interactie tussen CHIKV nsP3 en de Rasputin/
G3BP eiwitten van de gastheer vormt hierbij een potentieel aangrijpingspunt, 
aangezien het verstoren van deze interactie de stress-respons van de gastheer 
kan herstellen en CHIKV replicatie en transmissie remt.
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List of abbreviations
arbovirus arthropod-borne virus
AGO2 argonaute-2 
ATF Activating transcription factor 
Ae. Aedes
ActD actinomycin D
AP alkaline phosphatase
BiP Ca2+-dissociated heavy-chain binding protein 
CHOP DNA damage-inducible protein C/EBP-homologous protein 10 
C Capsid
CHIKV chikungunya virus
CPE cytopathic effects
Cx. Culex
CHX cycloheximide
CMV cytomegalo virus
CRM1 chromosome region maintenance 1 
DENV Dengue virus
Dcr-2 Dicer
dpi days post infection
dsRNA double-stranded RNA
EIP extrinsic incubation period 
eIF2α eukaryotic initiation factor 2α
EGFP enhanced green fluorescent protein
ER endoplasmic reticulum
E Envelope
FBS fetal bovine serum
Fluc firefly luciferase
FMDV Foot-and-mouth disease virus
G3BP Ras-GAP SH3 domain-binding protein
gRNA genomic RNA
GAS gamma activating sequence
Gr’10 WNV isolate Greece 2010
GRP glucose regulated protein
hpt hours post transfection
hpi hours post infection
IMD immune deficiency pathway
IFN interferon
IRF IFN response factor
IFNAR IFN alpha receptor
ISRE IFN-stimulated response element
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ISG IFN-stimulated gene
IRE1α inositol-requiring 1α
IFA immunofluorescence assay 
IU international units
JAK Jannus kinase
JEV Japanese encephalitis virus
LGTV Langat virus
LCCM Langerhans cell conditioned medium
MDA5 melanoma differentiation-associated gene 5 
mRNP messenger ribonucleoproteins 
MOI multiplicity of infection 
MEF mouse embryonic fibroblasts 
MIB midgut infection barrier 
MEB mesenteron escape barrier
nsP non-structural protein
NWE north-western Europe
NA North American
NLS nuclear localization signal
NY'99 WNV isolate New York 1999
NTF2 nuclear transport factor 2
OAS 2'-5'-oligoadenylate synthetase 2
ONNV O’nyong nyong virus 
ORF open reading frame
PB processing body
PxxPxR consensus sequence of SH3 domain-binding motif 
PKR protein kinase R
pfu plaque forming unit
PBS phosphate-buffered saline 
PERK protein kinase R-like ER kinase
PRR pattern recognition receptor
PIAS protein inhibitors of activated STAT1 
RIG-I retinoic acid-inducible gene I 
Rin Rasputin
RH relative humidity
RNA Ribonucleic acid
RNAi RNA interference
RC replication complex
RRM RNA recognition motif
RGG arginine glycine-rich box
Rluc Renila luciferase
RRV Ross River virus
RPB1 DNA-directed RNA polymerase II subunit rpb1
RT room temperature
RISC RNA silencing complex 
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siRNA small-interfering RNA 
SINV Sindbis virus
SFV Semliki Forest virus
SG stress granule
SDS sodium dodecyl sulfate 
sf Spodoptera frugiperda
SH-3 Src homology-3
sgRNA subgenomic RNA 
STAT Signal Transducers and Activators of Transcription 
S spliced XBP1 mRNA
SLEV St Louis encephalitis virus 
sfRNA subgenomic flavivirus RNA 
ssRNA single-stranded RNA
TCID tissue culture infectious dose
tm tunicamycin
T total XBP1 mRNA
TIA-1 T cell intracellular antigen-1 
TIAR TIA1-related protein 
TLR Toll-like receptor
Tyk 2 Tyrosine kinase 2
TBEV tick borne encephalitis virus 
U unspliced XBP1 mRNA
USUV Usutu virus
UTR untranslated region 
UPR unfolded protein response 
VC vectorial capacity 
VSR viral suppressors of RNAi 
viRNA virus-derived siRNA 
VEEV Venezuelan Equine Encephalitis virus 
WNV West Nile virus
WB western blot
XBP1 X-box binding protein 1 
YFV yellow fever virus
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Dankwoord
In eerste instantie was ik niet van plan om in Wageningen te gaan promoveren, 
maar tijdens mijn MSc thesis bij virologie werd al snel duidelijk dat je op een 
hele prettige manier onderzoek kunt doen in Wageningen. De sfeer van de hele 
groep, de manier van werken en de mogelijkheid een eigen invulling aan het 
project te geven hebben me destijds toch overgehaald in Wageningen te blijven 
en het promotietraject in te gaan. Vier jaar zijn in rap tempo voorbij gevlogen, 
maar kunnen niet besloten worden voordat ik een poging heb gedaan om 
iedereen te bedanken voor zijn/haar bijdrage aan dit proefschrift.
Op de eerste plaats wil ik Gorben bedanken. Als begeleider van mijn MSc 
thesis was jij voor een groot deel verantwoordelijk voor de goede indruk die het 
laboratorium van virologie destijds bij mij heeft achtergelaten. Als klap op de 
vuurpijl wist je ook mijn promotieplek te creëren en mij  over te halen om toch 
maar in Wageningen te blijven. Terugkijkend heb ik van die keuze absoluut 
geen spijt. De afgelopen vier jaar verliepen naar mijn mening erg soepel en 
onze samenwerking was wat mij betreft meer dan uitstekend. Zo creëer je voor 
al je AIOs de ruimte en middelen voor verdere ontwikkeling en ben je altijd 
te porren voor gekke nieuwe experimenten. Zet daarnaast alle internationale 
werkbesprekingen en conferenties, waar de vele nieuwe wetenschappelijke 
inzichten en contacten die alleen maar voorbijgestreefd werden door het aantal 
nieuwe rondjes en je bent wat mij betreft een ideale begeleider. Om maar met 
de bekende laatste woorden te eindigen: Bedankt Chef!
Een promotie kan natuurlijk niet zonder promotor, of in dit geval promotoren. 
Just en Willem, ik wil jullie dan ook hartelijk bedanken dat jullie dit project 
mede mogelijk hebben gemaakt. Op de momenten dat het nodig was waren 
jullie altijd aanwezig en met name tijdens de laatste fase, het afronden van het 
proefschrift, waren jullie vlot met commentaar en suggesties en was er altijd 
minstens één van jullie paraat. Ik hoor weleens dat er een inverse correlatie 
bestaat tussen het aantal begeleiders en het succes van het project, maar niets 
is minder waar. Beide heren professoren, heel erg bedankt!    
Sander, jij hebt natuurlijk ook een grote bijdrage geleverd tijdens het opzetten 
van dit project en het BSL3 laboratorium. Buiten dat om, waren de eerste 
twee hoofdstukken van het proefschrift nooit tot stand gekomen zonder jouw 
muggenlijnen en input. Succes met het vervolg van het vectoren werk en ik hoop 
dat ik heb kunnen bijdragen aan een vruchtbare toekomstige samenwerking 
tussen entomologie en  virologie. 
Chantal, ook jij hebt natuurlijk enorm bijgedragen aan de eerste twee 
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hoofdstukken van dit proefschrift. Je kreeg het altijd voor elkaar om zelfs mijn 
meest slecht geplande experimenten van voldoende muggen te voorzien, heel 
erg bedankt daarvoor. Je bent nu zelf ook al een tijdje flink uren aan het maken 
in het BSL3 en ik weet zeker dat daar straks een mooi proefschrift uit komt. 
Succes!
Dan mevrouw de professor, Monique: ook al was je niet direct betrokken bij 
mijn project, vaak naar aanleiding van een maandagochtendseminar hebben 
we toch een aantal goede discussies gehad. Na de wisseling van de wacht op 
virologie heb je ook een aantal zaken voor mij persoonlijk heel goed weten te 
regelen, waarvoor veel dank! 
Dan zijn we aanbeland bij de vrouw die alleen maar bestaat uit rechterhanden, 
Corinne. Niet alleen ben je een enorm efficiënte labmanager en kundige analist 
voor de hele arbo-groep, maar ook een goede vriendin en chauffeur. Ik kon bij 
jou altijd mee rijden, zelfs met racefiets en bakken yoghurt en dan in de auto 
nog eens heerlijk klagen over alle andere gekken (…) achter het stuur. Mislukte 
kloneer exercities werden feilloos opgelost en titraties in het BSL3 lab gingen 
twee keer zo snel met jouw hulp. Helaas voor mij kon je de laatste tijd niet meer 
helpen in het BSL3, maar dat is je uiteraard vergeven. Ik wil jou en Simon dan 
ook nog heel veel plezier wensen met Pepino pequeño en jullie moeten maar 
eens snel whisky (en appelsap) komen drinken.
Mia, jij stond letterlijk altijd aan mijn zijde. Het zal wel even wennen zijn om 
het straks zonder dat gezellige gekakel te moeten stellen. Niet alleen op het lab, 
maar ook in de kroeg was je altijd goed gezelschap. Nu ik niet meer naast je sta 
te pipetteren moeten we maar zo vaak mogelijk in de kroeg afspreken. Maar ook 
de etentjes, taartjes, worstenbroodjes en reserve tandenborstels zijn absoluut 
niet vergeten. Hopelijk kunnen we straks de rollen omdraaien en kom je bij mij 
op visite en wie weet, als jij je vierkante broek aan trekt kun je misschien wel 
verblijven in een grote ananas. Dat er over een jaar een goed boekje ligt is zeker. 
Hopelijk komt daar de laatste grote knaller ook nog in, succes!    
Stefan sinds jij ons hebt verlaten miste ik toch wel een bepaald soort humor op 
de werkvloer. Ook de scherpe discussies, de lekkere nummertjes en de galmende 
stem van Elvis in het lab hebben enorm bijgedragen aan dit proefschrift. Je bent 
al lekker aan het knallen in het beloofde land, maar mocht je in de buurt zijn, 
staat er altijd een goed glas whisky klaar.  
Double doctor Amaya, when you took Stefan’s desk, officially surrounding 
me with only women, I must admit, I feared the worst (notice the correct use 
of the word worst), but you proved to be a wonderful addition to our corner. 
You have become a good friend and I hope to see you more often either in the 
Netherlands, Scotland or Spain!  
Giel, ik weet zeker dat de arbo-groep met jou weer een paar jaar aan de weg kan 
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timmeren. Daarnaast ben je ook een gezellige aanwinst en heb je de vrouwelijke 
ban van de arbo-groep weten te doorbreken. Natuurlijk ben ik niet alleen maar 
altruïstisch, ik ben ook heel blij dat zo’n goed opgeleide MSc een aantal van 
mijn lopende projecten en pilot proeven een goed vervolg kan gaan geven. Heel 
veel succes, maar dat komt vast wel goed.     
Dryas, Athos, Paulus, Han, Stineke and Patrick, you all have been around 
the virology lab together with me for a substantial amount of time. You are an 
incredibly colourful bunch and I had lots of fun making movies, playing soccer, 
having drinks, or just chit-chatting around the lab and coffee table. Athos; you 
are particularly colourful, with your dark humour. I have really enjoyed all of 
your complaining. I guess you’re up next, so good luck mate. Corien en Bob, 
onze tijd samen is erg kort geweest, maar ik vond het leuk om toch nog even de 
nieuwe viro lieden te hebben leren kennen.  
De rest van de vaste staf, Vera, Richard, Jan, Marleen, Dick, Dick, Els en 
Hanke, er is niemand van jullie die niet heeft bijgedragen in gezelligheid of 
wetenschap. Dus heel erg bedankt daarvoor. 
Dan wil ik al mijn MSc en BSc studenten bedanken. Jullie hebben in meer of 
mindere mate je steentje bijgedragen aan dit proefschrift. Helaas heb ik niet al 
jullie werk kunnen opnemen, maar het wordt daarom niet minder gewaardeerd. 
Erika, Hetty, Jeroen, Christel, Ruud, Sabine, Sabine, Sjoerd, Wouter, 
Leontien en Daniël heel erg bedankt. In addition I have to thank three other 
ex-MSc students of virology:  Jacky, Jim en Natalia. Your work has greatly 
contributed to this thesis, it is still fruitful today, and without it we would have 
never been on the cover of JVI!
Besides the people at virology and entomology in Wageningen I cannot forget 
the growing list of collaborators, from which I just want to highlight Martijn, 
Florine, Andreas, Lee, Alex, Ronald, Pascal, Ab, Byron, Anna-Bella and 
Karima. Thanks for all your experimental contributions, input, and discussions 
and I am looking forward to more collaborations in the future. 
Then I would also like to thank all the people who made my time in Wageningen 
enjoyable. With a special mentioning of Olaf, Pier, Marco and partners. The 
sexy pasta, dinner parties, Mario cart and our poor choice in action movies will 
not be forgotten. Bart, Bas, Bosse en de Wajos met barbecues, fietstochtjes 
en de laatste jaren vooral het jaarlijkse Wajo weekend als hoogtepunt. Volgende 
keer in Schotland! The members of the tripod, Jeroen, Peter en Marcela. We 
have already been to most continents together sharing some great experiences 
and sometimes tiny little tents. Marcelita you are the fourth, smallest and most 
talkative member of the tripod and I have the deepest respect for your ability 
to withstand our company and still smile as much as you do! Jeroen bij jou 
stond de deur altijd voor me open en Peter, wie had ooit gedacht dat we nog 
eens als coauteurs op een manuscript zouden staan. Wat ik vooral wil zeggen 
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is enorm bedankt voor alle fitness, bier en bitterballen sessies, het was niet het 
zelfde geweest zonder jullie. You guys will keep hearing from me when I visit 
the Netherlands, and I propose that we keep doing what we do best, Cheers! 
Lieve Pa en Ma, de wetenschap werd er thuis al vroeg ingebracht, of we nu een 
hut wilden bouwen of weer een maf huisdier wilden onderhouden, zolang er 
van te voren voldoende onderzoek naar gedaan werd was bijna alles mogelijk. 
Jullie onvoorwaardelijke steun heeft er voor gezorgd dat (ik nog altijd denk dat) 
nog steeds bijna alles mogelijk is. Daarnaast heeft de Fros farm zich de laatste 
jaren ontwikkeld tot een rustiek landhuis waar ik altijd mijn toevlucht kon 
zoeken als ik weer eens te lang in het lab had gestaan of niet meer naar huis 
kon rijden na een uit de hand gelopen vrijdagmiddagborrel. Ik wil jullie en ook 
de rest van de familie daar dan ook heel erg voor bedanken. In het bijzonder, 
Fenke, jij hebt fantastisch werk geleverd om mijn ideeën om te zetten in een, 
naar mijn mening, hele mooie cover.    
  
Annelientje, ik mag van geluk spreken dat je het al zo lang met mij uit weet 
te houden, dat is pas een echte prestatie. Ontzettend bedankt voor de leuke 
tijd die we hebben gehad en ik weet zeker dat er nog veel zullen volgen. Ook 
je familie mag ik niet vergeten, jullie stonden altijd paraat voor taalkundig 
advies, een goed glas wijn, barbecue of andere gezelligheid. Bedankt allemaal!

C
u
rr
ic
u
lu
m
 V
it
a
e
Curriculum Vitae
190
About the author
Jelke Jan Fros was born on December 25th, 1985 in Ede. After attending 
primary and high school in Wageningen, he started his studies in Psychology 
at the University of Groningen in 2004. After completion of the first year, he 
switched to Life Sciences and Technology in 2005, whereupon he completed 
his Bachelor’s degree with an internship at TNO in 2008. He then returned to 
Wageningen for his Master’s degree in Biotechnology at Wageningen University. 
He researched and wrote his thesis on ‘the inhibition of the JAK-STAT pathway 
by chikungunya virus non-structural proteins’ at the laboratory of virology in 
Wageningen, for which he won the MSc thesis award from the Wageningen 
University Fund. After this he started an internship at the QIMR Berghofer 
medical research institute in Brisbane, Australia, under the supervision of prof. 
A. Suhrbier, working on chikungunya virus and the unfolded protein response. 
He graduated cum laude in 2010 and continued his research on arboviruses 
in a collaborative PhD between the laboratories of Virology and Entomology 
at Wageningen University, under the supervision of prof. J.M. Vlak, prof. W. 
Takken and dr. G.P. Pijlman. During this time, he performed experiments with 
chikungunya and West Nile virus infections in both mammalian and insect 
cell culture systems as well as in live mosquitoes. His research led to various 
publications, and was presented at several international scientific conferences, 
including the chikungunya 2013 conference for which he received the young 
investigators award. After receiving his doctoral degree, Jelke will spend four 
weeks in Sierra Leone, contributing to diagnostics for the detection of ebola 
virus. He will then start his post-doctoral research at the Roslin Institute in 
Edinburgh, under supervision of prof. P. Simmonds. 
Curriculum Vitae
191
List of Publications
Fros, Jelke J, Lee D Major, Florine E M Scholte, Joy Gardner, Martijn J van 
Hemert, Andreas Suhrbier, and Gorben P Pijlman. 2014. “Chikungunya Virus 
nsP2-Mediated Host Shut-off Disables the Unfolded Protein Response.” 
The Journal of General Virology 96 (Pt 3): 580-9.
Van Cleef, Koen W R, Joël T van Mierlo, Pascal Miesen, Gijs J Overheul, Jelke 
J Fros, Susan Schuster, Marco Marklewitz, Gorben P Pijlman, Sandra Junglen, 
and Ronald P van Rij. 2014. “Mosquito and Drosophila Entomobirnaviruses 
Suppress dsRNA- and siRNA-Induced RNAi.” Nucleic Acids Research 42 (13): 
8732–44.  
Fros, Jelke J, Erika van der Maten, Just M Vlak, and Gorben P Pijlman. 2013. 
“The C-Terminal Domain of Chikungunya Virus nsP2 Independently 
Governs Viral RNA Replication, Cytopathicity, and Inhibition of 
Interferon Signaling.” Journal of Virology 87 (18): 10394–400.
Fros, Jelke J, Natalia E Domeradzka, Jim Baggen, Corinne Geertsema, Jacky 
Flipse, Just M Vlak, and Gorben P Pijlman. 2012. “Chikungunya Virus nsP3 
Blocks Stress Granule Assembly by Recruitment of G3BP into Cytoplasmic 
Foci.” Journal of Virology 86 (19): 10873–9. 
Fros, Jelke J, Wen Jun Liu, Natalie A Prow, Corinne Geertsema, Maarten 
Ligtenberg, Dana L Vanlandingham, Esther Schnettler, Just M Vlak, Andreas 
Suhrbier, Alexander A Khromykh, and Gorben P Pijlman. 2010. “Chikungunya 
Virus Nonstructural Protein 2 Inhibits Type I/II Interferon-Stimulated 
JAK-STAT Signaling.” Journal of Virology 84 (20): 10877–87. 
Fros, Jelke J, Corinne Geertsema, Chantal B Vogels, Peter P Roosjen, Anna-
Bella Failloux, Just M Vlak, Constantianus J Koenraadt, Willem Takken and 
Gorben P Pijlman. “West Nile virus: High chance of transmission by 
north-western European mosquitoes warrants increased surveillance 
and awareness.” Submitted.
Fros, Jelke J, Chantal B Vogels, Constantianus J Koenraadt, Willem Takken and 
Gorben P Pijlman. “Usutu virus, highly transmissible by common house 
mosquitoes and a prelude to WNV activity in Europe.” Manuscript in prep.
Fros, Jelke J, Corinne Geertsema, Karima Zouache, Jim Baggen, Natalia 
Domeradzka, Jacky Flipse, Just M Vlak, Anna-Bella Failloux and Gorben P 
Pijlman. “Mosquito Rasputin interacts with chikungunya virus nsP3 and 
determines the infection rate in Aedes albopictus.” Manuscript in prep.
Curriculum Vitae
192
Training activities
Review of literature and writing of the project proposal
Arbovirus-host interactions 
Post-graduate courses, competence strengthening and laboratory 
training 
Safe handling of radioactive materials and sources 
Hands-on molecular graphics 
ISGlobal course on arboviral diseases
Bedrijfshulpverlening
Making great scientific illustrations
Working with mosquitoes under biosafety level 3 conditions at the Institute 
Pasteur 
Invited review of (unpublished) journal manuscript 
Archives of Virology
Journal of Virology 
PLoS NTD
International conferences and other scientific meetings
American society of virology 31 annual conference, USA (2012)*
22nd Annual meeting of the society for virology, Germany (2012)*
Gordon conference, viruses and cells, Italy (2013)**
Chikungunya, Malaysia (2013)*
American society of virology 33 annual conference, USA (2014)*
Yearly entomology laboratory research exchange meeting (2011)*
FP7 Vectorie meetings (2011-2013)
Dutch annual virology symposium (2011-2014)
FP7 Vectorie workshop (2013)
PE&RC Days (2011-2015)
Teaching activities
Cell biology and health (2011, 2012)
Molecular virology (2011-2013)
Immunotechnology (2013, 2014, 2015)
Supervision of 10 MSc and 2 BSc students during their thesis
* Oral, ** Poster
The research described in this thesis was carried out at the Laboratories of 
Virology and Entomology at Wageningen University, The Netherlands, and was 
financially supported by the European 195 Community’s Seventh Framework 
Programme (FP7 VECTORIE project number 261466).
Cover
Fotographs: Mosquitoes Hans Smid (Bugsinthepicture.com), Microscopy 
Jelke J. Fros. Design: Fenke N. Fros and Jelke J. Fros
Printed by Gildeprint Drukkerijen, Enschede, The Netherlands 

